,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
R-HSA-1799339,R-HSA-1799339,SRP-dependent cotranslational protein targeting to membrane,74/379,108/8183,4.60586462728722e-75,4.27424237412254e-72,3.04471893256461e-72,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/SEC11C/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/SSR4/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/SPCS1/RPL26/RPL11/SEC61B/RPS21/RPL37A/RPN2/RPN1/RPL23A/SEC11A/RPL27/RPL7/RPL37/SRP14/SSR2/RPS11/RPL21/RPS27/RPL31/RPS25,74
R-HSA-156902,R-HSA-156902,Peptide chain elongation,66/379,85/8183,5.59560008153645e-73,2.59635843783291e-70,1.84949307958152e-70,RPLP1/RPL41/RPS15/EEF1A1/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/RPL11/RPS21/RPL37A/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,66
R-HSA-156842,R-HSA-156842,Eukaryotic Translation Elongation,67/379,89/8183,1.82239758837206e-72,5.63728320669756e-70,4.01566907192158e-70,RPLP1/RPL41/RPS15/EEF1A1/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/EEF1B2/RPL22/RPL13/RPL35/RPL26/RPL11/RPS21/RPL37A/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,67
R-HSA-192823,R-HSA-192823,Viral mRNA Translation,65/379,85/8183,4.58195186866035e-71,1.0630128335292e-68,7.572278351365e-69,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/RPL11/RPS21/RPL37A/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,65
R-HSA-72764,R-HSA-72764,Eukaryotic Translation Termination,66/379,89/8183,1.32100749720583e-70,2.45178991481402e-68,1.74651096472687e-68,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/TRMT112/RPL11/RPS21/RPL37A/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,66
R-HSA-2408557,R-HSA-2408557,Selenocysteine synthesis,65/379,89/8183,9.01001033359602e-69,1.39354826492952e-66,9.92681840262859e-67,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/RPL11/RPS21/RPL37A/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,65
R-HSA-975956,R-HSA-975956,Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC),65/379,91/8183,1.05018774560202e-67,1.39224889702668e-65,9.9175624697454e-66,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/RPL11/RPS21/RPL37A/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,65
R-HSA-72689,R-HSA-72689,Formation of a pool of free 40S subunits,66/379,97/8183,1.77365947529227e-66,2.05744499133903e-64,1.46560282958361e-64,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/EIF3E/RPL11/RPS21/RPL37A/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,66
R-HSA-156827,R-HSA-156827,L13a-mediated translational silencing of Ceruloplasmin expression,66/379,107/8183,3.76812333003648e-62,3.88535383363762e-60,2.76769760381627e-60,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/EIF3E/RPL11/RPS21/RPL37A/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,66
R-HSA-72706,R-HSA-72706,GTP hydrolysis and joining of the 60S ribosomal subunit,66/379,108/8183,9.31969897061685e-62,8.64868064473244e-60,6.16081153004988e-60,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/EIF3E/RPL11/RPS21/RPL37A/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,66
R-HSA-927802,R-HSA-927802,Nonsense-Mediated Decay (NMD),66/379,111/8183,1.29630053230139e-60,1.00247241164641e-58,7.14102398495854e-59,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/RPL11/RPS21/RPL37A/RPL23A/MAGOH/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,66
R-HSA-975957,R-HSA-975957,Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC),66/379,111/8183,1.29630053230139e-60,1.00247241164641e-58,7.14102398495854e-59,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/RPL11/RPS21/RPL37A/RPL23A/MAGOH/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,66
R-HSA-2408522,R-HSA-2408522,Selenoamino acid metabolism,66/379,113/8183,7.01994394774436e-60,5.0111599873129e-58,3.56965570784086e-58,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/RPL11/RPS21/RPL37A/RPL23A/AIMP1/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,66
R-HSA-72613,R-HSA-72613,Eukaryotic Translation Initiation,66/379,115/8183,3.61974875566237e-59,2.23941789683645e-57,1.59522962705682e-57,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/EIF3E/RPL11/RPS21/RPL37A/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,66
R-HSA-72737,R-HSA-72737,Cap-dependent Translation Initiation,66/379,115/8183,3.61974875566237e-59,2.23941789683645e-57,1.59522962705682e-57,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/EIF3E/RPL11/RPS21/RPL37A/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,66
R-HSA-168255,R-HSA-168255,Influenza Life Cycle,71/379,139/8183,7.65147087807889e-59,4.43785310928576e-57,3.16126559962733e-57,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/POLR2G/RPL35/RPL26/CALR/POLR2L/RPL11/RPS21/HSPA1B/RPL37A/RPL23A/SEC13/HSPA1A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,71
R-HSA-9010553,R-HSA-9010553,Regulation of expression of SLITs and ROBOs,75/379,162/8183,4.03058202894855e-58,2.20022360168486e-56,1.56730991590074e-56,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/PSMA7/RPL11/RPS21/RPL37A/PSMA4/RPL23A/PSMB8/MAGOH/PSMB7/RPL27/RPL7/ELOB/PSMC3/RPL37/UBB/PSMC5/PSMD13/RPS11/RPL21/RPS27/RPL31/RPS25,75
R-HSA-168273,R-HSA-168273,Influenza Viral RNA Transcription and Replication,68/379,129/8183,1.52458110801726e-57,7.86006260133344e-56,5.59904640839088e-56,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/POLR2G/RPL35/RPL26/POLR2L/RPL11/RPS21/RPL37A/RPL23A/SEC13/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,68
R-HSA-168254,R-HSA-168254,Influenza Infection,71/379,149/8183,4.51732983398484e-56,2.20635899259891e-54,1.57168040761356e-54,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/POLR2G/RPL35/RPL26/CALR/POLR2L/RPL11/RPS21/HSPA1B/RPL37A/RPL23A/SEC13/HSPA1A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,71
R-HSA-72766,R-HSA-72766,Translation,93/379,287/8183,9.08533551325038e-56,4.21559567814818e-54,3.00294247490592e-54,RPLP1/RPL41/RPS15/EEF1A1/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/SEC11C/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/SSR4/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/EEF1B2/RPL22/RPL13/RPL35/SPCS1/RPL26/TRMT112/EIF3E/RPL11/SEC61B/MRPL13/RPS21/RPL37A/RPN2/RPN1/MRPL24/MRPL52/RPL23A/SEC11A/MRPL22/MRPL55/MRPL17/MRPL2/AIMP1/MRPL3/MRPL40/MRPS18A/MRPL54/MRPS35/MRPL11/RPL27/RPL7/RPL37/SRP14/SSR2/PPA1/RPS11/RPL21/RPS27/RPL31/RPS25,93
R-HSA-376176,R-HSA-376176,Signaling by ROBO receptors,77/379,205/8183,2.51069790720265e-51,1.10948936089717e-49,7.90334980312414e-50,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/PSMA7/RHOA/RPL11/RPS21/RPL37A/PSMA4/RPL23A/PFN1/PSMB8/MAGOH/PSMB7/RPL27/RPL7/ELOB/PSMC3/RPL37/UBB/PSMC5/PSMD13/RPS11/RPL21/RPS27/RPL31/RPS25,77
R-HSA-5663205,R-HSA-5663205,Infectious disease,92/379,362/8183,5.92940388890963e-45,2.50113036768552e-43,1.78165820202643e-43,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/PPIA/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/B2M/RPL10A/RPL36/RPLP2/RPL3/HSP90AB1/RPL22/RPL13/CD9/POLR2G/RPL35/RPL26/PSMA7/CALR/POLR2L/RPL11/NELFE/BANF1/RPS21/HSPA1B/RPL37A/PSMA4/RPL23A/SEC13/HSPA1A/PSMB8/NPM1/CALM3/PSMB7/RPL27/RPL7/SUPT4H1/ELOB/PSMC3/RPL37/UBB/PSMC5/PSMD13/RPS11/RPL21/SKP1/RPS27/CALM2/MET/RPL31/RPS25,92
R-HSA-6791226,R-HSA-6791226,Major pathway of rRNA processing in the nucleolus and cytosol,66/379,179/8183,3.08631016751199e-43,1.24525905889179e-41,8.87049329609852e-42,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/RPL11/RPS21/RPL37A/SNU13/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,66
R-HSA-8868773,R-HSA-8868773,rRNA processing in the nucleus and cytosol,67/379,189/8183,1.30466159822026e-42,5.04469151311834e-41,3.59354159509791e-41,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/TRMT112/RPL11/RPS21/RPL37A/SNU13/RPL23A/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,67
R-HSA-72312,R-HSA-72312,rRNA processing,68/379,198/8183,3.24922644770193e-42,1.20611285738696e-40,8.59163877539711e-41,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/TRMT112/RPL11/RPS21/RPL37A/SNU13/RPL23A/HSD17B10/RPL27/RPL7/RPL37/RPS11/RPL21/RPS27/RPL31/RPS25,68
R-HSA-71291,R-HSA-71291,Metabolism of amino acids and derivatives,81/379,320/8183,3.35435019037556e-39,1.19724499102635e-37,8.52846930994273e-38,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/RPL22/RPL13/RPL35/RPL26/PSMA7/CKB/PCBD1/TSTD1/RPL11/RPS21/RPL37A/PSMA4/PDHB/RPL23A/PSMB8/AIMP1/HSD17B10/PSMB7/RPL27/RPL7/APIP/PSMC3/RPL37/PSMC5/OAZ1/PSMD13/RPS11/RPL21/RPS27/RPL31/GAMT/RPS25,81
R-HSA-422475,R-HSA-422475,Axon guidance,91/379,498/8183,4.95613045476981e-32,1.70344039334311e-30,1.21343077021265e-30,RPLP1/RPL41/RPS15/RPS18/RPS3A/RPS4X/RPLP0/RPS8/RPS27A/RPL10/RPS14/RPL8/RPL19/RPS12/RPL28/RPL18/RPS13/RPL15/RPS23/RPS19/RPL7A/RPL29/RPS15A/RPS5/RPL32/RPS28/RPL18A/RPSA/RPS6/RPL6/RPS9/RPL14/RPS7/UBA52/RPL39/RPL12/RPL30/RPS24/RPL24/RPS26/RPL5/ACTG1/RPS3/RPL9/RPL35A/RPS16/RPL10A/RPL36/RPLP2/RPL3/HSP90AB1/RPL22/RPL13/RPL35/RPL26/PSMA7/RHOA/RPL11/RPS21/RPL37A/MYL12B/NCSTN/PSMA4/RPL23A/MYL6/PFN1/PSMB8/CD24/MAGOH/PSMB7/ARPC5/MYL12A/RPL27/PSENEN/RPL7/ACTB/CFL1/ELOB/PSMC3/RPL37/UBB/PSMC5/PSMD13/RPS11/RPL21/RPS27/SEMA3E/MET/RPL31/RPS25/TUBA1B,91
R-HSA-72695,R-HSA-72695,Formation of the ternary complex, and subsequently, the 43S complex,27/379,50/8183,1.54897937317725e-23,5.13376020824459e-22,3.6569888960726e-22,RPS15/RPS18/RPS3A/RPS4X/RPS8/RPS27A/RPS14/RPS12/RPS13/RPS23/RPS19/RPS15A/RPS5/RPS28/RPSA/RPS6/RPS9/RPS7/RPS24/RPS26/RPS3/RPS16/EIF3E/RPS21/RPS11/RPS27/RPS25,27
R-HSA-72649,R-HSA-72649,Translation initiation complex formation,27/379,57/8183,1.49318757521471e-21,4.61892689933084e-20,3.29025192012224e-20,RPS15/RPS18/RPS3A/RPS4X/RPS8/RPS27A/RPS14/RPS12/RPS13/RPS23/RPS19/RPS15A/RPS5/RPS28/RPSA/RPS6/RPS9/RPS7/RPS24/RPS26/RPS3/RPS16/EIF3E/RPS21/RPS11/RPS27/RPS25,27
R-HSA-72702,R-HSA-72702,Ribosomal scanning and start codon recognition,27/379,57/8183,1.49318757521471e-21,4.61892689933084e-20,3.29025192012224e-20,RPS15/RPS18/RPS3A/RPS4X/RPS8/RPS27A/RPS14/RPS12/RPS13/RPS23/RPS19/RPS15A/RPS5/RPS28/RPSA/RPS6/RPS9/RPS7/RPS24/RPS26/RPS3/RPS16/EIF3E/RPS21/RPS11/RPS27/RPS25,27
R-HSA-72662,R-HSA-72662,Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S,27/379,58/8183,2.67722994218687e-21,8.01441737532069e-20,5.70899967298253e-20,RPS15/RPS18/RPS3A/RPS4X/RPS8/RPS27A/RPS14/RPS12/RPS13/RPS23/RPS19/RPS15A/RPS5/RPS28/RPSA/RPS6/RPS9/RPS7/RPS24/RPS26/RPS3/RPS16/EIF3E/RPS21/RPS11/RPS27/RPS25,27
R-HSA-163200,R-HSA-163200,Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.,29/379,110/8183,7.02465433698156e-15,2.03714975772465e-13,1.45114569856066e-13,NDUFS5/COX6A1/COX8A/UQCR11/UQCRH/ATP5MC2/COX5B/NDUFAF3/SDHB/NDUFB2/ATP5MF/NDUFA6/NDUFB11/NDUFB4/COX14/NDUFA13/COX7C/COX6C/NDUFC2/NDUFB1/NDUFB9/COX5A/ATP5F1B/COX4I1/ATP5MG/COX6B1/NDUFA4/UQCRQ/ATP5MC3,29
R-HSA-1428517,R-HSA-1428517,The citric acid (TCA) cycle and respiratory electron transport,33/379,158/8183,1.35785008986356e-13,3.81843904058602e-12,2.72003143998188e-12,NDUFS5/COX6A1/COX8A/BSG/UQCR11/UQCRH/ATP5MC2/COX5B/NDUFAF3/SUCLG1/PDHB/SDHB/NDUFB2/ATP5MF/NDUFA6/NDUFB11/NDUFB4/COX14/NDUFA13/COX7C/COX6C/NDUFC2/NDUFB1/NDUFB9/COX5A/ATP5F1B/COX4I1/ATP5MG/COX6B1/NDUFA4/UQCRQ/LDHA/ATP5MC3,33
R-HSA-611105,R-HSA-611105,Respiratory electron transport,24/379,90/8183,1.22387102569086e-12,3.3404479760033e-11,2.37953871248874e-11,NDUFS5/COX6A1/COX8A/UQCR11/UQCRH/COX5B/NDUFAF3/SDHB/NDUFB2/NDUFA6/NDUFB11/NDUFB4/COX14/NDUFA13/COX7C/COX6C/NDUFC2/NDUFB1/NDUFB9/COX5A/COX4I1/COX6B1/NDUFA4/UQCRQ,24
R-HSA-1236974,R-HSA-1236974,ER-Phagosome pathway,18/379,78/8183,1.06218910614717e-08,2.81631854429879e-07,2.00617972529451e-07,RPS27A/UBA52/B2M/HLA-C/PSMA7/CALR/HLA-A/SEC61B/PSMA4/VAMP8/HLA-B/PSMB8/PSMB7/PDIA3/PSMC3/UBB/PSMC5/PSMD13,18
R-HSA-1236975,R-HSA-1236975,Antigen processing-Cross presentation,19/379,89/8183,1.6297411607048e-08,4.2011105475946e-07,2.99262411965677e-07,RPS27A/UBA52/B2M/HLA-C/PSMA7/CALR/HLA-A/SEC61B/PSMA4/VAMP8/CTSL/HLA-B/PSMB8/PSMB7/PDIA3/PSMC3/UBB/PSMC5/PSMD13,19
R-HSA-6798695,R-HSA-6798695,Neutrophil degranulation,40/379,379/8183,7.15218102692592e-07,1.79384432242899e-05,1.27782921334551e-05,FTH1/EEF1A1/MIF/PPIA/B2M/GSTP1/FTL/HSP90AB1/CD63/HLA-C/HSPA6/NPC2/ATP6AP2/PRDX4/RHOA/HSPA1B/HEXB/DYNLT1/NCSTN/RAB7A/VAMP8/TMEM179B/HLA-B/HSPA1A/RNASET2/SERPINB1/PSMB7/APRT/NEU1/ARPC5/DYNLL1/ATP6V1D/NDUFC2/CST3/PSMC3/SRP14/PSMD13/SERPINB12/TUBB/DYNC1H1,40
R-HSA-1168372,R-HSA-1168372,Downstream signaling events of B Cell Receptor (BCR),15/379,78/8183,2.21307070603818e-06,5.40455161895641e-05,3.849884773939e-05,RPS27A/PPIA/UBA52/PSMA7/FKBP1A/PSMA4/PSMB8/CALM3/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1/CALM2,15
R-HSA-5628897,R-HSA-5628897,TP53 Regulates Metabolic Genes,15/379,81/8183,3.63307392212784e-06,8.64485281983239e-05,6.15808481267553e-05,COX6A1/COX8A/PRDX5/COX5B/TXN/COX14/PRDX2/COX7C/LAMTOR4/COX6C/COX5A/COX4I1/COX6B1/NDUFA4/RRAGC,15
R-HSA-450408,R-HSA-450408,AUF1 (hnRNP D0) binds and destabilizes mRNA,12/379,54/8183,4.80210178973393e-06,0.000111408761521827,7.93610506303397e-05,RPS27A/UBA52/PSMA7/HSPA1B/PSMA4/HSPA1A/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,12
R-HSA-8953897,R-HSA-8953897,Cellular responses to external stimuli,44/379,470/8183,5.08447222894285e-06,0.000115082688498999,8.19781401739694e-05,EEF1A1/RPS27A/H3F3A/UBA52/GSTP1/HSP90AB1/ANAPC11/PRDX5/PSMA7/HSPA6/MT1G/TXN/HSPA1B/MT1E/PSMA4/SEC13/RPS19BP1/HSPA1A/DNAJB1/BAG1/PSMB8/SCMH1/ATOX1/PSMB7/PRDX2/LAMTOR4/DYNLL1/NUDT2/SOD1/DCTN2/MT1F/ELOB/PSMC3/UBB/PSMC5/TOMM7/PSMD13/MT2A/TUBA1B/RRAGC/DYNC1H1/CA9/MT1X/HIST1H1C,44
R-HSA-180534,R-HSA-180534,Vpu mediated degradation of CD4,11/379,49/8183,1.0809838557008e-05,0.000238845956688178,0.000170139814882232,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-114608,R-HSA-114608,Platelet degranulation ,16/379,103/8183,1.8178139556501e-05,0.000392309616475185,0.000279458302117078,PPIA/TIMP1/CD9/LGALS3BP/CD63/MANF/PFN1/CALM3/MAGED2/SOD1/HGF/CFL1/TMSB4X/ANXA5/CALM2/CLU,16
R-HSA-180585,R-HSA-180585,Vif-mediated degradation of APOBEC3G,11/379,52/8183,1.97709432268569e-05,0.000407720784767181,0.000290436312198038,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/ELOB/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-8854050,R-HSA-8854050,FBXL7 down-regulates AURKA during mitotic entry and in early mitosis,11/379,52/8183,1.97709432268569e-05,0.000407720784767181,0.000290436312198038,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-174113,R-HSA-174113,SCF-beta-TrCP mediated degradation of Emi1,11/379,53/8183,2.39288514184168e-05,0.000482738567745453,0.000343874569582741,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-76005,R-HSA-76005,Response to elevated platelet cytosolic Ca2+,16/379,106/8183,2.62820861337777e-05,0.000518931402811611,0.000369656217066347,PPIA/TIMP1/CD9/LGALS3BP/CD63/MANF/PFN1/CALM3/MAGED2/SOD1/HGF/CFL1/TMSB4X/ANXA5/CALM2/CLU,16
R-HSA-2262752,R-HSA-2262752,Cellular responses to stress,36/379,378/8183,2.68936694718314e-05,0.000519944276455408,0.000370377728691012,EEF1A1/RPS27A/H3F3A/UBA52/GSTP1/HSP90AB1/ANAPC11/PRDX5/PSMA7/HSPA6/TXN/HSPA1B/PSMA4/SEC13/RPS19BP1/HSPA1A/DNAJB1/BAG1/PSMB8/SCMH1/ATOX1/PSMB7/PRDX2/DYNLL1/NUDT2/SOD1/DCTN2/ELOB/PSMC3/UBB/PSMC5/PSMD13/TUBA1B/DYNC1H1/CA9/HIST1H1C,36
R-HSA-9604323,R-HSA-9604323,Negative regulation of NOTCH4 signaling,11/379,54/8183,2.88217408583124e-05,0.000545848479928855,0.000388830360021916,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-5610780,R-HSA-5610780,Degradation of GLI1 by the proteasome,11/379,56/8183,4.12446407922713e-05,0.000736058204908226,0.000524324583351141,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-5610783,R-HSA-5610783,Degradation of GLI2 by the proteasome,11/379,56/8183,4.12446407922713e-05,0.000736058204908226,0.000524324583351141,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-5610785,R-HSA-5610785,GLI3 is processed to GLI3R by the proteasome,11/379,56/8183,4.12446407922713e-05,0.000736058204908226,0.000524324583351141,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-162909,R-HSA-162909,Host Interactions of HIV factors,17/379,122/8183,4.26801828331587e-05,0.000747305842814552,0.000532336739210003,RPS27A/PPIA/UBA52/B2M/PSMA7/BANF1/PSMA4/SEC13/PSMB8/NPM1/PSMB7/ELOB/PSMC3/UBB/PSMC5/PSMD13/SKP1,17
R-HSA-5676590,R-HSA-5676590,NIK-->noncanonical NF-kB signaling,11/379,57/8183,4.90200084759099e-05,0.000842417923437859,0.000600088992648565,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-211733,R-HSA-211733,Regulation of activated PAK-2p34 by proteasome mediated degradation,10/379,48/8183,5.43516376274683e-05,0.000917060358514374,0.000653259874259332,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-983705,R-HSA-983705,Signaling by the B Cell Receptor (BCR),15/379,101/8183,5.68808548077982e-05,0.000942597022529227,0.000671450692092053,RPS27A/PPIA/UBA52/PSMA7/FKBP1A/PSMA4/PSMB8/CALM3/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1/CALM2,15
R-HSA-5607761,R-HSA-5607761,Dectin-1 mediated noncanonical NF-kB signaling,11/379,58/8183,5.80226693383659e-05,0.00094464977449129,0.000672912951883542,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-6799198,R-HSA-6799198,Complex I biogenesis,10/379,49/8183,6.55162014916891e-05,0.00103456473863445,0.000736963085143416,NDUFS5/NDUFAF3/NDUFB2/NDUFA6/NDUFB11/NDUFB4/NDUFA13/NDUFC2/NDUFB1/NDUFB9,10
R-HSA-8852276,R-HSA-8852276,The role of GTSE1 in G2/M progression after G2 checkpoint,12/379,69/8183,6.57751288571472e-05,0.00103456473863445,0.000736963085143416,RPS27A/UBA52/HSP90AB1/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/TUBA1B,12
R-HSA-1236977,R-HSA-1236977,Endosomal/Vacuolar pathway,5/379,11/8183,7.60889424392594e-05,0.00112177142339234,0.000799083999421948,B2M/HLA-C/HLA-A/CTSL/HLA-B,5
R-HSA-349425,R-HSA-349425,Autodegradation of the E3 ubiquitin ligase COP1,10/379,50/8183,7.85723518539894e-05,0.00112177142339234,0.000799083999421948,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-69601,R-HSA-69601,Ubiquitin Mediated Degradation of Phosphorylated Cdc25A,10/379,50/8183,7.85723518539894e-05,0.00112177142339234,0.000799083999421948,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-69610,R-HSA-69610,p53-Independent DNA Damage Response,10/379,50/8183,7.85723518539894e-05,0.00112177142339234,0.000799083999421948,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-69613,R-HSA-69613,p53-Independent G1/S DNA damage checkpoint,10/379,50/8183,7.85723518539894e-05,0.00112177142339234,0.000799083999421948,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-75815,R-HSA-75815,Ubiquitin-dependent degradation of Cyclin D,10/379,50/8183,7.85723518539894e-05,0.00112177142339234,0.000799083999421948,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-187577,R-HSA-187577,SCF(Skp2)-mediated degradation of p27/p21,11/379,60/8183,8.03467434022434e-05,0.00112972390723154,0.000804748881285628,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-1234174,R-HSA-1234174,Cellular response to hypoxia,12/379,71/8183,8.78566821101852e-05,0.00121688061191421,0.000866834192697507,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/ELOB/PSMC3/UBB/PSMC5/PSMD13/CA9,12
R-HSA-9013694,R-HSA-9013694,Signaling by NOTCH4,13/379,82/8183,8.92503933922629e-05,0.00121800536864735,0.000867635403256054,RPS27A/UBA52/PSMA7/NCSTN/PSMA4/PSMB8/PSMB7/PSENEN/PSMC3/UBB/PSMC5/PSMD13/SKP1,13
R-HSA-169911,R-HSA-169911,Regulation of Apoptosis,10/379,51/8183,9.37720878606974e-05,0.00124314996478182,0.000885546934985233,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-917937,R-HSA-917937,Iron uptake and transport,10/379,51/8183,9.37720878606974e-05,0.00124314996478182,0.000885546934985233,FTH1/RPS27A/UBA52/ATP6V1F/FTL/ATP6V0D1/ATP6V1D/UBB/ATP6V0B/SKP1,10
R-HSA-983170,R-HSA-983170,Antigen Presentation: Folding, assembly and peptide loading of class I MHC,7/379,25/8183,0.000100665322061715,0.00131573829398974,0.000937254592361112,B2M/HLA-C/CALR/HLA-A/HLA-B/SEC13/PDIA3,7
R-HSA-5607764,R-HSA-5607764,CLEC7A (Dectin-1) signaling,14/379,95/8183,0.000109209412991716,0.001407587989671,0.0010026829146023,RPS27A/UBA52/PSMA7/PSMA4/UBE2N/PSMB8/CALM3/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1/CALM2,14
R-HSA-5660526,R-HSA-5660526,Response to metal ions,5/379,12/8183,0.000125498514076541,0.00157660119253848,0.00112307798198067,MT1G/MT1E/MT1F/MT2A/MT1X,5
R-HSA-1234176,R-HSA-1234176,Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha,11/379,63/8183,0.000127419277414209,0.00157660119253848,0.00112307798198067,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/ELOB/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-174084,R-HSA-174084,Autodegradation of Cdh1 by Cdh1:APC/C,11/379,63/8183,0.000127419277414209,0.00157660119253848,0.00112307798198067,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-4641257,R-HSA-4641257,Degradation of AXIN,10/379,53/8183,0.00013173153745189,0.00158762164617342,0.00113092830512354,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-5362768,R-HSA-5362768,Hh mutants that don't undergo autocatalytic processing are degraded by ERAD,10/379,53/8183,0.00013173153745189,0.00158762164617342,0.00113092830512354,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-1169091,R-HSA-1169091,Activation of NF-kappaB in B cells,11/379,64/8183,0.000147593275945984,0.00175598153945991,0.00125085799317244,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-2871837,R-HSA-2871837,FCERI mediated NF-kB activation,12/379,75/8183,0.000151649224617147,0.00178139848664194,0.00126896353177307,RPS27A/UBA52/PSMA7/PSMA4/UBE2N/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,12
R-HSA-4641258,R-HSA-4641258,Degradation of DVL,10/379,54/8183,0.000155120127586794,0.0017993934800068,0.0012817821069014,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-5368286,R-HSA-5368286,Mitochondrial translation initiation,13/379,87/8183,0.000165945902322508,0.00185539514885889,0.00132167440277153,MRPL13/MRPL24/MRPL52/MRPL22/MRPL55/MRPL17/MRPL2/MRPL3/MRPL40/MRPS18A/MRPL54/MRPS35/MRPL11,13
R-HSA-5389840,R-HSA-5389840,Mitochondrial translation elongation,13/379,87/8183,0.000165945902322508,0.00185539514885889,0.00132167440277153,MRPL13/MRPL24/MRPL52/MRPL22/MRPL55/MRPL17/MRPL2/MRPL3/MRPL40/MRPS18A/MRPL54/MRPS35/MRPL11,13
R-HSA-5419276,R-HSA-5419276,Mitochondrial translation termination,13/379,87/8183,0.000165945902322508,0.00185539514885889,0.00132167440277153,MRPL13/MRPL24/MRPL52/MRPL22/MRPL55/MRPL17/MRPL2/MRPL3/MRPL40/MRPS18A/MRPL54/MRPS35/MRPL11,13
R-HSA-174154,R-HSA-174154,APC/C:Cdc20 mediated degradation of Securin,11/379,65/8183,0.000170419464191358,0.00188272931868548,0.00134114565804728,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-5387390,R-HSA-5387390,Hh mutants abrogate ligand secretion,10/379,55/8183,0.000181912420776144,0.00194039915494553,0.00138222625828697,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-69541,R-HSA-69541,Stabilization of p53,10/379,55/8183,0.000181912420776144,0.00194039915494553,0.00138222625828697,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-8941858,R-HSA-8941858,Regulation of RUNX3 expression and activity,10/379,55/8183,0.000181912420776144,0.00194039915494553,0.00138222625828697,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-3299685,R-HSA-3299685,Detoxification of Reactive Oxygen Species,7/379,28/8183,0.000219813516780058,0.00231803344968061,0.00165123072413728,GSTP1/PRDX5/TXN/ATOX1/PRDX2/NUDT2/SOD1,7
R-HSA-176408,R-HSA-176408,Regulation of APC/C activators between G1/S and early anaphase,12/379,78/8183,0.000222408217835448,0.00231904299046399,0.00165194986162816,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,12
R-HSA-68827,R-HSA-68827,CDT1 association with the CDC6:ORC:origin complex,10/379,57/8183,0.00024727372708924,0.00254966687487572,0.00181623275569641,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-8939902,R-HSA-8939902,Regulation of RUNX2 expression and activity,11/379,68/8183,0.000257664765608125,0.00262761431301473,0.00187175792714752,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-72163,R-HSA-72163,mRNA Splicing - Major Pathway,20/379,182/8183,0.000275420119024628,0.00277815076581364,0.00197899124425019,POLR2G/SNRPB/SF3B5/POLR2L/HNRNPA1/SNU13/PUF60/HNRNPU/SNRPD2/MAGOH/SRRM2/LSM6/HNRNPH1/SF1/SRSF11/SYF2/FUS/LSM7/SRSF7/SF3B1,20
R-HSA-5696394,R-HSA-5696394,DNA Damage Recognition in GG-NER,8/379,38/8183,0.000282789975342379,0.00282181824857772,0.00201009739122823,RPS27A/UBA52/INO80E/COPS5/COPS3/ACTB/CETN2/UBB,8
R-HSA-68949,R-HSA-68949,Orc1 removal from chromatin,11/379,69/8183,0.000294057627750552,0.00290303700587779,0.00206795285808898,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-5368287,R-HSA-5368287,Mitochondrial translation,13/379,93/8183,0.000327283494931522,0.00313728178091097,0.0022348150617197,MRPL13/MRPL24/MRPL52/MRPL22/MRPL55/MRPL17/MRPL2/MRPL3/MRPL40/MRPS18A/MRPL54/MRPS35/MRPL11,13
R-HSA-5678895,R-HSA-5678895,Defective CFTR causes cystic fibrosis,10/379,59/8183,0.000331250591136431,0.00313728178091097,0.0022348150617197,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-174178,R-HSA-174178,APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1,11/379,70/8183,0.000334688465851493,0.00313728178091097,0.0022348150617197,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-174184,R-HSA-174184,Cdc20:Phospho-APC/C mediated degradation of Cyclin A,11/379,70/8183,0.000334688465851493,0.00313728178091097,0.0022348150617197,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-69017,R-HSA-69017,CDK-mediated phosphorylation and removal of Cdc6,11/379,70/8183,0.000334688465851493,0.00313728178091097,0.0022348150617197,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-2979096,R-HSA-2979096,NOTCH2 Activation and Transmission of Signal to the Nucleus,6/379,22/8183,0.000376007291346968,0.00348934766369986,0.00248560609437785,RPS27A/UBA52/MDK/NCSTN/PSENEN/UBB,6
R-HSA-179419,R-HSA-179419,APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint,11/379,71/8183,0.0003799409595374,0.00349094267772977,0.00248674228858246,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-5689603,R-HSA-5689603,UCH proteinases,13/379,95/8183,0.000404651585417968,0.0036815359928223,0.00262250975895236,RPS27A/UBA52/PSMA7/PSMA4/INO80E/HIST3H2A/PSMB8/PSMB7/ACTB/PSMC3/UBB/PSMC5/PSMD13,13
R-HSA-163210,R-HSA-163210,Formation of ATP by chemiosmotic coupling,5/379,15/8183,0.000423919096307217,0.00381938758614658,0.00272070712806267,ATP5MC2/ATP5MF/ATP5F1B/ATP5MG/ATP5MC3,5
R-HSA-4608870,R-HSA-4608870,Asymmetric localization of PCP proteins,10/379,61/8183,0.000437785748306818,0.00386919213741645,0.00275618496177124,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-5358346,R-HSA-5358346,Hedgehog ligand biogenesis,10/379,61/8183,0.000437785748306818,0.00386919213741645,0.00275618496177124,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-174143,R-HSA-174143,APC/C-mediated degradation of cell cycle proteins,12/379,84/8183,0.000450440290662353,0.00387044990495059,0.0027570809214031,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,12
R-HSA-453276,R-HSA-453276,Regulation of mitotic cell cycle,12/379,84/8183,0.000450440290662353,0.00387044990495059,0.0027570809214031,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,12
R-HSA-5696399,R-HSA-5696399,Global Genome Nucleotide Excision Repair (GG-NER),12/379,84/8183,0.000450440290662353,0.00387044990495059,0.0027570809214031,RPS27A/UBA52/INO80E/UBE2N/COPS5/COPS3/POLD2/SUMO2/ACTB/CETN2/UBB/PCNA,12
R-HSA-72172,R-HSA-72172,mRNA Splicing,20/379,190/8183,0.000485564506765459,0.00409977477624501,0.00292043847491137,POLR2G/SNRPB/SF3B5/POLR2L/HNRNPA1/SNU13/PUF60/HNRNPU/SNRPD2/MAGOH/SRRM2/LSM6/HNRNPH1/SF1/SRSF11/SYF2/FUS/LSM7/SRSF7/SF3B1,20
R-HSA-176409,R-HSA-176409,APC/C:Cdc20 mediated degradation of mitotic proteins,11/379,73/8183,0.000485964682529042,0.00409977477624501,0.00292043847491137,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-5696398,R-HSA-5696398,Nucleotide Excision Repair,14/379,110/8183,0.000522134357545162,0.00436523138560279,0.0031095341539911,RPS27A/UBA52/POLR2G/POLR2L/INO80E/UBE2N/COPS5/COPS3/POLD2/SUMO2/ACTB/CETN2/UBB/PCNA,14
R-HSA-8950505,R-HSA-8950505,Gene and protein expression by JAK-STAT signaling after Interleukin-12 stimulation,7/379,32/8183,0.000532344615085185,0.00441085538213439,0.00314203400632985,RPLP0/MIF/PPIA/AIP/SOD1/CFL1/GSTO1,7
R-HSA-176814,R-HSA-176814,Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins,11/379,74/8183,0.000547624001085977,0.00448618102077584,0.00319569156198642,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-202424,R-HSA-202424,Downstream TCR signaling,12/379,86/8183,0.00056077262759698,0.00448618102077584,0.00319569156198642,RPS27A/UBA52/PSMA7/PSMA4/UBE2N/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,12
R-HSA-4086400,R-HSA-4086400,PCP/CE pathway,12/379,86/8183,0.00056077262759698,0.00448618102077584,0.00319569156198642,RPS27A/UBA52/PSMA7/RHOA/PSMA4/PFN1/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,12
R-HSA-450531,R-HSA-450531,Regulation of mRNA stability by proteins that bind AU-rich elements,12/379,86/8183,0.00056077262759698,0.00448618102077584,0.00319569156198642,RPS27A/UBA52/PSMA7/HSPA1B/PSMA4/HSPA1A/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,12
R-HSA-205043,R-HSA-205043,NRIF signals cell death from the nucleus,5/379,16/8183,0.000593362159381906,0.00466644138903736,0.00332409844863369,RPS27A/UBA52/NCSTN/PSENEN/UBB,5
R-HSA-2173791,R-HSA-2173791,TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),5/379,16/8183,0.000593362159381906,0.00466644138903736,0.00332409844863369,RPS27A/UBA52/FKBP1A/RHOA/UBB,5
R-HSA-69563,R-HSA-69563,p53-Dependent G1 DNA Damage Response,10/379,64/8183,0.000649831276932959,0.00502536187494821,0.00357977229749033,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-69580,R-HSA-69580,p53-Dependent G1/S DNA damage checkpoint,10/379,64/8183,0.000649831276932959,0.00502536187494821,0.00357977229749033,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-69052,R-HSA-69052,Switching of origins to a post-replicative state,12/379,88/8183,0.000692982393522639,0.0053147740594133,0.00378593251963651,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,12
R-HSA-5658442,R-HSA-5658442,Regulation of RAS by GAPs,10/379,65/8183,0.000736997061067792,0.00560601043172878,0.0039933921859411,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-2025928,R-HSA-2025928,Calcineurin activates NFAT,4/379,10/8183,0.000761282914788129,0.00574366296685678,0.00409144775769743,PPIA/FKBP1A/CALM3/CALM2,4
R-HSA-68867,R-HSA-68867,Assembly of the pre-replicative complex,10/379,66/8183,0.000833572787808093,0.00613932973877707,0.00437329749994555,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-69615,R-HSA-69615,G1/S DNA Damage Checkpoints,10/379,66/8183,0.000833572787808093,0.00613932973877707,0.00437329749994555,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-8948751,R-HSA-8948751,Regulation of PTEN stability and activity,10/379,66/8183,0.000833572787808093,0.00613932973877707,0.00437329749994555,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-195253,R-HSA-195253,Degradation of beta-catenin by the destruction complex,11/379,78/8183,0.000863454900731691,0.00630933974707881,0.00449440263290097,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-351202,R-HSA-351202,Metabolism of polyamines,11/379,79/8183,0.000962445284375139,0.00697772831171975,0.00497052334364792,PSMA7/CKB/PSMA4/PSMB8/PSMB7/APIP/PSMC3/PSMC5/OAZ1/PSMD13/GAMT,11
R-HSA-69239,R-HSA-69239,Synthesis of DNA,14/379,117/8183,0.000974162790086527,0.00700793076899455,0.00499203779824022,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/POLD2/PSMB7/PSMC3/UBB/PSMC5/PSMD13/PCNA/SKP1,14
R-HSA-901042,R-HSA-901042,Calnexin/calreticulin cycle,6/379,26/8183,0.000991396187213151,0.00707704355179849,0.0050412696807276,RPS27A/UBA52/CALR/PDIA3/UBB/PRKCSH,6
R-HSA-69275,R-HSA-69275,G2/M Transition,19/379,187/8183,0.00102879182364565,0.00723685569260432,0.00515511045253575,RPS27A/UBA52/HSP90AB1/PSMA7/PSMA4/PSMB8/PSMB7/DYNLL1/CETN2/DCTN2/PSMC3/UBB/PSMC5/PSMD13/SKP1/AKAP9/TUBB/TUBA1B/DYNC1H1,19
R-HSA-3858494,R-HSA-3858494,Beta-catenin independent WNT signaling,15/379,131/8183,0.00102938033558596,0.00723685569260432,0.00515511045253575,RPS27A/UBA52/PSMA7/GNG5/RHOA/PSMA4/PFN1/PSMB8/CALM3/PSMB7/PSMC3/UBB/PSMC5/PSMD13/CALM2,15
R-HSA-3371497,R-HSA-3371497,HSP90 chaperone cycle for steroid hormone receptors (SHR),8/379,46/8183,0.00109133001962771,0.00761469367078581,0.00542426001049625,HSP90AB1/HSPA1B/HSPA1A/DNAJB1/DYNLL1/DCTN2/TUBA1B/DYNC1H1,8
R-HSA-975110,R-HSA-975110,TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling,4/379,11/8183,0.00115282232755891,0.00798372477593036,0.00568713606996854,RPS27A/UBA52/UBE2N/UBB,4
R-HSA-453274,R-HSA-453274,Mitotic G2-G2/M phases,19/379,189/8183,0.00116882542211945,0.00803459253131003,0.00572337126776622,RPS27A/UBA52/HSP90AB1/PSMA7/PSMA4/PSMB8/PSMB7/DYNLL1/CETN2/DCTN2/PSMC3/UBB/PSMC5/PSMD13/SKP1/AKAP9/TUBB/TUBA1B/DYNC1H1,19
R-HSA-5687128,R-HSA-5687128,MAPK6/MAPK4 signaling,11/379,81/8183,0.00118866607120825,0.0081108978976563,0.00577772672382958,RPS27A/UBA52/PSMA7/PSMA4/DNAJB1/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-162906,R-HSA-162906,HIV Infection,21/379,219/8183,0.00120499846729027,0.00816232538427277,0.00581436064124693,RPS27A/PPIA/UBA52/B2M/POLR2G/PSMA7/POLR2L/NELFE/BANF1/PSMA4/SEC13/PSMB8/NPM1/PSMB7/SUPT4H1/ELOB/PSMC3/UBB/PSMC5/PSMD13/SKP1,21
R-HSA-9020702,R-HSA-9020702,Interleukin-1 signaling,12/379,94/8183,0.00125531149997933,0.00844151501435378,0.00601323891675837,RPS27A/UBA52/PSMA7/PSMA4/UBE2N/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,12
R-HSA-5668541,R-HSA-5668541,TNFR2 non-canonical NF-kB pathway,11/379,82/8183,0.00131720452216147,0.00879399853644495,0.00626432745109735,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-5619084,R-HSA-5619084,ABC transporter disorders,10/379,70/8183,0.00132963014952022,0.00881354841967689,0.00627825363833608,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-69202,R-HSA-69202,Cyclin E associated events during G1/S transition ,11/379,83/8183,0.00145694550575085,0.00958897467614743,0.00683062170669304,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-9020591,R-HSA-9020591,Interleukin-12 signaling,7/379,38/8183,0.00157090412575106,0.0102661903429365,0.00731303032595747,RPLP0/MIF/PPIA/AIP/SOD1/CFL1/GSTO1,7
R-HSA-156581,R-HSA-156581,Methylation,4/379,12/8183,0.0016664842343001,0.0106215526117535,0.0075661695101874,TRMT112/COMT/MAT2A/GSTO1,4
R-HSA-381771,R-HSA-381771,Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1),4/379,12/8183,0.0016664842343001,0.0106215526117535,0.0075661695101874,SEC11C/GRP/SPCS1/SEC11A,4
R-HSA-422085,R-HSA-422085,Synthesis, secretion, and deacylation of Ghrelin,4/379,12/8183,0.0016664842343001,0.0106215526117535,0.0075661695101874,SEC11C/SPCS1/SEC11A/GHRL,4
R-HSA-350562,R-HSA-350562,Regulation of ornithine decarboxylase (ODC),8/379,49/8183,0.00167106323417674,0.0106215526117535,0.0075661695101874,PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/PSMC5/OAZ1/PSMD13,8
R-HSA-2454202,R-HSA-2454202,Fc epsilon receptor (FCERI) signaling,14/379,124/8183,0.00171848549272806,0.0107030505855815,0.00762422387448407,RPS27A/UBA52/PSMA7/PSMA4/UBE2N/PSMB8/CALM3/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1/CALM2,14
R-HSA-5621481,R-HSA-5621481,C-type lectin receptors (CLRs),14/379,124/8183,0.00171848549272806,0.0107030505855815,0.00762422387448407,RPS27A/UBA52/PSMA7/PSMA4/UBE2N/PSMB8/CALM3/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1/CALM2,14
R-HSA-69306,R-HSA-69306,DNA Replication,14/379,124/8183,0.00171848549272806,0.0107030505855815,0.00762422387448407,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/POLD2/PSMB7/PSMC3/UBB/PSMC5/PSMD13/PCNA/SKP1,14
R-HSA-69656,R-HSA-69656,Cyclin A:Cdk2-associated events at S phase entry,11/379,85/8183,0.00177294856081769,0.0109686417629254,0.00781341541188428,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-5627117,R-HSA-5627117,RHO GTPases Activate ROCKs,5/379,20/8183,0.00180681886471858,0.0111041583209195,0.00790994943913048,RHOA/MYL12B/MYL6/MYL12A/CFL1,5
R-HSA-6807004,R-HSA-6807004,Negative regulation of MET activity,5/379,21/8183,0.00228255922474804,0.013935624740567,0.00992691962009534,RPS27A/UBA52/HGF/UBB/MET,5
R-HSA-3000480,R-HSA-3000480,Scavenging by Class A Receptors,4/379,13/8183,0.00231993476666322,0.0139798666458667,0.00995843495191046,FTH1/FTL/CALR/HSP90B1,4
R-HSA-400508,R-HSA-400508,Incretin synthesis, secretion, and inactivation,4/379,13/8183,0.00231993476666322,0.0139798666458667,0.00995843495191046,SEC11C/GRP/SPCS1/SEC11A,4
R-HSA-72165,R-HSA-72165,mRNA Splicing - Minor Pathway,8/379,52/8183,0.00247100329776508,0.0147941358730709,0.0105384724685669,POLR2G/SNRPB/SF3B5/POLR2L/SNU13/SNRPD2/SRSF7/SF3B1,8
R-HSA-5632684,R-HSA-5632684,Hedgehog 'on' state,10/379,76/8183,0.00250108395546423,0.0148631129820789,0.0105876077050199,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-983169,R-HSA-983169,Class I MHC mediated antigen processing & presentation,28/379,344/8183,0.00251455682994222,0.0148631129820789,0.0105876077050199,RPS27A/UBA52/B2M/WSB1/ANAPC11/HLA-C/PSMA7/CALR/HLA-A/NPEPPS/SEC61B/PSMA4/ANAPC13/VAMP8/CTSL/HLA-B/SEC13/UBE2N/PSMB8/PSMB7/PDIA3/ELOB/PSMC3/RNF7/UBB/PSMC5/PSMD13/SKP1,28
R-HSA-5610787,R-HSA-5610787,Hedgehog 'off' state,12/379,102/8183,0.00254757839504264,0.0149629920924023,0.0106587557101051,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1/TUBA1B,12
R-HSA-202403,R-HSA-202403,TCR signaling,12/379,104/8183,0.00300029264902483,0.0175111420018556,0.0124739078688354,RPS27A/UBA52/PSMA7/PSMA4/UBE2N/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,12
R-HSA-1980145,R-HSA-1980145,Signaling by NOTCH2,6/379,32/8183,0.00308552980728257,0.0178223218541421,0.0126955740975513,RPS27A/UBA52/MDK/NCSTN/PSENEN/UBB,6
R-HSA-3371568,R-HSA-3371568,Attenuation phase,4/379,14/8183,0.00313042937739781,0.0178223218541421,0.0126955740975513,HSP90AB1/HSPA1B/HSPA1A/DNAJB1,4
R-HSA-937039,R-HSA-937039,IRAK1 recruits IKK complex,4/379,14/8183,0.00313042937739781,0.0178223218541421,0.0126955740975513,RPS27A/UBA52/UBE2N/UBB,4
R-HSA-975144,R-HSA-975144,IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation,4/379,14/8183,0.00313042937739781,0.0178223218541421,0.0126955740975513,RPS27A/UBA52/UBE2N/UBB,4
R-HSA-68882,R-HSA-68882,Mitotic Anaphase,18/379,192/8183,0.00337874203855993,0.0191187354377049,0.0136190629025394,RPS27A/UBA52/ANAPC11/PSMA7/BANF1/PSMA4/SEC13/PSMB8/PSMB7/DYNLL1/PSMC3/UBB/PSMC5/PSMD13/ESPL1/RPS27/TUBA1B/DYNC1H1,18
R-HSA-72203,R-HSA-72203,Processing of Capped Intron-Containing Pre-mRNA,21/379,239/8183,0.00351462501806394,0.019767103131899,0.0140809219224508,POLR2G/SNRPB/SF3B5/POLR2L/HNRNPA1/SNU13/PUF60/SEC13/HNRNPU/SNRPD2/MAGOH/SRRM2/LSM6/HNRNPH1/SF1/SRSF11/SYF2/FUS/LSM7/SRSF7/SF3B1,21
R-HSA-109581,R-HSA-109581,Apoptosis,16/379,163/8183,0.00355621095813449,0.0198501166948446,0.0141400559033149,RPS27A/UBA52/PSMA7/BAD/PSMA4/PSMB8/HMGB2/PSMB7/DYNLL1/MAGED1/APIP/PSMC3/UBB/PSMC5/PSMD13/HIST1H1C,16
R-HSA-2555396,R-HSA-2555396,Mitotic Metaphase and Anaphase,18/379,193/8183,0.0035721653965938,0.0198501166948446,0.0141400559033149,RPS27A/UBA52/ANAPC11/PSMA7/BANF1/PSMA4/SEC13/PSMB8/PSMB7/DYNLL1/PSMC3/UBB/PSMC5/PSMD13/ESPL1/RPS27/TUBA1B/DYNC1H1,18
R-HSA-8875360,R-HSA-8875360,InlB-mediated entry of Listeria monocytogenes into host cell,4/379,15/8183,0.00411461493415803,0.0226824749025136,0.0161576613416272,RPS27A/UBA52/UBB/MET,4
R-HSA-400685,R-HSA-400685,Sema4D in semaphorin signaling,5/379,24/8183,0.0042526077058147,0.0226824749025136,0.0161576613416272,RHOA/MYL12B/MYL6/MYL12A/MET,5
R-HSA-5627123,R-HSA-5627123,RHO GTPases activate PAKs,5/379,24/8183,0.0042526077058147,0.0226824749025136,0.0161576613416272,MYL12B/MYL6/CALM3/MYL12A/CALM2,5
R-HSA-9013507,R-HSA-9013507,NOTCH3 Activation and Transmission of Signal to the Nucleus,5/379,24/8183,0.0042526077058147,0.0226824749025136,0.0161576613416272,RPS27A/UBA52/NCSTN/PSENEN/UBB,5
R-HSA-2467813,R-HSA-2467813,Separation of Sister Chromatids,17/379,181/8183,0.00425654853445738,0.0226824749025136,0.0161576613416272,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/SEC13/PSMB8/PSMB7/DYNLL1/PSMC3/UBB/PSMC5/PSMD13/ESPL1/RPS27/TUBA1B/DYNC1H1,17
R-HSA-5357801,R-HSA-5357801,Programmed Cell Death,16/379,166/8183,0.00425738159874126,0.0226824749025136,0.0161576613416272,RPS27A/UBA52/PSMA7/BAD/PSMA4/PSMB8/HMGB2/PSMB7/DYNLL1/MAGED1/APIP/PSMC3/UBB/PSMC5/PSMD13/HIST1H1C,16
R-HSA-1236978,R-HSA-1236978,Cross-presentation of soluble exogenous antigens (endosomes),7/379,45/8183,0.00427740636631452,0.0226824749025136,0.0161576613416272,PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/PSMC5/PSMD13,7
R-HSA-447115,R-HSA-447115,Interleukin-12 family signaling,7/379,45/8183,0.00427740636631452,0.0226824749025136,0.0161576613416272,RPLP0/MIF/PPIA/AIP/SOD1/CFL1/GSTO1,7
R-HSA-69002,R-HSA-69002,DNA Replication Pre-Initiation,10/379,82/8183,0.00438506822963452,0.0231212688471638,0.0164702323457564,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-532668,R-HSA-532668,N-glycan trimming in the ER and Calnexin/Calreticulin cycle,6/379,35/8183,0.00491702117184013,0.0257796364263708,0.0183638970913803,RPS27A/UBA52/CALR/PDIA3/UBB/PRKCSH,6
R-HSA-5696397,R-HSA-5696397,Gap-filling DNA repair synthesis and ligation in GG-NER,5/379,25/8183,0.00511747226497053,0.0266798554038913,0.0190051601561295,RPS27A/UBA52/POLD2/UBB/PCNA,5
R-HSA-110312,R-HSA-110312,Translesion synthesis by REV1,4/379,16/8183,0.0052883658590834,0.0271138315869028,0.0193142992701621,RPS27A/UBA52/UBB/PCNA,4
R-HSA-175474,R-HSA-175474,Assembly Of The HIV Virion,4/379,16/8183,0.0052883658590834,0.0271138315869028,0.0193142992701621,RPS27A/PPIA/UBA52/UBB,4
R-HSA-5684264,R-HSA-5684264,MAP3K8 (TPL2)-dependent MAPK1/3 activation,4/379,16/8183,0.0052883658590834,0.0271138315869028,0.0193142992701621,RPS27A/UBA52/UBB/SKP1,4
R-HSA-5626467,R-HSA-5626467,RHO GTPases activate IQGAPs,5/379,26/8183,0.00609987133110324,0.0305982734879125,0.021796410787669,ACTG1/CALM3/ACTB/CALM2/TUBA1B,5
R-HSA-6803529,R-HSA-6803529,FGFR2 alternative splicing,5/379,26/8183,0.00609987133110324,0.0305982734879125,0.021796410787669,POLR2G/POLR2L/HNRNPA1/TIA1/HNRNPH1,5
R-HSA-8949613,R-HSA-8949613,Cristae formation,5/379,26/8183,0.00609987133110324,0.0305982734879125,0.021796410787669,ATP5MC2/ATP5MF/ATP5F1B/ATP5MG/ATP5MC3,5
R-HSA-8982491,R-HSA-8982491,Glycogen metabolism,5/379,26/8183,0.00609987133110324,0.0305982734879125,0.021796410787669,RPS27A/UBA52/CALM3/UBB/CALM2,5
R-HSA-2565942,R-HSA-2565942,Regulation of PLK1 Activity at G2/M Transition,10/379,86/8183,0.00616458249221212,0.030756626627811,0.0219092122530233,RPS27A/UBA52/DYNLL1/CETN2/DCTN2/UBB/SKP1/AKAP9/TUBB/DYNC1H1,10
R-HSA-5655862,R-HSA-5655862,Translesion synthesis by POLK,4/379,17/8183,0.00666665065730794,0.0328330123995871,0.0233883073808311,RPS27A/UBA52/UBB/PCNA,4
R-HSA-5656121,R-HSA-5656121,Translesion synthesis by POLI,4/379,17/8183,0.00666665065730794,0.0328330123995871,0.0233883073808311,RPS27A/UBA52/UBB/PCNA,4
R-HSA-2682334,R-HSA-2682334,EPH-Ephrin signaling,10/379,87/8183,0.00668689584431247,0.0328330123995871,0.0233883073808311,ACTG1/RHOA/MYL12B/NCSTN/MYL6/ARPC5/MYL12A/PSENEN/ACTB/CFL1,10
R-HSA-446652,R-HSA-446652,Interleukin-1 family signaling,12/379,115/8183,0.0067911290741206,0.033169304109389,0.0236278618202091,RPS27A/UBA52/PSMA7/PSMA4/UBE2N/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,12
R-HSA-76002,R-HSA-76002,Platelet activation, signaling and aggregation,18/379,207/8183,0.00739028213726247,0.0359067111171705,0.0255778296070589,PPIA/TIMP1/CD9/LGALS3BP/CD63/GNG5/RHOA/MANF/PFN1/CALM3/MAGED2/SOD1/HGF/CFL1/TMSB4X/ANXA5/CALM2/CLU,18
R-HSA-382556,R-HSA-382556,ABC-family proteins mediated transport,10/379,89/8183,0.00783406225412522,0.0378646342282719,0.0269725389012645,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-373755,R-HSA-373755,Semaphorin interactions,8/379,63/8183,0.00818052365611869,0.0391315770766915,0.0278750344874798,HSP90AB1/RHOA/MYL12B/MYL6/MYL12A/CFL1/SEMA3E/MET,8
R-HSA-5654738,R-HSA-5654738,Signaling by FGFR2,8/379,63/8183,0.00818052365611869,0.0391315770766915,0.0278750344874798,RPS27A/UBA52/POLR2G/POLR2L/HNRNPA1/TIA1/HNRNPH1/UBB,8
R-HSA-168927,R-HSA-168927,TICAM1, RIP1-mediated IKK complex recruitment ,4/379,18/8183,0.00826342549610334,0.0393254300532508,0.0280131239490035,RPS27A/UBA52/UBE2N/UBB,4
R-HSA-6807070,R-HSA-6807070,PTEN Regulation,13/379,134/8183,0.00902987582355313,0.042753697776823,0.0304552202856679,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/SCMH1/PSMB7/LAMTOR4/PSMC3/UBB/PSMC5/PSMD13/RRAGC,13
R-HSA-3700989,R-HSA-3700989,Transcriptional Regulation by TP53,26/379,344/8183,0.00922067079295489,0.0430223514466138,0.030646593362606,RPS27A/UBA52/COX6A1/COX8A/POLR2G/PRDX5/POLR2L/COX5B/TXN/NELFE/COX14/NPM1/PRDX2/COX7C/LAMTOR4/TMEM219/COX6C/SUPT4H1/ELOB/COX5A/COX4I1/UBB/COX6B1/NDUFA4/PCNA/RRAGC,26
R-HSA-381183,R-HSA-381183,ATF6 (ATF6-alpha) activates chaperone genes,3/379,10/8183,0.00927205850142539,0.0430223514466138,0.030646593362606,CALR/HSP90B1/DDIT3,3
R-HSA-9014325,R-HSA-9014325,TICAM1,TRAF6-dependent induction of TAK1 complex,3/379,10/8183,0.00927205850142539,0.0430223514466138,0.030646593362606,RPS27A/UBA52/UBB,3
R-HSA-937042,R-HSA-937042,IRAK2 mediated activation of TAK1 complex,3/379,10/8183,0.00927205850142539,0.0430223514466138,0.030646593362606,RPS27A/UBA52/UBB,3
R-HSA-6781827,R-HSA-6781827,Transcription-Coupled Nucleotide Excision Repair (TC-NER),9/379,78/8183,0.00962623700890227,0.0444435221107528,0.0316589517758085,RPS27A/UBA52/POLR2G/POLR2L/COPS5/COPS3/POLD2/UBB/PCNA,9
R-HSA-110320,R-HSA-110320,Translesion Synthesis by POLH,4/379,19/8183,0.0100915517904156,0.0463611884232952,0.0330249844939081,RPS27A/UBA52/UBB/PCNA,4
R-HSA-8939236,R-HSA-8939236,RUNX1 regulates transcription of genes involved in differentiation of HSCs,11/379,107/8183,0.0104197540338116,0.0476331612974247,0.0339310631746628,RPS27A/H3F3A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-8878159,R-HSA-8878159,Transcriptional regulation by RUNX3,10/379,93/8183,0.0105780783853465,0.0478572133379696,0.034090664673599,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,10
R-HSA-6781823,R-HSA-6781823,Formation of TC-NER Pre-Incision Complex,7/379,53/8183,0.0105939132049082,0.0478572133379696,0.034090664673599,RPS27A/UBA52/POLR2G/POLR2L/COPS5/COPS3/UBB,7
R-HSA-5663202,R-HSA-5663202,Diseases of signal transduction,26/379,348/8183,0.0106234762366614,0.0478572133379696,0.034090664673599,RPS27A/UBA52/ACTG1/RBP1/POLR2G/PSMA7/FKBP1A/POLR2L/BAD/NCSTN/PSMA4/PSMB8/CALM3/PSMB7/PSENEN/ACTB/HGF/PSMC3/UBB/PSMC5/PSMD13/SKP1/CALM2/MET/AKAP9/PHB,26
R-HSA-8878166,R-HSA-8878166,Transcriptional regulation by RUNX2,11/379,108/8183,0.0111362750403527,0.0499249431760741,0.035563593823247,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1,11
R-HSA-977225,R-HSA-977225,Amyloid fiber formation,9/379,80/8183,0.0112930982566501,0.0499554920709643,0.0355853550596252,RPS27A/H3F3A/UBA52/B2M/NCSTN/NPPA/PSENEN/CST3/UBB,9
R-HSA-110314,R-HSA-110314,Recognition of DNA damage by PCNA-containing replication complex,5/379,30/8183,0.0113584146842387,0.0499554920709643,0.0355853550596252,RPS27A/UBA52/POLD2/UBB/PCNA,5
R-HSA-167238,R-HSA-167238,Pausing and recovery of Tat-mediated HIV elongation,5/379,30/8183,0.0113584146842387,0.0499554920709643,0.0355853550596252,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-167243,R-HSA-167243,Tat-mediated HIV elongation arrest and recovery,5/379,30/8183,0.0113584146842387,0.0499554920709643,0.0355853550596252,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-156580,R-HSA-156580,Phase II - Conjugation of compounds,8/379,67/8183,0.0117445369591638,0.0514100485759623,0.0366214955826955,GSTP1/TRMT112/MGST2/COMT/MAT2A/ESD/SLC35B2/GSTO1,8
R-HSA-5625900,R-HSA-5625900,RHO GTPases activate CIT,4/379,20/8183,0.0121627350218398,0.0527430752348941,0.0375710653896478,RHOA/MYL12B/MYL6/MYL12A,4
R-HSA-8876384,R-HSA-8876384,Listeria monocytogenes entry into host cells,4/379,20/8183,0.0121627350218398,0.0527430752348941,0.0375710653896478,RPS27A/UBA52/UBB/MET,4
R-HSA-5689877,R-HSA-5689877,Josephin domain DUBs,3/379,11/8183,0.0123167720666253,0.052916502212168,0.0376946045703738,RPS27A/UBA52/UBB,3
R-HSA-9013973,R-HSA-9013973,TICAM1-dependent activation of IRF3/IRF7,3/379,11/8183,0.0123167720666253,0.052916502212168,0.0376946045703738,RPS27A/UBA52/UBB,3
R-HSA-2122948,R-HSA-2122948,Activated NOTCH1 Transmits Signal to the Nucleus,5/379,31/8183,0.0130414160497181,0.0557715856872737,0.0397283981529128,RPS27A/UBA52/NCSTN/PSENEN/UBB,5
R-HSA-5696395,R-HSA-5696395,Formation of Incision Complex in GG-NER,6/379,43/8183,0.0135451792598777,0.0576602126292041,0.0410737449309666,RPS27A/UBA52/UBE2N/SUMO2/CETN2/UBB,6
R-HSA-416572,R-HSA-416572,Sema4D induced cell migration and growth-cone collapse,4/379,21/8183,0.0144874822682143,0.0611108342950132,0.0435317649016201,RHOA/MYL12B/MYL6/MYL12A,4
R-HSA-5205685,R-HSA-5205685,Pink/Parkin Mediated Mitophagy,4/379,21/8183,0.0144874822682143,0.0611108342950132,0.0435317649016201,RPS27A/UBA52/UBB/TOMM7,4
R-HSA-167287,R-HSA-167287,HIV elongation arrest and recovery,5/379,32/8183,0.0148850986872062,0.0619433703216472,0.0441248146120627,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-167290,R-HSA-167290,Pausing and recovery of HIV elongation,5/379,32/8183,0.0148850986872062,0.0619433703216472,0.0441248146120627,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-5656169,R-HSA-5656169,Termination of translesion DNA synthesis,5/379,32/8183,0.0148850986872062,0.0619433703216472,0.0441248146120627,RPS27A/UBA52/POLD2/UBB/PCNA,5
R-HSA-204998,R-HSA-204998,Cell death signalling via NRAGE, NRIF and NADE,8/379,70/8183,0.0150856884910184,0.0624978523199334,0.0445197949828927,RPS27A/UBA52/BAD/NCSTN/BEX3/PSENEN/MAGED1/UBB,8
R-HSA-69242,R-HSA-69242,S Phase,14/379,159/8183,0.0154334385919196,0.0636543600591172,0.0453436230911134,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/PSMB8/POLD2/PSMB7/PSMC3/UBB/PSMC5/PSMD13/PCNA/SKP1,14
R-HSA-381033,R-HSA-381033,ATF6 (ATF6-alpha) activates chaperones,3/379,12/8183,0.0158668680107337,0.0645809364647408,0.0460036616377691,CALR/HSP90B1/DDIT3,3
R-HSA-451306,R-HSA-451306,Ionotropic activity of kainate receptors,3/379,12/8183,0.0158668680107337,0.0645809364647408,0.0460036616377691,CALM3/GRIK2/CALM2,3
R-HSA-451308,R-HSA-451308,Activation of Ca-permeable Kainate Receptor,3/379,12/8183,0.0158668680107337,0.0645809364647408,0.0460036616377691,CALM3/GRIK2/CALM2,3
R-HSA-5673001,R-HSA-5673001,RAF/MAP kinase cascade,17/379,208/8183,0.016150663179405,0.0654489756789862,0.0466220017314012,RPS27A/UBA52/ACTG1/PSMA7/PSMA4/PSMB8/CALM3/PSMB7/ACTB/HGF/PSMC3/UBB/PSMC5/PSMD13/CALM2/MET/PHB,17
R-HSA-445355,R-HSA-445355,Smooth Muscle Contraction,5/379,33/8183,0.016895484073293,0.067900333194823,0.0483682046805228,MYL12B/MYL6/CALM3/MYL12A/CALM2,5
R-HSA-450321,R-HSA-450321,JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1,4/379,22/8183,0.0170750761515074,0.067900333194823,0.0483682046805228,RPS27A/UBA52/UBE2N/UBB,4
R-HSA-77387,R-HSA-77387,Insulin receptor recycling,4/379,22/8183,0.0170750761515074,0.067900333194823,0.0483682046805228,ATP6V1F/ATP6V0D1/ATP6V1D/ATP6V0B,4
R-HSA-937041,R-HSA-937041,IKK complex recruitment mediated by RIP1,4/379,22/8183,0.0170750761515074,0.067900333194823,0.0483682046805228,RPS27A/UBA52/UBE2N/UBB,4
R-HSA-69206,R-HSA-69206,G1/S Transition,12/379,130/8183,0.0171214202236946,0.067900333194823,0.0483682046805228,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/PCNA/SKP1,12
R-HSA-3371556,R-HSA-3371556,Cellular response to heat stress,9/379,87/8183,0.0188533763930346,0.0744507799690899,0.0530343577819742,EEF1A1/HSP90AB1/HSPA6/HSPA1B/SEC13/RPS19BP1/HSPA1A/DNAJB1/BAG1,9
R-HSA-211859,R-HSA-211859,Biological oxidations,12/379,132/8183,0.0191004807634001,0.0751069752052341,0.0535017926824944,GSTP1/HSP90AB1/TRMT112/AIP/MGST2/EPHX1/COMT/MAT2A/AKR7A2/ESD/SLC35B2/GSTO1,12
R-HSA-1358803,R-HSA-1358803,Downregulation of ERBB2:ERBB3 signaling,3/379,13/8183,0.0199309479839549,0.0755371602705154,0.053808231227182,RPS27A/UBA52/UBB,3
R-HSA-209543,R-HSA-209543,p75NTR recruits signalling complexes,3/379,13/8183,0.0199309479839549,0.0755371602705154,0.053808231227182,RPS27A/UBA52/UBB,3
R-HSA-209560,R-HSA-209560,NF-kB is activated and signals survival,3/379,13/8183,0.0199309479839549,0.0755371602705154,0.053808231227182,RPS27A/UBA52/UBB,3
R-HSA-3134975,R-HSA-3134975,Regulation of innate immune responses to cytosolic DNA,3/379,13/8183,0.0199309479839549,0.0755371602705154,0.053808231227182,RPS27A/UBA52/UBB,3
R-HSA-3229121,R-HSA-3229121,Glycogen storage diseases,3/379,13/8183,0.0199309479839549,0.0755371602705154,0.053808231227182,RPS27A/UBA52/UBB,3
R-HSA-167242,R-HSA-167242,Abortive elongation of HIV-1 transcript in the absence of Tat,4/379,23/8183,0.0199335631239311,0.0755371602705154,0.053808231227182,POLR2G/POLR2L/NELFE/SUPT4H1,4
R-HSA-174048,R-HSA-174048,APC/C:Cdc20 mediated degradation of Cyclin B,4/379,23/8183,0.0199335631239311,0.0755371602705154,0.053808231227182,RPS27A/UBA52/ANAPC11/UBB,4
R-HSA-450302,R-HSA-450302,activated TAK1 mediates p38 MAPK activation,4/379,23/8183,0.0199335631239311,0.0755371602705154,0.053808231227182,RPS27A/UBA52/UBE2N/UBB,4
R-HSA-5684996,R-HSA-5684996,MAPK1/MAPK3 signaling,17/379,213/8183,0.0199424614938322,0.0755371602705154,0.053808231227182,RPS27A/UBA52/ACTG1/PSMA7/PSMA4/PSMB8/CALM3/PSMB7/ACTB/HGF/PSMC3/UBB/PSMC5/PSMD13/CALM2/MET/PHB,17
R-HSA-5358351,R-HSA-5358351,Signaling by Hedgehog,12/379,134/8183,0.0212458771341865,0.0801470487013213,0.0570920446738087,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1/TUBA1B,12
R-HSA-2980736,R-HSA-2980736,Peptide hormone metabolism,7/379,61/8183,0.0219099706931417,0.0820504601323517,0.0584479230525373,CPB1/SEC11C/GRP/SPCS1/ATP6AP2/SEC11A/GHRL,7
R-HSA-446203,R-HSA-446203,Asparagine N-linked glycosylation,21/379,283/8183,0.0219272781388181,0.0820504601323517,0.0584479230525373,RPS27A/UBA52/LMAN2/CALR/TUSC3/RPN2/RPN1/SEC13/TMED3/ARF4/PDIA3/FOLR1/NEU1/DYNLL1/KDELR2/DCTN2/UBB/PRKCSH/ARF5/TUBA1B/DYNC1H1,21
R-HSA-193704,R-HSA-193704,p75 NTR receptor-mediated signalling,9/379,90/8183,0.0230204351671651,0.0856349276184418,0.0610012869151332,RPS27A/UBA52/RHOA/BAD/NCSTN/BEX3/PSENEN/MAGED1/UBB,9
R-HSA-3371571,R-HSA-3371571,HSF1-dependent transactivation,4/379,24/8183,0.0230697542075544,0.0856349276184418,0.0610012869151332,HSP90AB1/HSPA1B/HSPA1A/DNAJB1,4
R-HSA-190236,R-HSA-190236,Signaling by FGFR,8/379,76/8183,0.0237501855528767,0.0878094509684048,0.0625502894829381,RPS27A/UBA52/POLR2G/POLR2L/HNRNPA1/TIA1/HNRNPH1/UBB,8
R-HSA-174490,R-HSA-174490,Membrane binding and targetting of GAG proteins,3/379,14/8183,0.024512907603925,0.088723355613021,0.0632013014121792,RPS27A/UBA52/UBB,3
R-HSA-174495,R-HSA-174495,Synthesis And Processing Of GAG, GAGPOL Polyproteins,3/379,14/8183,0.024512907603925,0.088723355613021,0.0632013014121792,RPS27A/UBA52/UBB,3
R-HSA-3322077,R-HSA-3322077,Glycogen synthesis,3/379,14/8183,0.024512907603925,0.088723355613021,0.0632013014121792,RPS27A/UBA52/UBB,3
R-HSA-975163,R-HSA-975163,IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation,3/379,14/8183,0.024512907603925,0.088723355613021,0.0632013014121792,RPS27A/UBA52/UBB,3
R-HSA-6807878,R-HSA-6807878,COPI-mediated anterograde transport,9/379,91/8183,0.0245452886395738,0.088723355613021,0.0632013014121792,TMED3/ARF4/FOLR1/DYNLL1/KDELR2/DCTN2/ARF5/TUBA1B/DYNC1H1,9
R-HSA-8848021,R-HSA-8848021,Signaling by PTK6,6/379,49/8183,0.0246666225734477,0.088723355613021,0.0632013014121792,RPS27A/UBA52/RHOA/KHDRBS1/UBB/SFPQ,6
R-HSA-9006927,R-HSA-9006927,Signaling by Non-Receptor Tyrosine Kinases,6/379,49/8183,0.0246666225734477,0.088723355613021,0.0632013014121792,RPS27A/UBA52/RHOA/KHDRBS1/UBB/SFPQ,6
R-HSA-179409,R-HSA-179409,APC-Cdc20 mediated degradation of Nek2A,4/379,25/8183,0.0264892364823322,0.0949112411413295,0.0676091872014007,RPS27A/UBA52/ANAPC11/UBB,4
R-HSA-6782210,R-HSA-6782210,Gap-filling DNA repair synthesis and ligation in TC-NER,7/379,64/8183,0.027751824391265,0.0990526655195919,0.070559294403702,RPS27A/UBA52/POLR2G/POLR2L/POLD2/UBB/PCNA,7
R-HSA-168643,R-HSA-168643,Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways,6/379,51/8183,0.0294256816935648,0.104092356650865,0.0741492740208066,RPS27A/UBA52/HSP90AB1/TXN/UBE2N/UBB,6
R-HSA-2691230,R-HSA-2691230,Signaling by NOTCH1 HD Domain Mutants in Cancer,3/379,15/8183,0.0296124807713667,0.104092356650865,0.0741492740208066,RPS27A/UBA52/UBB,3
R-HSA-2691232,R-HSA-2691232,Constitutive Signaling by NOTCH1 HD Domain Mutants,3/379,15/8183,0.0296124807713667,0.104092356650865,0.0741492740208066,RPS27A/UBA52/UBB,3
R-HSA-937072,R-HSA-937072,TRAF6-mediated induction of TAK1 complex within TLR4 complex,3/379,15/8183,0.0296124807713667,0.104092356650865,0.0741492740208066,RPS27A/UBA52/UBB,3
R-HSA-6782135,R-HSA-6782135,Dual incision in TC-NER,7/379,65/8183,0.0299132284214747,0.104752739528787,0.0746196919510868,RPS27A/UBA52/POLR2G/POLR2L/POLD2/UBB/PCNA,7
R-HSA-1222556,R-HSA-1222556,ROS and RNS production in phagocytes,4/379,26/8183,0.0301963937825557,0.104952260038246,0.074761818629785,ATP6V1F/ATP6V0D1/ATP6V1D/ATP6V0B,4
R-HSA-3928663,R-HSA-3928663,EPHA-mediated growth cone collapse,4/379,26/8183,0.0301963937825557,0.104952260038246,0.074761818629785,RHOA/MYL12B/MYL6/MYL12A,4
R-HSA-110313,R-HSA-110313,Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template,5/379,39/8183,0.0327417878262292,0.112953082166322,0.0804611338480609,RPS27A/UBA52/POLD2/UBB/PCNA,5
R-HSA-1236394,R-HSA-1236394,Signaling by ERBB4,5/379,39/8183,0.0327417878262292,0.112953082166322,0.0804611338480609,RPS27A/UBA52/NCSTN/PSENEN/UBB,5
R-HSA-156590,R-HSA-156590,Glutathione conjugation,4/379,27/8183,0.034194435213329,0.117527540288775,0.0837197088263961,GSTP1/MGST2/ESD/GSTO1,4
R-HSA-3371453,R-HSA-3371453,Regulation of HSF1-mediated heat shock response,7/379,67/8183,0.0345700775284187,0.118380191684032,0.0843270875426178,HSPA6/HSPA1B/SEC13/RPS19BP1/HSPA1A/DNAJB1/BAG1,7
R-HSA-8866654,R-HSA-8866654,E3 ubiquitin ligases ubiquitinate target proteins,6/379,53/8183,0.0347511226657039,0.118562653800637,0.0844570628253176,RPS27A/UBA52/HLA-A/UBE2N/UBB/PCNA,6
R-HSA-1295596,R-HSA-1295596,Spry regulation of FGF signaling,3/379,16/8183,0.0352257380588167,0.118870854249389,0.0846766067021507,RPS27A/UBA52/UBB,3
R-HSA-193639,R-HSA-193639,p75NTR signals via NF-kB,3/379,16/8183,0.0352257380588167,0.118870854249389,0.0846766067021507,RPS27A/UBA52/UBB,3
R-HSA-936964,R-HSA-936964,Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon,3/379,16/8183,0.0352257380588167,0.118870854249389,0.0846766067021507,RPS27A/UBA52/UBB,3
R-HSA-5683057,R-HSA-5683057,MAPK family signaling cascades,18/379,246/8183,0.0364254323377705,0.122473917425547,0.0872432170408845,RPS27A/UBA52/ACTG1/PSMA7/PSMA4/DNAJB1/PSMB8/CALM3/PSMB7/ACTB/HGF/PSMC3/UBB/PSMC5/PSMD13/CALM2/MET/PHB,18
R-HSA-5205647,R-HSA-5205647,Mitophagy,4/379,28/8183,0.0384854302377838,0.128469349858501,0.0915140105616365,RPS27A/UBA52/UBB/TOMM7,4
R-HSA-917977,R-HSA-917977,Transferrin endocytosis and recycling,4/379,28/8183,0.0384854302377838,0.128469349858501,0.0915140105616365,ATP6V1F/ATP6V0D1/ATP6V1D/ATP6V0B,4
R-HSA-3928662,R-HSA-3928662,EPHB-mediated forward signaling,5/379,41/8183,0.039559227760989,0.131110583436421,0.0933954700522598,ACTG1/RHOA/ARPC5/ACTB/CFL1,5
R-HSA-5696400,R-HSA-5696400,Dual Incision in GG-NER,5/379,41/8183,0.039559227760989,0.131110583436421,0.0933954700522598,RPS27A/UBA52/POLD2/UBB/PCNA,5
R-HSA-5675482,R-HSA-5675482,Regulation of necroptotic cell death,3/379,17/8183,0.0413455425019972,0.136543286269941,0.0972654080961013,RPS27A/UBA52/UBB,3
R-HSA-453279,R-HSA-453279,Mitotic G1-G1/S phases,12/379,148/8183,0.0415365692467057,0.136687717237386,0.0973682922244538,RPS27A/UBA52/PSMA7/PSMA4/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13/PCNA/SKP1,12
R-HSA-162588,R-HSA-162588,Budding and maturation of HIV virion,4/379,29/8183,0.0430703492132698,0.138936849396555,0.0989704417207766,RPS27A/PPIA/UBA52/UBB,4
R-HSA-451326,R-HSA-451326,Activation of kainate receptors upon glutamate binding,4/379,29/8183,0.0430703492132698,0.138936849396555,0.0989704417207766,GNG5/CALM3/GRIK2/CALM2,4
R-HSA-5339562,R-HSA-5339562,Uptake and actions of bacterial toxins,4/379,29/8183,0.0430703492132698,0.138936849396555,0.0989704417207766,HSP90AB1/CD9/CALM3/CALM2,4
R-HSA-5663084,R-HSA-5663084,Diseases of carbohydrate metabolism,4/379,29/8183,0.0430703492132698,0.138936849396555,0.0989704417207766,RPS27A/UBA52/DCXR/UBB,4
R-HSA-167169,R-HSA-167169,HIV Transcription Elongation,5/379,42/8183,0.0432680490038841,0.138936849396555,0.0989704417207766,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-167200,R-HSA-167200,Formation of HIV-1 elongation complex containing HIV-1 Tat,5/379,42/8183,0.0432680490038841,0.138936849396555,0.0989704417207766,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-167246,R-HSA-167246,Tat-mediated elongation of the HIV-1 transcript,5/379,42/8183,0.0432680490038841,0.138936849396555,0.0989704417207766,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-2029482,R-HSA-2029482,Regulation of actin dynamics for phagocytic cup formation,6/379,57/8183,0.0471719828740487,0.148858543003837,0.106038072829412,ACTG1/BRK1/HSP90AB1/ARPC5/ACTB/CFL1,6
R-HSA-6802946,R-HSA-6802946,Signaling by moderate kinase activity BRAF mutants,5/379,43/8183,0.0471789529175692,0.148858543003837,0.106038072829412,ACTG1/CALM3/ACTB/CALM2/PHB,5
R-HSA-6802955,R-HSA-6802955,Paradoxical activation of RAF signaling by kinase inactive BRAF,5/379,43/8183,0.0471789529175692,0.148858543003837,0.106038072829412,ACTG1/CALM3/ACTB/CALM2/PHB,5
R-HSA-2173782,R-HSA-2173782,Binding and Uptake of Ligands by Scavenger Receptors,4/379,30/8183,0.0479491083715824,0.148858543003837,0.106038072829412,FTH1/FTL/CALR/HSP90B1,4
R-HSA-445989,R-HSA-445989,TAK1 activates NFkB by phosphorylation and activation of IKKs complex,4/379,30/8183,0.0479491083715824,0.148858543003837,0.106038072829412,RPS27A/UBA52/UBE2N/UBB,4
R-HSA-5357956,R-HSA-5357956,TNFR1-induced NFkappaB signaling pathway,4/379,30/8183,0.0479491083715824,0.148858543003837,0.106038072829412,RPS27A/UBA52/RACK1/UBB,4
R-HSA-1236382,R-HSA-1236382,Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,3/379,18/8183,0.047961965903176,0.148858543003837,0.106038072829412,RPS27A/UBA52/UBB,3
R-HSA-438066,R-HSA-438066,Unblocking of NMDA receptors, glutamate binding and activation,3/379,18/8183,0.047961965903176,0.148858543003837,0.106038072829412,GRIA2/CALM3/CALM2,3
R-HSA-4641263,R-HSA-4641263,Regulation of FZD by ubiquitination,3/379,18/8183,0.047961965903176,0.148858543003837,0.106038072829412,RPS27A/UBA52/UBB,3
R-HSA-5637815,R-HSA-5637815,Signaling by Ligand-Responsive EGFR Variants in Cancer,3/379,18/8183,0.047961965903176,0.148858543003837,0.106038072829412,RPS27A/UBA52/UBB,3
R-HSA-8951664,R-HSA-8951664,Neddylation,16/379,220/8183,0.0489451222728639,0.151403578230726,0.107851006271433,RPS27A/UBA52/WSB1/PSMA7/PSMA4/PSMB8/COPS5/COPS3/PSMB7/ELOB/PSMC3/RNF7/UBB/PSMC5/PSMD13/SKP1,16
R-HSA-2644602,R-HSA-2644602,Signaling by NOTCH1 PEST Domain Mutants in Cancer,6/379,58/8183,0.0506555729021085,0.154125808698874,0.109790163183862,RPS27A/UBA52/NCSTN/PSENEN/UBB/SKP1,6
R-HSA-2644603,R-HSA-2644603,Signaling by NOTCH1 in Cancer,6/379,58/8183,0.0506555729021085,0.154125808698874,0.109790163183862,RPS27A/UBA52/NCSTN/PSENEN/UBB/SKP1,6
R-HSA-2644606,R-HSA-2644606,Constitutive Signaling by NOTCH1 PEST Domain Mutants,6/379,58/8183,0.0506555729021085,0.154125808698874,0.109790163183862,RPS27A/UBA52/NCSTN/PSENEN/UBB/SKP1,6
R-HSA-2894858,R-HSA-2894858,Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,6/379,58/8183,0.0506555729021085,0.154125808698874,0.109790163183862,RPS27A/UBA52/NCSTN/PSENEN/UBB/SKP1,6
R-HSA-2894862,R-HSA-2894862,Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,6/379,58/8183,0.0506555729021085,0.154125808698874,0.109790163183862,RPS27A/UBA52/NCSTN/PSENEN/UBB/SKP1,6
R-HSA-9609507,R-HSA-9609507,Protein localization,12/379,153/8183,0.0512926120596904,0.155048109649119,0.110447156147512,RPS27A/UBA52/CYB5A/ASNA1/SEC61B/SCP2/CHCHD2/TIMM17A/COA6/ATP5F1B/UBB/TOMM7,12
R-HSA-167152,R-HSA-167152,Formation of HIV elongation complex in the absence of HIV Tat,5/379,44/8183,0.0512928552395252,0.155048109649119,0.110447156147512,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-2173789,R-HSA-2173789,TGF-beta receptor signaling activates SMADs,4/379,31/8183,0.0531206183451918,0.160051733195903,0.114011443338279,RPS27A/UBA52/FKBP1A/UBB,4
R-HSA-5213460,R-HSA-5213460,RIPK1-mediated regulated necrosis,3/379,19/8183,0.0550626685493185,0.163776142351819,0.116664493417584,RPS27A/UBA52/UBB,3
R-HSA-5218859,R-HSA-5218859,Regulated Necrosis,3/379,19/8183,0.0550626685493185,0.163776142351819,0.116664493417584,RPS27A/UBA52/UBB,3
R-HSA-6804760,R-HSA-6804760,Regulation of TP53 Activity through Methylation,3/379,19/8183,0.0550626685493185,0.163776142351819,0.116664493417584,RPS27A/UBA52/UBB,3
R-HSA-8876725,R-HSA-8876725,Protein methylation,3/379,19/8183,0.0550626685493185,0.163776142351819,0.116664493417584,EEF1A1/CALM3/CALM2,3
R-HSA-6790901,R-HSA-6790901,rRNA modification in the nucleus and cytosol,6/379,60/8183,0.0580843326931771,0.172211695652615,0.122673485560166,RPS14/RPS6/RPS9/RPS7/TRMT112/SNU13,6
R-HSA-5689901,R-HSA-5689901,Metalloprotease DUBs,4/379,32/8183,0.0585828354391897,0.173136532762956,0.123332285135136,RPS27A/UBA52/HIST3H2A/UBB,4
R-HSA-9012852,R-HSA-9012852,Signaling by NOTCH3,5/379,46/8183,0.0601309854604226,0.177147792086578,0.126189670406501,RPS27A/UBA52/NCSTN/PSENEN/UBB,5
R-HSA-199977,R-HSA-199977,ER to Golgi Anterograde Transport,11/379,141/8183,0.0622428206074146,0.182789042796458,0.130208165694392,LMAN2/SEC13/TMED3/ARF4/FOLR1/DYNLL1/KDELR2/DCTN2/ARF5/TUBA1B/DYNC1H1,11
R-HSA-6803157,R-HSA-6803157,Antimicrobial peptides,3/379,20/8183,0.0626332450541677,0.183355367224819,0.130611581916046,ATOX1/CHGA/CLU,3
R-HSA-113418,R-HSA-113418,Formation of the Early Elongation Complex,4/379,33/8183,0.0643328149379342,0.186565163320009,0.132898051911259,POLR2G/POLR2L/NELFE/SUPT4H1,4
R-HSA-167158,R-HSA-167158,Formation of the HIV-1 Early Elongation Complex,4/379,33/8183,0.0643328149379342,0.186565163320009,0.132898051911259,POLR2G/POLR2L/NELFE/SUPT4H1,4
R-HSA-5357905,R-HSA-5357905,Regulation of TNFR1 signaling,4/379,33/8183,0.0643328149379342,0.186565163320009,0.132898051911259,RPS27A/UBA52/RACK1/UBB,4
R-HSA-5619115,R-HSA-5619115,Disorders of transmembrane transporters,11/379,142/8183,0.0648124626846706,0.187370608633565,0.133471803790697,RPS27A/UBA52/PSMA7/PSMA4/SEC13/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-157118,R-HSA-157118,Signaling by NOTCH,15/379,212/8183,0.0670106935624454,0.193123986415992,0.137570171811754,RPS27A/H3F3A/UBA52/MDK/PSMA7/NCSTN/PSMA4/PSMB8/PSMB7/PSENEN/PSMC3/UBB/PSMC5/PSMD13/SKP1,15
R-HSA-162587,R-HSA-162587,HIV Life Cycle,11/379,143/8183,0.067450264631085,0.19378899559643,0.138043885247911,RPS27A/PPIA/UBA52/POLR2G/POLR2L/NELFE/BANF1/SEC13/SUPT4H1/ELOB/UBB,11
R-HSA-73893,R-HSA-73893,DNA Damage Bypass,5/379,48/8183,0.0697805713756167,0.199865340236334,0.14237231586708,RPS27A/UBA52/POLD2/UBB/PCNA,5
R-HSA-901032,R-HSA-901032,ER Quality Control Compartment (ERQC),3/379,21/8183,0.0706575388518266,0.200520477230872,0.142838996938507,RPS27A/UBA52/UBB,3
R-HSA-912631,R-HSA-912631,Regulation of signaling by CBL,3/379,21/8183,0.0706575388518266,0.200520477230872,0.142838996938507,RPS27A/UBA52/UBB,3
R-HSA-9609523,R-HSA-9609523,Insertion of tail-anchored proteins into the endoplasmic reticulum membrane,3/379,21/8183,0.0706575388518266,0.200520477230872,0.142838996938507,CYB5A/ASNA1/SEC61B,3
R-HSA-913531,R-HSA-913531,Interferon Signaling,12/379,162/8183,0.0725620167991684,0.205297413383013,0.146241805359043,RPS27A/UBA52/B2M/HLA-C/HLA-A/HLA-B/SEC13/UBE2N/PSMB8/IFI6/UBB/MT2A,12
R-HSA-449147,R-HSA-449147,Signaling by Interleukins,22/379,342/8183,0.0732882138023802,0.206721770238933,0.147256433427915,RPLP0/RPS27A/MIF/PPIA/UBA52/TIMP1/PSMA7/AIP/PSMA4/UBE2N/PSMB8/PSMB7/SOD1/HGF/CFL1/PSMC3/UBB/PSMC5/PSMD13/HSP90B1/SKP1/GSTO1,22
R-HSA-1257604,R-HSA-1257604,PIP3 activates AKT signaling,16/379,233/8183,0.0740553775870643,0.20791216134371,0.148104398053369,RPS27A/UBA52/PSMA7/BAD/PSMA4/PSMB8/SCMH1/PSMB7/LAMTOR4/HGF/PSMC3/UBB/PSMC5/PSMD13/MET/RRAGC,16
R-HSA-174437,R-HSA-174437,Removal of the Flap Intermediate from the C-strand,2/379,10/8183,0.0752785411761708,0.20791216134371,0.148104398053369,POLD2/PCNA,2
R-HSA-196025,R-HSA-196025,Formation of annular gap junctions,2/379,10/8183,0.0752785411761708,0.20791216134371,0.148104398053369,ACTG1/ACTB,2
R-HSA-2022377,R-HSA-2022377,Metabolism of Angiotensinogen to Angiotensins,2/379,10/8183,0.0752785411761708,0.20791216134371,0.148104398053369,CPB1/ATP6AP2,2
R-HSA-425561,R-HSA-425561,Sodium/Calcium exchangers,2/379,10/8183,0.0752785411761708,0.20791216134371,0.148104398053369,CALM3/CALM2,2
R-HSA-442729,R-HSA-442729,CREB1 phosphorylation through the activation of CaMKII/CaMKK/CaMKIV cascasde,2/379,10/8183,0.0752785411761708,0.20791216134371,0.148104398053369,CALM3/CALM2,2
R-HSA-8875656,R-HSA-8875656,MET receptor recycling,2/379,10/8183,0.0752785411761708,0.20791216134371,0.148104398053369,HGF/MET,2
R-HSA-8957275,R-HSA-8957275,Post-translational protein phosphorylation,7/379,80/8183,0.0764596743349393,0.209908963569419,0.149526802542644,TIMP1/PDIA6/CST3/PRKCSH/HSP90B1/LGALS1/CHGB,7
R-HSA-168638,R-HSA-168638,NOD1/2 Signaling Pathway,4/379,35/8183,0.0766801063039149,0.209908963569419,0.149526802542644,RPS27A/UBA52/UBE2N/UBB,4
R-HSA-5663213,R-HSA-5663213,RHO GTPases Activate WASPs and WAVEs,4/379,35/8183,0.0766801063039149,0.209908963569419,0.149526802542644,ACTG1/BRK1/ARPC5/ACTB,4
R-HSA-9006925,R-HSA-9006925,Intracellular signaling by second messengers,18/379,271/8183,0.0781088647935334,0.213191254495291,0.151864913592381,RPS27A/UBA52/PSMA7/BAD/PSMA4/PSMB8/SCMH1/CALM3/PSMB7/LAMTOR4/HGF/PSMC3/UBB/PSMC5/PSMD13/CALM2/MET/RRAGC,18
R-HSA-1643713,R-HSA-1643713,Signaling by EGFR in Cancer,3/379,22/8183,0.0791179276992454,0.214056667361224,0.15248138282991,RPS27A/UBA52/UBB,3
R-HSA-9619483,R-HSA-9619483,Activation of AMPK downstream of NMDARs,3/379,22/8183,0.0791179276992454,0.214056667361224,0.15248138282991,CALM3/CALM2/TUBA1B,3
R-HSA-9620244,R-HSA-9620244,Long-term potentiation,3/379,22/8183,0.0791179276992454,0.214056667361224,0.15248138282991,GRIA2/CALM3/CALM2,3
R-HSA-68886,R-HSA-68886,M Phase,23/379,364/8183,0.0794936066444519,0.214447869087359,0.152760051936095,RPS27A/H3F3A/UBA52/ANAPC11/PSMA7/BANF1/PSMA4/SEC13/PSMB8/PSMB7/DYNLL1/CETN2/DCTN2/PSMC3/UBB/PSMC5/PSMD13/ESPL1/RPS27/AKAP9/TUBB/TUBA1B/DYNC1H1,23
R-HSA-8878171,R-HSA-8878171,Transcriptional regulation by RUNX1,14/379,200/8183,0.0803323779697084,0.216082454364897,0.153924434370639,RPS27A/H3F3A/UBA52/PSMA7/PSMA4/CTSL/KMT2E/PSMB8/SCMH1/PSMB7/PSMC3/UBB/PSMC5/PSMD13,14
R-HSA-73887,R-HSA-73887,Death Receptor Signalling,10/379,131/8183,0.0820153292565737,0.219971750144799,0.156694939985179,RPS27A/UBA52/RACK1/RHOA/BAD/NCSTN/BEX3/PSENEN/MAGED1/UBB,10
R-HSA-5689896,R-HSA-5689896,Ovarian tumor domain proteases,4/379,36/8183,0.0832675198034451,0.222686623566562,0.158628856170373,RPS27A/UBA52/RHOA/UBB,4
R-HSA-162599,R-HSA-162599,Late Phase of HIV Life Cycle,10/379,132/8183,0.0852868083818578,0.227431489018288,0.16200881930976,RPS27A/PPIA/UBA52/POLR2G/POLR2L/NELFE/SEC13/SUPT4H1/ELOB/UBB,10
R-HSA-166208,R-HSA-166208,mTORC1-mediated signalling,3/379,23/8183,0.0879955823855426,0.228846967271545,0.163017122784177,RPS6/LAMTOR4/RRAGC,3
R-HSA-2173795,R-HSA-2173795,Downregulation of SMAD2/3:SMAD4 transcriptional activity,3/379,23/8183,0.0879955823855426,0.228846967271545,0.163017122784177,RPS27A/UBA52/UBB,3
R-HSA-5654732,R-HSA-5654732,Negative regulation of FGFR3 signaling,3/379,23/8183,0.0879955823855426,0.228846967271545,0.163017122784177,RPS27A/UBA52/UBB,3
R-HSA-5654733,R-HSA-5654733,Negative regulation of FGFR4 signaling,3/379,23/8183,0.0879955823855426,0.228846967271545,0.163017122784177,RPS27A/UBA52/UBB,3
R-HSA-195721,R-HSA-195721,Signaling by WNT,18/379,276/8183,0.0892091293214333,0.228846967271545,0.163017122784177,RPS27A/H3F3A/UBA52/PSMA7/GNG5/RHOA/PSMA4/PFN1/PSMB8/SOX4/CALM3/PSMB7/PSMC3/UBB/PSMC5/PSMD13/SKP1/CALM2,18
R-HSA-140342,R-HSA-140342,Apoptosis induced DNA fragmentation,2/379,11/8183,0.0892700454227365,0.228846967271545,0.163017122784177,HMGB2/HIST1H1C,2
R-HSA-1474151,R-HSA-1474151,Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation,2/379,11/8183,0.0892700454227365,0.228846967271545,0.163017122784177,CALM3/CALM2,2
R-HSA-174414,R-HSA-174414,Processive synthesis on the C-strand of the telomere,2/379,11/8183,0.0892700454227365,0.228846967271545,0.163017122784177,POLD2/PCNA,2
R-HSA-190873,R-HSA-190873,Gap junction degradation,2/379,11/8183,0.0892700454227365,0.228846967271545,0.163017122784177,ACTG1/ACTB,2
R-HSA-193692,R-HSA-193692,Regulated proteolysis of p75NTR,2/379,11/8183,0.0892700454227365,0.228846967271545,0.163017122784177,NCSTN/PSENEN,2
R-HSA-5423646,R-HSA-5423646,Aflatoxin activation and detoxification,2/379,11/8183,0.0892700454227365,0.228846967271545,0.163017122784177,MGST2/AKR7A2,2
R-HSA-8851805,R-HSA-8851805,MET activates RAS signaling,2/379,11/8183,0.0892700454227365,0.228846967271545,0.163017122784177,HGF/MET,2
R-HSA-8875555,R-HSA-8875555,MET activates RAP1 and RAC1,2/379,11/8183,0.0892700454227365,0.228846967271545,0.163017122784177,HGF/MET,2
R-HSA-9013700,R-HSA-9013700,NOTCH4 Activation and Transmission of Signal to the Nucleus,2/379,11/8183,0.0892700454227365,0.228846967271545,0.163017122784177,NCSTN/PSENEN,2
R-HSA-3769402,R-HSA-3769402,Deactivation of the beta-catenin transactivating complex,4/379,37/8183,0.090123010755164,0.230397118404386,0.16412135929895,RPS27A/UBA52/SOX4/UBB,4
R-HSA-71406,R-HSA-71406,Pyruvate metabolism and Citric Acid (TCA) cycle,5/379,52/8183,0.0914721822320624,0.232564890716038,0.165665552824038,BSG/SUCLG1/PDHB/SDHB/LDHA,5
R-HSA-909733,R-HSA-909733,Interferon alpha/beta signaling,5/379,52/8183,0.0914721822320624,0.232564890716038,0.165665552824038,HLA-C/HLA-A/HLA-B/PSMB8/IFI6,5
R-HSA-380259,R-HSA-380259,Loss of Nlp from mitotic centrosomes,6/379,69/8183,0.0991418770876493,0.250691176940977,0.178577653265578,DYNLL1/CETN2/DCTN2/AKAP9/TUBB/DYNC1H1,6
R-HSA-380284,R-HSA-380284,Loss of proteins required for interphase microtubule organization from the centrosome,6/379,69/8183,0.0991418770876493,0.250691176940977,0.178577653265578,DYNLL1/CETN2/DCTN2/AKAP9/TUBB/DYNC1H1,6
R-HSA-111932,R-HSA-111932,CaMK IV-mediated phosphorylation of CREB,2/379,12/8183,0.103950680905137,0.258622605576319,0.184227536640119,CALM3/CALM2,2
R-HSA-162594,R-HSA-162594,Early Phase of HIV Life Cycle,2/379,12/8183,0.103950680905137,0.258622605576319,0.184227536640119,PPIA/BANF1,2
R-HSA-203615,R-HSA-203615,eNOS activation,2/379,12/8183,0.103950680905137,0.258622605576319,0.184227536640119,CALM3/CALM2,2
R-HSA-3371511,R-HSA-3371511,HSF1 activation,2/379,12/8183,0.103950680905137,0.258622605576319,0.184227536640119,EEF1A1/HSP90AB1,2
R-HSA-442720,R-HSA-442720,CREB1 phosphorylation through the activation of Adenylate Cyclase,2/379,12/8183,0.103950680905137,0.258622605576319,0.184227536640119,CALM3/CALM2,2
R-HSA-5607763,R-HSA-5607763,CLEC7A (Dectin-1) induces NFAT activation,2/379,12/8183,0.103950680905137,0.258622605576319,0.184227536640119,CALM3/CALM2,2
R-HSA-2173788,R-HSA-2173788,Downregulation of TGF-beta receptor signaling,3/379,25/8183,0.106922718544095,0.263894369172661,0.187982831034971,RPS27A/UBA52/UBB,3
R-HSA-418990,R-HSA-418990,Adherens junctions interactions,3/379,25/8183,0.106922718544095,0.263894369172661,0.187982831034971,ACTG1/CDH18/ACTB,3
R-HSA-5654727,R-HSA-5654727,Negative regulation of FGFR2 signaling,3/379,25/8183,0.106922718544095,0.263894369172661,0.187982831034971,RPS27A/UBA52/UBB,3
R-HSA-1592230,R-HSA-1592230,Mitochondrial biogenesis,7/379,87/8183,0.107657684633747,0.264302463862744,0.18827353369533,ATP5MC2/ATP5MF/CALM3/ATP5F1B/ATP5MG/ATP5MC3/CALM2,7
R-HSA-381119,R-HSA-381119,Unfolded Protein Response (UPR),7/379,87/8183,0.107657684633747,0.264302463862744,0.18827353369533,CALR/ATP6V0D1/PDIA6/YIF1A/HSP90B1/MYDGF/DDIT3,7
R-HSA-69481,R-HSA-69481,G2/M Checkpoints,11/379,156/8183,0.108046081474344,0.2645561045071,0.188454212375747,RPS27A/UBA52/PSMA7/PSMA4/UBE2N/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-6802949,R-HSA-6802949,Signaling by RAS mutants,5/379,55/8183,0.10975897608363,0.268042973172655,0.190938052577617,ACTG1/CALM3/ACTB/CALM2/PHB,5
R-HSA-380320,R-HSA-380320,Recruitment of NuMA to mitotic centrosomes,7/379,88/8183,0.112599670664029,0.274258515423148,0.195365639389447,DYNLL1/CETN2/DCTN2/AKAP9/TUBB/TUBA1B/DYNC1H1,7
R-HSA-5250924,R-HSA-5250924,B-WICH complex positively regulates rRNA expression,6/379,72/8183,0.115530640887794,0.279928028051887,0.199404266806471,H3F3A/POLR2L/ZNRD1/POLR1D/ACTB/SF3B1,6
R-HSA-8854518,R-HSA-8854518,AURKA Activation by TPX2,6/379,72/8183,0.115530640887794,0.279928028051887,0.199404266806471,DYNLL1/CETN2/DCTN2/AKAP9/TUBB/DYNC1H1,6
R-HSA-389958,R-HSA-389958,Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding,3/379,26/8183,0.116930500034731,0.281117886093861,0.200251851709329,ACTB/PFDN5/TUBA1B,3
R-HSA-5654726,R-HSA-5654726,Negative regulation of FGFR1 signaling,3/379,26/8183,0.116930500034731,0.281117886093861,0.200251851709329,RPS27A/UBA52/UBB,3
R-HSA-8863795,R-HSA-8863795,Downregulation of ERBB2 signaling,3/379,26/8183,0.116930500034731,0.281117886093861,0.200251851709329,RPS27A/UBA52/UBB,3
R-HSA-1632852,R-HSA-1632852,Macroautophagy,7/379,89/8183,0.11765954248169,0.282139678095628,0.200979716247793,RPS27A/UBA52/LAMTOR4/DYNLL1/UBB/TOMM7/RRAGC,7
R-HSA-418359,R-HSA-418359,Reduction of cytosolic Ca++ levels,2/379,13/8183,0.119226995981716,0.283699108387262,0.202090562689656,CALM3/CALM2,2
R-HSA-5210891,R-HSA-5210891,Uptake and function of anthrax toxins,2/379,13/8183,0.119226995981716,0.283699108387262,0.202090562689656,CALM3/CALM2,2
R-HSA-71336,R-HSA-71336,Pentose phosphate pathway,2/379,13/8183,0.119226995981716,0.283699108387262,0.202090562689656,PGLS/TKT,2
R-HSA-1980143,R-HSA-1980143,Signaling by NOTCH1,6/379,73/8183,0.121279269622744,0.287110107678334,0.204520358010428,RPS27A/UBA52/NCSTN/PSENEN/UBB/SKP1,6
R-HSA-8852135,R-HSA-8852135,Protein ubiquitination,6/379,73/8183,0.121279269622744,0.287110107678334,0.204520358010428,RPS27A/UBA52/HLA-A/UBE2N/UBB/PCNA,6
R-HSA-112382,R-HSA-112382,Formation of RNA Pol II elongation complex ,5/379,57/8183,0.122860893483715,0.288645339627564,0.205613966976078,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-75955,R-HSA-75955,RNA Polymerase II Transcription Elongation,5/379,57/8183,0.122860893483715,0.288645339627564,0.205613966976078,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-8986944,R-HSA-8986944,Transcriptional Regulation by MECP2,5/379,57/8183,0.122860893483715,0.288645339627564,0.205613966976078,GRIA2/CALM3/CALM2/MET/GAMT,5
R-HSA-983168,R-HSA-983168,Antigen processing: Ubiquitination & Proteasome degradation,18/379,290/8183,0.125494291168102,0.294087631828278,0.209490735921233,RPS27A/UBA52/WSB1/ANAPC11/PSMA7/NPEPPS/PSMA4/ANAPC13/UBE2N/PSMB8/PSMB7/ELOB/PSMC3/RNF7/UBB/PSMC5/PSMD13/SKP1,18
R-HSA-6806834,R-HSA-6806834,Signaling by MET,6/379,74/8183,0.127166756491042,0.296755998873148,0.211391523698204,RPS27A/UBA52/SPINT2/HGF/UBB/MET,6
R-HSA-76066,R-HSA-76066,RNA Polymerase III Transcription Initiation From Type 2 Promoter,3/379,27/8183,0.127272508137406,0.296755998873148,0.211391523698204,POLR2L/POLR1D/GTF3C6,3
R-HSA-381426,R-HSA-381426,Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs),7/379,91/8183,0.128126917028359,0.297841702090647,0.212164914828637,TIMP1/PDIA6/CST3/PRKCSH/HSP90B1/LGALS1/CHGB,7
R-HSA-195258,R-HSA-195258,RHO GTPase Effectors,18/379,291/8183,0.128380044004589,0.297841702090647,0.212164914828637,H3F3A/ACTG1/BRK1/RHOA/MYL12B/MYL6/SEC13/PFN1/CALM3/ARPC5/DYNLL1/MYL12A/ACTB/CFL1/RPS27/CALM2/TUBA1B/DYNC1H1,18
R-HSA-1834949,R-HSA-1834949,Cytosolic sensors of pathogen-associated DNA ,5/379,58/8183,0.129672716180093,0.300090475349442,0.213766808665438,RPS27A/UBA52/POLR2L/POLR1D/UBB,5
R-HSA-174411,R-HSA-174411,Polymerase switching on the C-strand of the telomere,2/379,14/8183,0.135012677378014,0.304846142595613,0.217154466368018,POLD2/PCNA,2
R-HSA-5358565,R-HSA-5358565,Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha),2/379,14/8183,0.135012677378014,0.304846142595613,0.217154466368018,POLD2/PCNA,2
R-HSA-5358606,R-HSA-5358606,Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta),2/379,14/8183,0.135012677378014,0.304846142595613,0.217154466368018,POLD2/PCNA,2
R-HSA-69091,R-HSA-69091,Polymerase switching,2/379,14/8183,0.135012677378014,0.304846142595613,0.217154466368018,POLD2/PCNA,2
R-HSA-69109,R-HSA-69109,Leading Strand Synthesis,2/379,14/8183,0.135012677378014,0.304846142595613,0.217154466368018,POLD2/PCNA,2
R-HSA-69166,R-HSA-69166,Removal of the Flap Intermediate,2/379,14/8183,0.135012677378014,0.304846142595613,0.217154466368018,POLD2/PCNA,2
R-HSA-844456,R-HSA-844456,The NLRP3 inflammasome,2/379,14/8183,0.135012677378014,0.304846142595613,0.217154466368018,HSP90AB1/TXN,2
R-HSA-9005891,R-HSA-9005891,Loss of function of MECP2 in Rett syndrome,2/379,14/8183,0.135012677378014,0.304846142595613,0.217154466368018,CALM3/CALM2,2
R-HSA-9005895,R-HSA-9005895,Pervasive developmental disorders,2/379,14/8183,0.135012677378014,0.304846142595613,0.217154466368018,CALM3/CALM2,2
R-HSA-9022699,R-HSA-9022699,MECP2 regulates neuronal receptors and channels,2/379,14/8183,0.135012677378014,0.304846142595613,0.217154466368018,GRIA2/MET,2
R-HSA-6811436,R-HSA-6811436,COPI-independent Golgi-to-ER retrograde traffic,4/379,43/8183,0.136478059319495,0.306662564282061,0.218448378367893,DYNLL1/DCTN2/TUBA1B/DYNC1H1,4
R-HSA-75893,R-HSA-75893,TNF signaling,4/379,43/8183,0.136478059319495,0.306662564282061,0.218448378367893,RPS27A/UBA52/RACK1/UBB,4
R-HSA-182971,R-HSA-182971,EGFR downregulation,3/379,28/8183,0.137926957485361,0.307683212851959,0.219175428392729,RPS27A/UBA52/UBB,3
R-HSA-70268,R-HSA-70268,Pyruvate metabolism,3/379,28/8183,0.137926957485361,0.307683212851959,0.219175428392729,BSG/PDHB/LDHA,3
R-HSA-76061,R-HSA-76061,RNA Polymerase III Transcription Initiation From Type 1 Promoter,3/379,28/8183,0.137926957485361,0.307683212851959,0.219175428392729,POLR2L/POLR1D/GTF3C6,3
R-HSA-983712,R-HSA-983712,Ion channel transport,10/379,146/8183,0.139235204489367,0.309856762029095,0.220723737017096,RPS27A/UBA52/ATP6V1F/ATP6V0D1/ANO10/CALM3/ATP6V1D/UBB/ATP6V0B/CALM2,10
R-HSA-1852241,R-HSA-1852241,Organelle biogenesis and maintenance,17/379,277/8183,0.143432845533259,0.318434642714986,0.226834114819659,ATP5MC2/ATP5MF/IFT22/ARF4/CALM3/DYNLL1/TCTEX1D2/CETN2/DCTN2/ATP5F1B/ATP5MG/ATP5MC3/CALM2/AKAP9/TUBB/TUBA1B/DYNC1H1,17
R-HSA-69231,R-HSA-69231,Cyclin D associated events in G1,4/379,44/8183,0.144996579727492,0.32037339520741,0.228215168092393,RPS27A/UBA52/UBB/SKP1,4
R-HSA-69236,R-HSA-69236,G1 Phase,4/379,44/8183,0.144996579727492,0.32037339520741,0.228215168092393,RPS27A/UBA52/UBB/SKP1,4
R-HSA-190828,R-HSA-190828,Gap junction trafficking,3/379,29/8183,0.148871950747525,0.328154798797395,0.23375818244642,ACTG1/ACTB/TUBA1B,3
R-HSA-1268020,R-HSA-1268020,Mitochondrial protein import,5/379,61/8183,0.151095264895918,0.328664331614177,0.234121143663457,CHCHD2/TIMM17A/COA6/ATP5F1B/TOMM7,5
R-HSA-6796648,R-HSA-6796648,TP53 Regulates Transcription of DNA Repair Genes,5/379,61/8183,0.151095264895918,0.328664331614177,0.234121143663457,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-430039,R-HSA-430039,mRNA decay by 5' to 3' exoribonuclease,2/379,15/8183,0.151228092240575,0.328664331614177,0.234121143663457,LSM6/LSM7,2
R-HSA-5358508,R-HSA-5358508,Mismatch Repair,2/379,15/8183,0.151228092240575,0.328664331614177,0.234121143663457,POLD2/PCNA,2
R-HSA-69183,R-HSA-69183,Processive synthesis on the lagging strand,2/379,15/8183,0.151228092240575,0.328664331614177,0.234121143663457,POLD2/PCNA,2
R-HSA-70221,R-HSA-70221,Glycogen breakdown (glycogenolysis),2/379,15/8183,0.151228092240575,0.328664331614177,0.234121143663457,CALM3/CALM2,2
R-HSA-6802957,R-HSA-6802957,Oncogenic MAPK signaling,6/379,78/8183,0.152049476184702,0.32967736892384,0.23484277187406,ACTG1/CALM3/ACTB/CALM2/AKAP9/PHB,6
R-HSA-5663220,R-HSA-5663220,RHO GTPases Activate Formins,9/379,131/8183,0.153209788491135,0.331418843169634,0.236083295724286,ACTG1/RHOA/SEC13/PFN1/DYNLL1/ACTB/RPS27/TUBA1B/DYNC1H1,9
R-HSA-2029480,R-HSA-2029480,Fcgamma receptor (FCGR) dependent phagocytosis,6/379,79/8183,0.158588019258116,0.342255074119841,0.243802389459233,ACTG1/BRK1/HSP90AB1/ARPC5/ACTB/CFL1,6
R-HSA-499943,R-HSA-499943,Interconversion of nucleotide di- and triphosphates,3/379,30/8183,0.160085599900408,0.343887584971246,0.244965294194581,GUK1/TXN/AK2,3
R-HSA-8866652,R-HSA-8866652,Synthesis of active ubiquitin: roles of E1 and E2 enzymes,3/379,30/8183,0.160085599900408,0.343887584971246,0.244965294194581,RPS27A/UBA52/UBB,3
R-HSA-948021,R-HSA-948021,Transport to the Golgi and subsequent modification,11/379,170/8183,0.16467128676514,0.352921372097113,0.251400432936691,LMAN2/SEC13/TMED3/ARF4/FOLR1/DYNLL1/KDELR2/DCTN2/ARF5/TUBA1B/DYNC1H1,11
R-HSA-9006934,R-HSA-9006934,Signaling by Receptor Tyrosine Kinases,23/379,400/8183,0.165325977911262,0.353508081801039,0.25181837042996,RPS27A/UBA52/ACTG1/SPINT2/BRK1/ATP6V1F/POLR2G/POLR2L/RHOA/HNRNPA1/ATP6V0D1/NCSTN/TIA1/CALM3/HNRNPH1/ATP6V1D/PSENEN/ACTB/HGF/UBB/ATP6V0B/CALM2/MET,23
R-HSA-450294,R-HSA-450294,MAP kinase activation,5/379,63/8183,0.166148217172534,0.353636572330532,0.251909899527647,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-6802952,R-HSA-6802952,Signaling by BRAF and RAF fusions,5/379,63/8183,0.166148217172534,0.353636572330532,0.251909899527647,ACTG1/CALM3/ACTB/CALM2/AKAP9,5
R-HSA-202131,R-HSA-202131,Metabolism of nitric oxide: eNOS activation and regulation,2/379,16/8183,0.167799857123683,0.353905153206314,0.252101220750414,CALM3/CALM2,2
R-HSA-389977,R-HSA-389977,Post-chaperonin tubulin folding pathway,2/379,16/8183,0.167799857123683,0.353905153206314,0.252101220750414,TBCA/TUBA1B,2
R-HSA-399954,R-HSA-399954,Sema3A PAK dependent Axon repulsion,2/379,16/8183,0.167799857123683,0.353905153206314,0.252101220750414,HSP90AB1/CFL1,2
R-HSA-8949664,R-HSA-8949664,Processing of SMDT1,2/379,16/8183,0.167799857123683,0.353905153206314,0.252101220750414,SMDT1/PHB,2
R-HSA-8856828,R-HSA-8856828,Clathrin-mediated endocytosis,9/379,134/8183,0.168350910808836,0.354262234082993,0.252355584169827,RPS27A/UBA52/ACTG1/VAMP8/COPS5/COPS3/ARPC5/ACTB/UBB,9
R-HSA-157858,R-HSA-157858,Gap junction trafficking and regulation,3/379,31/8183,0.171546133638467,0.355539946154321,0.253265751117189,ACTG1/ACTB/TUBA1B,3
R-HSA-2173796,R-HSA-2173796,SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,3/379,31/8183,0.171546133638467,0.355539946154321,0.253265751117189,RPS27A/UBA52/UBB,3
R-HSA-73863,R-HSA-73863,RNA Polymerase I Transcription Termination,3/379,31/8183,0.171546133638467,0.355539946154321,0.253265751117189,POLR2L/ZNRD1/POLR1D,3
R-HSA-1227986,R-HSA-1227986,Signaling by ERBB2,4/379,47/8183,0.171725564016074,0.355539946154321,0.253265751117189,RPS27A/UBA52/RHOA/UBB,4
R-HSA-2122947,R-HSA-2122947,NOTCH1 Intracellular Domain Regulates Transcription,4/379,47/8183,0.171725564016074,0.355539946154321,0.253265751117189,RPS27A/UBA52/UBB/SKP1,4
R-HSA-381038,R-HSA-381038,XBP1(S) activates chaperone genes,4/379,47/8183,0.171725564016074,0.355539946154321,0.253265751117189,ATP6V0D1/PDIA6/YIF1A/MYDGF,4
R-HSA-380270,R-HSA-380270,Recruitment of mitotic centrosome proteins and complexes,6/379,81/8183,0.172023098947511,0.355539946154321,0.253265751117189,DYNLL1/CETN2/DCTN2/AKAP9/TUBB/DYNC1H1,6
R-HSA-380287,R-HSA-380287,Centrosome maturation,6/379,81/8183,0.172023098947511,0.355539946154321,0.253265751117189,DYNLL1/CETN2/DCTN2/AKAP9/TUBB/DYNC1H1,6
R-HSA-1445148,R-HSA-1445148,Translocation of SLC2A4 (GLUT4) to the plasma membrane,5/379,64/8183,0.173889711966495,0.358599228233128,0.255445003777682,ACTG1/CALM3/ACTB/CALM2/TUBA1B,5
R-HSA-2672351,R-HSA-2672351,Stimuli-sensing channels,6/379,82/8183,0.178912436675477,0.36813911582005,0.262240658728439,RPS27A/UBA52/ANO10/CALM3/UBB/CALM2,6
R-HSA-3928665,R-HSA-3928665,EPH-ephrin mediated repulsion of cells,4/379,48/8183,0.180993290619752,0.371596844458251,0.264703741288319,ACTG1/NCSTN/PSENEN/ACTB,4
R-HSA-168274,R-HSA-168274,Export of Viral Ribonucleoproteins from Nucleus,3/379,32/8183,0.183231992072875,0.37334396791569,0.265948289304734,HSPA1B/SEC13/HSPA1A,3
R-HSA-5673000,R-HSA-5673000,RAF activation,3/379,32/8183,0.183231992072875,0.37334396791569,0.265948289304734,CALM3/CALM2/PHB,3
R-HSA-917729,R-HSA-917729,Endosomal Sorting Complex Required For Transport (ESCRT),3/379,32/8183,0.183231992072875,0.37334396791569,0.265948289304734,RPS27A/UBA52/UBB,3
R-HSA-201681,R-HSA-201681,TCF dependent signaling in response to WNT,12/379,193/8183,0.183937470544469,0.37334396791569,0.265948289304734,RPS27A/H3F3A/UBA52/PSMA7/PSMA4/PSMB8/SOX4/PSMB7/PSMC3/UBB/PSMC5/PSMD13,12
R-HSA-163615,R-HSA-163615,PKA activation,2/379,17/8183,0.184660432406575,0.37334396791569,0.265948289304734,CALM3/CALM2,2
R-HSA-446353,R-HSA-446353,Cell-extracellular matrix interactions,2/379,17/8183,0.184660432406575,0.37334396791569,0.265948289304734,ACTG1/ACTB,2
R-HSA-622312,R-HSA-622312,Inflammasomes,2/379,17/8183,0.184660432406575,0.37334396791569,0.265948289304734,HSP90AB1/TXN,2
R-HSA-381070,R-HSA-381070,IRE1alpha activates chaperones,4/379,49/8183,0.190423169211128,0.384158045712884,0.273651602436129,ATP6V0D1/PDIA6/YIF1A/MYDGF,4
R-HSA-2559585,R-HSA-2559585,Oncogene Induced Senescence,3/379,33/8183,0.195121909786369,0.391933186757035,0.279190155720755,RPS27A/UBA52/UBB,3
R-HSA-5654743,R-HSA-5654743,Signaling by FGFR4,3/379,33/8183,0.195121909786369,0.391933186757035,0.279190155720755,RPS27A/UBA52/UBB,3
R-HSA-167172,R-HSA-167172,Transcription of the HIV genome,5/379,67/8183,0.197904859023976,0.394966392245823,0.281350832951879,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-5685942,R-HSA-5685942,HDR through Homologous Recombination (HRR),5/379,67/8183,0.197904859023976,0.394966392245823,0.281350832951879,RPS27A/UBA52/POLD2/UBB/PCNA,5
R-HSA-8856688,R-HSA-8856688,Golgi-to-ER retrograde transport,8/379,121/8183,0.197908806459383,0.394966392245823,0.281350832951879,TMED3/ARF4/DYNLL1/KDELR2/DCTN2/ARF5/TUBA1B/DYNC1H1,8
R-HSA-5620924,R-HSA-5620924,Intraflagellar transport,4/379,50/8183,0.200004943437226,0.398293106244089,0.283720588386216,IFT22/DYNLL1/TCTEX1D2/TUBA1B,4
R-HSA-73780,R-HSA-73780,RNA Polymerase III Chain Elongation,2/379,18/8183,0.2017477407195,0.400903433378364,0.285580031943753,POLR2L/POLR1D,2
R-HSA-448424,R-HSA-448424,Interleukin-17 signaling,5/379,68/8183,0.206153522588077,0.408783053337041,0.2911930098635,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-5654741,R-HSA-5654741,Signaling by FGFR3,3/379,34/8183,0.207194988235034,0.409099891664066,0.291418706856889,RPS27A/UBA52/UBB,3
R-HSA-936440,R-HSA-936440,Negative regulators of DDX58/IFIH1 signaling,3/379,34/8183,0.207194988235034,0.409099891664066,0.291418706856889,RPS27A/UBA52/UBB,3
R-HSA-5689880,R-HSA-5689880,Ub-specific processing proteases,11/379,180/8183,0.212537444440124,0.418757427686698,0.298298167635261,RPS27A/UBA52/PSMA7/PSMA4/HIST3H2A/PSMB8/PSMB7/PSMC3/UBB/PSMC5/PSMD13,11
R-HSA-5250913,R-HSA-5250913,Positive epigenetic regulation of rRNA expression,6/379,87/8183,0.214923955146258,0.422562352490948,0.301008572327944,H3F3A/POLR2L/ZNRD1/POLR1D/ACTB/SF3B1,6
R-HSA-111931,R-HSA-111931,PKA-mediated phosphorylation of CREB,2/379,19/8183,0.219004808033639,0.425118463069141,0.302829395198979,CALM3/CALM2,2
R-HSA-392451,R-HSA-392451,G beta:gamma signalling through PI3Kgamma,2/379,19/8183,0.219004808033639,0.425118463069141,0.302829395198979,GNG5/RHOA,2
R-HSA-442982,R-HSA-442982,Ras activation upon Ca2+ influx through NMDA receptor,2/379,19/8183,0.219004808033639,0.425118463069141,0.302829395198979,CALM3/CALM2,2
R-HSA-5218921,R-HSA-5218921,VEGFR2 mediated cell proliferation,2/379,19/8183,0.219004808033639,0.425118463069141,0.302829395198979,CALM3/CALM2,2
R-HSA-8851708,R-HSA-8851708,Signaling by FGFR2 IIIa TM,2/379,19/8183,0.219004808033639,0.425118463069141,0.302829395198979,POLR2G/POLR2L,2
R-HSA-8978934,R-HSA-8978934,Metabolism of cofactors,2/379,19/8183,0.219004808033639,0.425118463069141,0.302829395198979,CALM3/CALM2,2
R-HSA-425397,R-HSA-425397,Transport of vitamins, nucleosides, and related molecules,3/379,35/8183,0.219430758416076,0.425118463069141,0.302829395198979,APOD/LCN15/SLC35B2,3
R-HSA-1169408,R-HSA-1169408,ISG15 antiviral mechanism,5/379,70/8183,0.222979505242306,0.431093710135125,0.307085809851246,RPS27A/UBA52/SEC13/UBE2N/UBB,5
R-HSA-69620,R-HSA-69620,Cell Cycle Checkpoints,16/379,280/8183,0.226049873998686,0.436121170625324,0.310667077078838,RPS27A/UBA52/ANAPC11/PSMA7/PSMA4/SEC13/UBE2N/PSMB8/PSMB7/DYNLL1/PSMC3/UBB/PSMC5/PSMD13/RPS27/DYNC1H1,16
R-HSA-2132295,R-HSA-2132295,MHC class II antigen presentation,7/379,107/8183,0.226661143620707,0.436393239170159,0.310860882711955,RAB7A/CTSL/SEC13/DYNLL1/DCTN2/TUBA1B/DYNC1H1,7
R-HSA-170834,R-HSA-170834,Signaling by TGF-beta Receptor Complex,5/379,71/8183,0.231544364663613,0.441722730510327,0.314657298956994,RPS27A/UBA52/FKBP1A/RHOA/UBB,5
R-HSA-877300,R-HSA-877300,Interferon gamma signaling,5/379,71/8183,0.231544364663613,0.441722730510327,0.314657298956994,B2M/HLA-C/HLA-A/HLA-B/MT2A,5
R-HSA-6804757,R-HSA-6804757,Regulation of TP53 Degradation,3/379,36/8183,0.231809234653588,0.441722730510327,0.314657298956994,RPS27A/UBA52/UBB,3
R-HSA-6806003,R-HSA-6806003,Regulation of TP53 Expression and Degradation,3/379,36/8183,0.231809234653588,0.441722730510327,0.314657298956994,RPS27A/UBA52/UBB,3
R-HSA-76046,R-HSA-76046,RNA Polymerase III Transcription Initiation,3/379,36/8183,0.231809234653588,0.441722730510327,0.314657298956994,POLR2L/POLR1D/GTF3C6,3
R-HSA-69186,R-HSA-69186,Lagging Strand Synthesis,2/379,20/8183,0.236379426142469,0.449508416926662,0.320203364144673,POLD2/PCNA,2
R-HSA-4420097,R-HSA-4420097,VEGFA-VEGFR2 Pathway,6/379,91/8183,0.245367021569333,0.465645390626464,0.331698395319215,ACTG1/BRK1/RHOA/CALM3/ACTB/CALM2,6
R-HSA-210991,R-HSA-210991,Basigin interactions,2/379,21/8183,0.253823835330958,0.478757152819367,0.341038443705266,PPIA/BSG,2
R-HSA-5651801,R-HSA-5651801,PCNA-Dependent Long Patch Base Excision Repair,2/379,21/8183,0.253823835330958,0.478757152819367,0.341038443705266,POLD2/PCNA,2
R-HSA-9617324,R-HSA-9617324,Negative regulation of NMDA receptor-mediated neuronal transmission,2/379,21/8183,0.253823835330958,0.478757152819367,0.341038443705266,CALM3/CALM2,2
R-HSA-5625740,R-HSA-5625740,RHO GTPases activate PKNs,5/379,75/8183,0.266669660596111,0.501966419945621,0.357571360850556,H3F3A/RHOA/MYL12B/MYL6/MYL12A,5
R-HSA-8856825,R-HSA-8856825,Cargo recognition for clathrin-mediated endocytosis,6/379,94/8183,0.268974326890216,0.503415169090577,0.358603364551818,RPS27A/UBA52/VAMP8/COPS5/COPS3/UBB,6
R-HSA-165159,R-HSA-165159,mTOR signalling,3/379,39/8183,0.269609201549587,0.503415169090577,0.358603364551818,RPS6/LAMTOR4/RRAGC,3
R-HSA-512988,R-HSA-512988,Interleukin-3, Interleukin-5 and GM-CSF signaling,3/379,39/8183,0.269609201549587,0.503415169090577,0.358603364551818,RPS27A/UBA52/UBB,3
R-HSA-5675221,R-HSA-5675221,Negative regulation of MAPK pathway,3/379,39/8183,0.269609201549587,0.503415169090577,0.358603364551818,RPS27A/UBA52/UBB,3
R-HSA-1251985,R-HSA-1251985,Nuclear signaling by ERBB4,2/379,22/8183,0.271294426094129,0.503522454830703,0.358679788604448,NCSTN/PSENEN,2
R-HSA-71403,R-HSA-71403,Citric acid cycle (TCA cycle),2/379,22/8183,0.271294426094129,0.503522454830703,0.358679788604448,SUCLG1/SDHB,2
R-HSA-8949215,R-HSA-8949215,Mitochondrial calcium ion transport,2/379,22/8183,0.271294426094129,0.503522454830703,0.358679788604448,SMDT1/PHB,2
R-HSA-168898,R-HSA-168898,Toll-like Receptor Cascades,8/379,133/8183,0.27440124473976,0.508272165905184,0.362063203480553,RPS27A/S100A1/UBA52/CTSL/UBE2N/UBB/HSP90B1/SKP1,8
R-HSA-9033241,R-HSA-9033241,Peroxisomal protein import,4/379,58/8183,0.280897871130132,0.519269371332196,0.369896965967127,RPS27A/UBA52/SCP2/UBB,4
R-HSA-437239,R-HSA-437239,Recycling pathway of L1,3/379,40/8183,0.282369761139792,0.519918925273267,0.37035966999956,ACTG1/ACTB/TUBA1B,3
R-HSA-6783310,R-HSA-6783310,Fanconi Anemia Pathway,3/379,40/8183,0.282369761139792,0.519918925273267,0.37035966999956,RPS27A/UBA52/UBB,3
R-HSA-1169410,R-HSA-1169410,Antiviral mechanism by IFN-stimulated genes,5/379,77/8183,0.284663869696683,0.522717878125692,0.372353479427104,RPS27A/UBA52/SEC13/UBE2N/UBB,5
R-HSA-5620912,R-HSA-5620912,Anchoring of the basal body to the plasma membrane,6/379,96/8183,0.285016429236638,0.522717878125692,0.372353479427104,DYNLL1/CETN2/DCTN2/AKAP9/TUBB/DYNC1H1,6
R-HSA-418360,R-HSA-418360,Platelet calcium homeostasis,2/379,23/8183,0.28875145882828,0.52748297990678,0.375747857737588,CALM3/CALM2,2
R-HSA-73980,R-HSA-73980,RNA Polymerase III Transcription Termination,2/379,23/8183,0.28875145882828,0.52748297990678,0.375747857737588,POLR2L/POLR1D,2
R-HSA-194138,R-HSA-194138,Signaling by VEGF,6/379,97/8183,0.293115565618436,0.533458434298252,0.380004420076341,ACTG1/BRK1/RHOA/CALM3/ACTB/CALM2,6
R-HSA-5688426,R-HSA-5688426,Deubiquitination,14/379,255/8183,0.293552616537385,0.533458434298252,0.380004420076341,RPS27A/UBA52/PSMA7/RHOA/PSMA4/INO80E/HIST3H2A/PSMB8/PSMB7/ACTB/PSMC3/UBB/PSMC5/PSMD13,14
R-HSA-674695,R-HSA-674695,RNA Polymerase II Pre-transcription Events,5/379,78/8183,0.29374704733449,0.533458434298252,0.380004420076341,POLR2G/POLR2L/NELFE/SUPT4H1/ELOB,5
R-HSA-74158,R-HSA-74158,RNA Polymerase III Transcription,3/379,41/8183,0.295181703762402,0.533973920256353,0.380371621961195,POLR2L/POLR1D/GTF3C6,3
R-HSA-749476,R-HSA-749476,RNA Polymerase III Abortive And Retractive Initiation,3/379,41/8183,0.295181703762402,0.533973920256353,0.380371621961195,POLR2L/POLR1D/GTF3C6,3
R-HSA-109582,R-HSA-109582,Hemostasis,24/379,461/8183,0.303887421527561,0.544477341173754,0.387853641398727,H3F3A/MIF/PPIA/TIMP1/EPCAM/BSG/CD9/LGALS3BP/CD63/GNG5/RHOA/MANF/PFN1/CALM3/MAGED2/SOD1/ACTB/HGF/CFL1/TMSB4X/ANXA5/CALM2/CLU/TUBA1B,24
R-HSA-1614635,R-HSA-1614635,Sulfur amino acid metabolism,2/379,24/8183,0.306158800476607,0.544477341173754,0.387853641398727,TSTD1/APIP,2
R-HSA-174417,R-HSA-174417,Telomere C-strand (Lagging Strand) Synthesis,2/379,24/8183,0.306158800476607,0.544477341173754,0.387853641398727,POLD2/PCNA,2
R-HSA-1839126,R-HSA-1839126,FGFR2 mutant receptor activation,2/379,24/8183,0.306158800476607,0.544477341173754,0.387853641398727,POLR2G/POLR2L,2
R-HSA-203927,R-HSA-203927,MicroRNA (miRNA) biogenesis,2/379,24/8183,0.306158800476607,0.544477341173754,0.387853641398727,POLR2G/POLR2L,2
R-HSA-379716,R-HSA-379716,Cytosolic tRNA aminoacylation,2/379,24/8183,0.306158800476607,0.544477341173754,0.387853641398727,AIMP1/PPA1,2
R-HSA-389957,R-HSA-389957,Prefoldin mediated transfer of substrate  to CCT/TriC,2/379,24/8183,0.306158800476607,0.544477341173754,0.387853641398727,ACTB/PFDN5,2
R-HSA-397795,R-HSA-397795,G-protein beta:gamma signalling,2/379,24/8183,0.306158800476607,0.544477341173754,0.387853641398727,GNG5/RHOA,2
R-HSA-168325,R-HSA-168325,Viral Messenger RNA Synthesis,3/379,42/8183,0.308028668228686,0.544477341173754,0.387853641398727,POLR2G/POLR2L/SEC13,3
R-HSA-3899300,R-HSA-3899300,SUMOylation of transcription cofactors,3/379,42/8183,0.308028668228686,0.544477341173754,0.387853641398727,SCMH1/NPM1/SUMO2,3
R-HSA-5654736,R-HSA-5654736,Signaling by FGFR1,3/379,42/8183,0.308028668228686,0.544477341173754,0.387853641398727,RPS27A/UBA52/UBB,3
R-HSA-6782315,R-HSA-6782315,tRNA modification in the nucleus and cytosol,3/379,42/8183,0.308028668228686,0.544477341173754,0.387853641398727,TRMT112/TRIT1/LAGE3,3
R-HSA-5668914,R-HSA-5668914,Diseases of metabolism,5/379,80/8183,0.312054903419375,0.550545533028859,0.392176264453407,RPS27A/UBA52/CD320/DCXR/UBB,5
R-HSA-2173793,R-HSA-2173793,Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,3/379,43/8183,0.320894963896875,0.561108135346562,0.399700441240518,RPS27A/UBA52/UBB,3
R-HSA-168142,R-HSA-168142,Toll Like Receptor 10 (TLR10) Cascade,5/379,81/8183,0.321267522134629,0.561108135346562,0.399700441240518,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-168176,R-HSA-168176,Toll Like Receptor 5 (TLR5) Cascade,5/379,81/8183,0.321267522134629,0.561108135346562,0.399700441240518,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-975871,R-HSA-975871,MyD88 cascade initiated on plasma membrane,5/379,81/8183,0.321267522134629,0.561108135346562,0.399700441240518,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-74752,R-HSA-74752,Signaling by Insulin receptor,4/379,62/8183,0.323134262712891,0.561108135346562,0.399700441240518,ATP6V1F/ATP6V0D1/ATP6V1D/ATP6V0B,4
R-HSA-180024,R-HSA-180024,DARPP-32 events,2/379,25/8183,0.323483677166391,0.561108135346562,0.399700441240518,CALM3/CALM2,2
R-HSA-1855204,R-HSA-1855204,Synthesis of IP3 and IP4 in the cytosol,2/379,25/8183,0.323483677166391,0.561108135346562,0.399700441240518,CALM3/CALM2,2
R-HSA-2514859,R-HSA-2514859,Inactivation, recovery and regulation of the phototransduction cascade,2/379,25/8183,0.323483677166391,0.561108135346562,0.399700441240518,CALM3/CALM2,2
R-HSA-445095,R-HSA-445095,Interaction between L1 and Ankyrins,2/379,25/8183,0.323483677166391,0.561108135346562,0.399700441240518,ACTG1/ACTB,2
R-HSA-4615885,R-HSA-4615885,SUMOylation of DNA replication proteins,3/379,44/8183,0.333765577372684,0.576807100120002,0.410883460611798,SEC13/SUMO2/PCNA,3
R-HSA-198933,R-HSA-198933,Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell,4/379,63/8183,0.333777384444441,0.576807100120002,0.410883460611798,B2M/HLA-C/HLA-A/HLA-B,4
R-HSA-5693567,R-HSA-5693567,HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA),7/379,122/8183,0.335902216885778,0.579400106449819,0.41273056584674,RPS27A/UBA52/UBE2N/POLD2/SUMO2/UBB/PCNA,7
R-HSA-110373,R-HSA-110373,Resolution of AP sites via the multiple-nucleotide patch replacement pathway,2/379,26/8183,0.340696441927362,0.582258375890594,0.41476662892388,POLD2/PCNA,2
R-HSA-2514856,R-HSA-2514856,The phototransduction cascade,2/379,26/8183,0.340696441927362,0.582258375890594,0.41476662892388,CALM3/CALM2,2
R-HSA-5601884,R-HSA-5601884,PIWI-interacting RNA (piRNA) biogenesis,2/379,26/8183,0.340696441927362,0.582258375890594,0.41476662892388,POLR2G/POLR2L,2
R-HSA-8874081,R-HSA-8874081,MET activates PTK2 signaling,2/379,26/8183,0.340696441927362,0.582258375890594,0.41476662892388,HGF/MET,2
R-HSA-983695,R-HSA-983695,Antigen activates B Cell Receptor (BCR) leading to generation of second messengers,2/379,26/8183,0.340696441927362,0.582258375890594,0.41476662892388,CALM3/CALM2,2
R-HSA-4570464,R-HSA-4570464,SUMOylation of RNA binding proteins,3/379,45/8183,0.346626175627293,0.591303476070088,0.421209826420162,SEC13/SCMH1/SUMO2,3
R-HSA-975138,R-HSA-975138,TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation,5/379,84/8183,0.349069495917754,0.594378884792066,0.423400566752969,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-2559580,R-HSA-2559580,Oxidative Stress Induced Senescence,6/379,104/8183,0.350864655698473,0.595251189192291,0.424021945114291,RPS27A/H3F3A/UBA52/TXN/SCMH1/UBB,6
R-HSA-72306,R-HSA-72306,tRNA processing,6/379,104/8183,0.350864655698473,0.595251189192291,0.424021945114291,TRMT112/POP7/SEC13/TRIT1/HSD17B10/LAGE3,6
R-HSA-400253,R-HSA-400253,Circadian Clock,4/379,65/8183,0.355103424283069,0.597072950528761,0.425319660766858,RPS27A/UBA52/UBB/SKP1,4
R-HSA-5693565,R-HSA-5693565,Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks,4/379,65/8183,0.355103424283069,0.597072950528761,0.425319660766858,RPS27A/UBA52/UBE2N/UBB,4
R-HSA-167160,R-HSA-167160,RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,2/379,27/8183,0.357770356630559,0.597072950528761,0.425319660766858,POLR2G/POLR2L,2
R-HSA-442742,R-HSA-442742,CREB1 phosphorylation through NMDA receptor-mediated activation of RAS signaling,2/379,27/8183,0.357770356630559,0.597072950528761,0.425319660766858,CALM3/CALM2,2
R-HSA-5218920,R-HSA-5218920,VEGFR2 mediated vascular permeability,2/379,27/8183,0.357770356630559,0.597072950528761,0.425319660766858,CALM3/CALM2,2
R-HSA-70263,R-HSA-70263,Gluconeogenesis,2/379,27/8183,0.357770356630559,0.597072950528761,0.425319660766858,GAPDH/TPI1,2
R-HSA-77075,R-HSA-77075,RNA Pol II CTD phosphorylation and interaction with CE,2/379,27/8183,0.357770356630559,0.597072950528761,0.425319660766858,POLR2G/POLR2L,2
R-HSA-977606,R-HSA-977606,Regulation of Complement cascade,2/379,27/8183,0.357770356630559,0.597072950528761,0.425319660766858,CD46/CLU,2
R-HSA-168181,R-HSA-168181,Toll Like Receptor 7/8 (TLR7/8) Cascade,5/379,85/8183,0.358372449832457,0.597072950528761,0.425319660766858,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-975155,R-HSA-975155,MyD88 dependent cascade initiated on endosome,5/379,85/8183,0.358372449832457,0.597072950528761,0.425319660766858,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-177929,R-HSA-177929,Signaling by EGFR,3/379,46/8183,0.359463105918011,0.597816778300922,0.425849519933052,RPS27A/UBA52/UBB,3
R-HSA-5693606,R-HSA-5693606,DNA Double Strand Break Response,4/379,66/8183,0.365769840899925,0.60613287920559,0.431773421212693,RPS27A/UBA52/UBE2N/UBB,4
R-HSA-73856,R-HSA-73856,RNA Polymerase II Transcription Termination,4/379,66/8183,0.365769840899925,0.60613287920559,0.431773421212693,SNRPB/MAGOH/SRSF11/SRSF7,4
R-HSA-421270,R-HSA-421270,Cell-cell junction organization,3/379,47/8183,0.372263392865871,0.60867544538234,0.433584595848581,ACTG1/CDH18/ACTB,3
R-HSA-73762,R-HSA-73762,RNA Polymerase I Transcription Initiation,3/379,47/8183,0.372263392865871,0.60867544538234,0.433584595848581,POLR2L/ZNRD1/POLR1D,3
R-HSA-2871809,R-HSA-2871809,FCERI mediated Ca+2 mobilization,2/379,28/8183,0.374681387334035,0.60867544538234,0.433584595848581,CALM3/CALM2,2
R-HSA-380972,R-HSA-380972,Energy dependent regulation of mTOR by LKB1-AMPK,2/379,28/8183,0.374681387334035,0.60867544538234,0.433584595848581,LAMTOR4/RRAGC,2
R-HSA-76071,R-HSA-76071,RNA Polymerase III Transcription Initiation From Type 3 Promoter,2/379,28/8183,0.374681387334035,0.60867544538234,0.433584595848581,POLR2L/POLR1D,2
R-HSA-9009391,R-HSA-9009391,Non-genomic estrogen signaling,4/379,67/8183,0.376427934987287,0.60867544538234,0.433584595848581,UHMK1/GNG5/CALM3/CALM2,4
R-HSA-111367,R-HSA-111367,SLBP independent Processing of Histone Pre-mRNAs,1/379,10/8183,0.37779855230628,0.60867544538234,0.433584595848581,SNRPB,1
R-HSA-111458,R-HSA-111458,Formation of apoptosome,1/379,10/8183,0.37779855230628,0.60867544538234,0.433584595848581,APIP,1
R-HSA-1170546,R-HSA-1170546,Prolactin receptor signaling,1/379,10/8183,0.37779855230628,0.60867544538234,0.433584595848581,SKP1,1
R-HSA-1234158,R-HSA-1234158,Regulation of gene expression by Hypoxia-inducible Factor,1/379,10/8183,0.37779855230628,0.60867544538234,0.433584595848581,CA9,1
R-HSA-3215018,R-HSA-3215018,Processing and activation of SUMO,1/379,10/8183,0.37779855230628,0.60867544538234,0.433584595848581,SUMO2,1
R-HSA-390450,R-HSA-390450,Folding of actin by CCT/TriC,1/379,10/8183,0.37779855230628,0.60867544538234,0.433584595848581,ACTB,1
R-HSA-5578768,R-HSA-5578768,Physiological factors,1/379,10/8183,0.37779855230628,0.60867544538234,0.433584595848581,NPPA,1
R-HSA-9018677,R-HSA-9018677,Biosynthesis of DHA-derived SPMs,1/379,10/8183,0.37779855230628,0.60867544538234,0.433584595848581,GPX4,1
R-HSA-9617629,R-HSA-9617629,Regulation of FOXO transcriptional activity by acetylation,1/379,10/8183,0.37779855230628,0.60867544538234,0.433584595848581,TXN,1
R-HSA-9627069,R-HSA-9627069,Regulation of the apoptosome activity,1/379,10/8183,0.37779855230628,0.60867544538234,0.433584595848581,APIP,1
R-HSA-5693538,R-HSA-5693538,Homology Directed Repair,7/379,128/8183,0.381733483479787,0.613949172736989,0.437341289109379,RPS27A/UBA52/UBE2N/POLD2/SUMO2/UBB/PCNA,7
R-HSA-109606,R-HSA-109606,Intrinsic Pathway for Apoptosis,3/379,48/8183,0.385014733015612,0.61703386637155,0.439538643467937,BAD/DYNLL1/APIP,3
R-HSA-5617833,R-HSA-5617833,Cilium Assembly,10/379,190/8183,0.385200374048559,0.61703386637155,0.439538643467937,IFT22/ARF4/DYNLL1/TCTEX1D2/CETN2/DCTN2/AKAP9/TUBB/TUBA1B/DYNC1H1,10
R-HSA-391251,R-HSA-391251,Protein folding,5/379,88/8183,0.386311073665809,0.61703386637155,0.439538643467937,GNG5/TBCA/ACTB/PFDN5/TUBA1B,5
R-HSA-5693607,R-HSA-5693607,Processing of DNA double-strand break ends,5/379,88/8183,0.386311073665809,0.61703386637155,0.439538643467937,RPS27A/UBA52/UBE2N/SUMO2/UBB,5
R-HSA-438064,R-HSA-438064,Post NMDA receptor activation events,4/379,68/8183,0.387070085762238,0.617183916816764,0.439645530581814,GRIA2/CALM3/CALM2/TUBA1B,4
R-HSA-71387,R-HSA-71387,Metabolism of carbohydrates,13/379,253/8183,0.390390750464467,0.620900231424258,0.442292814580801,RPS27A/GAPDH/UBA52/TPI1/HEXB/PGLS/SEC13/CALM3/DCXR/UBB/SLC35B2/CALM2/TKT,13
R-HSA-114452,R-HSA-114452,Activation of BH3-only proteins,2/379,29/8183,0.39140801226637,0.620900231424258,0.442292814580801,BAD/DYNLL1,2
R-HSA-72086,R-HSA-72086,mRNA Capping,2/379,29/8183,0.39140801226637,0.620900231424258,0.442292814580801,POLR2G/POLR2L,2
R-HSA-166058,R-HSA-166058,MyD88:MAL(TIRAP) cascade initiated on plasma membrane,5/379,89/8183,0.395616286413136,0.622257481002356,0.443259639371007,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-168138,R-HSA-168138,Toll Like Receptor 9 (TLR9) Cascade,5/379,89/8183,0.395616286413136,0.622257481002356,0.443259639371007,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-168188,R-HSA-168188,Toll Like Receptor TLR6:TLR2 Cascade,5/379,89/8183,0.395616286413136,0.622257481002356,0.443259639371007,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-2559582,R-HSA-2559582,Senescence-Associated Secretory Phenotype (SASP),5/379,89/8183,0.395616286413136,0.622257481002356,0.443259639371007,RPS27A/H3F3A/UBA52/ANAPC11/UBB,5
R-HSA-6811434,R-HSA-6811434,COPI-dependent Golgi-to-ER retrograde traffic,5/379,89/8183,0.395616286413136,0.622257481002356,0.443259639371007,TMED3/ARF4/KDELR2/ARF5/TUBA1B,5
R-HSA-168164,R-HSA-168164,Toll Like Receptor 3 (TLR3) Cascade,5/379,90/8183,0.404909191214708,0.625719019367212,0.445725435756136,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-168179,R-HSA-168179,Toll Like Receptor TLR1:TLR2 Cascade,5/379,90/8183,0.404909191214708,0.625719019367212,0.445725435756136,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-181438,R-HSA-181438,Toll Like Receptor 2 (TLR2) Cascade,5/379,90/8183,0.404909191214708,0.625719019367212,0.445725435756136,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-1187000,R-HSA-1187000,Fertilization,1/379,11/8183,0.406651402994634,0.625719019367212,0.445725435756136,CD9,1
R-HSA-2022857,R-HSA-2022857,Keratan sulfate degradation,1/379,11/8183,0.406651402994634,0.625719019367212,0.445725435756136,HEXB,1
R-HSA-2032785,R-HSA-2032785,YAP1- and WWTR1 (TAZ)-stimulated gene expression,1/379,11/8183,0.406651402994634,0.625719019367212,0.445725435756136,NPPA,1
R-HSA-2160916,R-HSA-2160916,Hyaluronan uptake and degradation,1/379,11/8183,0.406651402994634,0.625719019367212,0.445725435756136,HEXB,1
R-HSA-2453902,R-HSA-2453902,The canonical retinoid cycle in rods (twilight vision),1/379,11/8183,0.406651402994634,0.625719019367212,0.445725435756136,RBP1,1
R-HSA-3296469,R-HSA-3296469,Defects in cobalamin (B12) metabolism,1/379,11/8183,0.406651402994634,0.625719019367212,0.445725435756136,CD320,1
R-HSA-5625970,R-HSA-5625970,RHO GTPases activate KTN1,1/379,11/8183,0.406651402994634,0.625719019367212,0.445725435756136,RHOA,1
R-HSA-5686938,R-HSA-5686938,Regulation of TLR by endogenous ligand,1/379,11/8183,0.406651402994634,0.625719019367212,0.445725435756136,S100A1,1
R-HSA-77588,R-HSA-77588,SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs,1/379,11/8183,0.406651402994634,0.625719019367212,0.445725435756136,SNRPB,1
R-HSA-879415,R-HSA-879415,Advanced glycosylation endproduct receptor signaling,1/379,11/8183,0.406651402994634,0.625719019367212,0.445725435756136,PRKCSH,1
R-HSA-180786,R-HSA-180786,Extension of Telomeres,2/379,30/8183,0.407931041721081,0.625719019367212,0.445725435756136,POLD2/PCNA,2
R-HSA-5694530,R-HSA-5694530,Cargo concentration in the ER,2/379,30/8183,0.407931041721081,0.625719019367212,0.445725435756136,LMAN2/FOLR1,2
R-HSA-159236,R-HSA-159236,Transport of Mature mRNA derived from an Intron-Containing Transcript,4/379,71/8183,0.418828608896339,0.641374503392413,0.456877481999133,SEC13/MAGOH/SRSF11/SRSF7,4
R-HSA-9006936,R-HSA-9006936,Signaling by TGF-beta family members,5/379,92/8183,0.423438655663395,0.647365852480446,0.461145366785072,RPS27A/UBA52/FKBP1A/RHOA/UBB,5
R-HSA-196854,R-HSA-196854,Metabolism of vitamins and cofactors,8/379,155/8183,0.428724685220219,0.652609767081189,0.464880823193043,RBP1/CYB5A/CD320/CALM3/NAXE/SHMT2/CALM2/GSTO1,8
R-HSA-73772,R-HSA-73772,RNA Polymerase I Promoter Escape,4/379,72/8183,0.429336050287659,0.652609767081189,0.464880823193043,H3F3A/POLR2L/ZNRD1/POLR1D,4
R-HSA-111461,R-HSA-111461,Cytochrome c-mediated apoptotic response,1/379,12/8183,0.434169650457316,0.652609767081189,0.464880823193043,APIP,1
R-HSA-1614558,R-HSA-1614558,Degradation of cysteine and homocysteine,1/379,12/8183,0.434169650457316,0.652609767081189,0.464880823193043,TSTD1,1
R-HSA-190840,R-HSA-190840,Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane,1/379,12/8183,0.434169650457316,0.652609767081189,0.464880823193043,TUBA1B,1
R-HSA-190872,R-HSA-190872,Transport of connexons to the plasma membrane,1/379,12/8183,0.434169650457316,0.652609767081189,0.464880823193043,TUBA1B,1
R-HSA-416993,R-HSA-416993,Trafficking of GluR2-containing AMPA receptors,1/379,12/8183,0.434169650457316,0.652609767081189,0.464880823193043,GRIA2,1
R-HSA-6785631,R-HSA-6785631,ERBB2 Regulates Cell Motility,1/379,12/8183,0.434169650457316,0.652609767081189,0.464880823193043,RHOA,1
R-HSA-74217,R-HSA-74217,Purine salvage,1/379,12/8183,0.434169650457316,0.652609767081189,0.464880823193043,APRT,1
R-HSA-9018678,R-HSA-9018678,Biosynthesis of specialized proresolving mediators (SPMs),1/379,12/8183,0.434169650457316,0.652609767081189,0.464880823193043,GPX4,1
R-HSA-191859,R-HSA-191859,snRNP Assembly,3/379,52/8183,0.435307592481957,0.652609767081189,0.464880823193043,SNRPB/SEC13/SNRPD2,3
R-HSA-194441,R-HSA-194441,Metabolism of non-coding RNA,3/379,52/8183,0.435307592481957,0.652609767081189,0.464880823193043,SNRPB/SEC13/SNRPD2,3
R-HSA-180746,R-HSA-180746,Nuclear import of Rev protein,2/379,32/8183,0.440300212981867,0.655856497025958,0.467193602690905,SEC13/NPM1,2
R-HSA-180910,R-HSA-180910,Vpr-mediated nuclear import of PICs,2/379,32/8183,0.440300212981867,0.655856497025958,0.467193602690905,BANF1/SEC13,2
R-HSA-6802948,R-HSA-6802948,Signaling by high-kinase activity BRAF mutants,2/379,32/8183,0.440300212981867,0.655856497025958,0.467193602690905,ACTG1/ACTB,2
R-HSA-69190,R-HSA-69190,DNA strand elongation,2/379,32/8183,0.440300212981867,0.655856497025958,0.467193602690905,POLD2/PCNA,2
R-HSA-166166,R-HSA-166166,MyD88-independent TLR4 cascade ,5/379,94/8183,0.441862000145187,0.656076697815573,0.46735046078514,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-937061,R-HSA-937061,TRIF(TICAM1)-mediated TLR4 signaling ,5/379,94/8183,0.441862000145187,0.656076697815573,0.46735046078514,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-4086398,R-HSA-4086398,Ca2+ pathway,3/379,53/8183,0.447652525946149,0.662554296775162,0.471964721387026,GNG5/CALM3/CALM2,3
R-HSA-6809371,R-HSA-6809371,Formation of the cornified envelope,3/379,53/8183,0.447652525946149,0.662554296775162,0.471964721387026,KRT18/KRT19/KRT12,3
R-HSA-111933,R-HSA-111933,Calmodulin induced events,2/379,33/8183,0.456118168026737,0.663626830581817,0.472728731403563,CALM3/CALM2,2
R-HSA-111997,R-HSA-111997,CaM pathway,2/379,33/8183,0.456118168026737,0.663626830581817,0.472728731403563,CALM3/CALM2,2
R-HSA-166658,R-HSA-166658,Complement cascade,2/379,33/8183,0.456118168026737,0.663626830581817,0.472728731403563,CD46/CLU,2
R-HSA-4085377,R-HSA-4085377,SUMOylation of SUMOylation proteins,2/379,33/8183,0.456118168026737,0.663626830581817,0.472728731403563,SEC13/SUMO2,2
R-HSA-77289,R-HSA-77289,Mitochondrial Fatty Acid Beta-Oxidation,2/379,33/8183,0.456118168026737,0.663626830581817,0.472728731403563,DBI/DECR1,2
R-HSA-8864260,R-HSA-8864260,Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors,2/379,33/8183,0.456118168026737,0.663626830581817,0.472728731403563,KDM5B/NPM1,2
R-HSA-9022692,R-HSA-9022692,Regulation of MECP2 expression and activity,2/379,33/8183,0.456118168026737,0.663626830581817,0.472728731403563,CALM3/CALM2,2
R-HSA-2151201,R-HSA-2151201,Transcriptional activation of mitochondrial biogenesis,3/379,54/8183,0.459888250679795,0.663626830581817,0.472728731403563,CALM3/ATP5F1B/CALM2,3
R-HSA-1362409,R-HSA-1362409,Mitochondrial iron-sulfur cluster biogenesis,1/379,13/8183,0.460414871663616,0.663626830581817,0.472728731403563,ISCU,1
R-HSA-196741,R-HSA-196741,Cobalamin (Cbl, vitamin B12) transport and metabolism,1/379,13/8183,0.460414871663616,0.663626830581817,0.472728731403563,CD320,1
R-HSA-2024101,R-HSA-2024101,CS/DS degradation,1/379,13/8183,0.460414871663616,0.663626830581817,0.472728731403563,HEXB,1
R-HSA-2046104,R-HSA-2046104,alpha-linolenic (omega3) and linoleic (omega6) acid metabolism,1/379,13/8183,0.460414871663616,0.663626830581817,0.472728731403563,SCP2,1
R-HSA-2046106,R-HSA-2046106,alpha-linolenic acid (ALA) metabolism,1/379,13/8183,0.460414871663616,0.663626830581817,0.472728731403563,SCP2,1
R-HSA-2559584,R-HSA-2559584,Formation of Senescence-Associated Heterochromatin Foci (SAHF),1/379,13/8183,0.460414871663616,0.663626830581817,0.472728731403563,HIST1H1C,1
R-HSA-2995383,R-HSA-2995383,Initiation of Nuclear Envelope Reformation,1/379,13/8183,0.460414871663616,0.663626830581817,0.472728731403563,BANF1,1
R-HSA-2995410,R-HSA-2995410,Nuclear Envelope Reassembly,1/379,13/8183,0.460414871663616,0.663626830581817,0.472728731403563,BANF1,1
R-HSA-3108214,R-HSA-3108214,SUMOylation of DNA damage response and repair proteins,4/379,75/8183,0.460534136739968,0.663626830581817,0.472728731403563,SEC13/SCMH1/SUMO2/CETN2,4
R-HSA-442755,R-HSA-442755,Activation of NMDA receptors and postsynaptic events,4/379,76/8183,0.470806254771682,0.675486426476437,0.481176810148823,GRIA2/CALM3/CALM2/TUBA1B,4
R-HSA-111996,R-HSA-111996,Ca-dependent events,2/379,34/8183,0.471675866763719,0.675486426476437,0.481176810148823,CALM3/CALM2,2
R-HSA-5576892,R-HSA-5576892,Phase 0 - rapid depolarisation,2/379,34/8183,0.471675866763719,0.675486426476437,0.481176810148823,CALM3/CALM2,2
R-HSA-5655253,R-HSA-5655253,Signaling by FGFR2 in disease,2/379,34/8183,0.471675866763719,0.675486426476437,0.481176810148823,POLR2G/POLR2L,2
R-HSA-432722,R-HSA-432722,Golgi Associated Vesicle Biogenesis,3/379,56/8183,0.48400101490421,0.688828304874958,0.490680779788423,FTH1/FTL/VAMP8,3
R-HSA-111471,R-HSA-111471,Apoptotic factor-mediated response,1/379,14/8183,0.485445809685585,0.688828304874958,0.490680779788423,APIP,1
R-HSA-198323,R-HSA-198323,AKT phosphorylates targets in the cytosol,1/379,14/8183,0.485445809685585,0.688828304874958,0.490680779788423,BAD,1
R-HSA-2142845,R-HSA-2142845,Hyaluronan metabolism,1/379,14/8183,0.485445809685585,0.688828304874958,0.490680779788423,HEXB,1
R-HSA-8849471,R-HSA-8849471,PTK6 Regulates RHO GTPases, RAS GTPase and MAP kinases,1/379,14/8183,0.485445809685585,0.688828304874958,0.490680779788423,RHOA,1
R-HSA-8964315,R-HSA-8964315,G beta:gamma signalling through BTK,1/379,14/8183,0.485445809685585,0.688828304874958,0.490680779788423,GNG5,1
R-HSA-176033,R-HSA-176033,Interactions of Vpr with host cellular proteins,2/379,35/8183,0.486963449087819,0.688875123099841,0.490714130338816,BANF1/SEC13,2
R-HSA-177243,R-HSA-177243,Interactions of Rev with host cellular proteins,2/379,35/8183,0.486963449087819,0.688875123099841,0.490714130338816,SEC13/NPM1,2
R-HSA-72187,R-HSA-72187,mRNA 3'-end processing,3/379,57/8183,0.495863929615606,0.700398366336807,0.498922611229032,MAGOH/SRSF11/SRSF7,3
R-HSA-5674135,R-HSA-5674135,MAP2K and MAPK activation,2/379,36/8183,0.501972520525126,0.706874808873015,0.503536048062901,ACTG1/ACTB,2
R-HSA-8875878,R-HSA-8875878,MET promotes cell motility,2/379,36/8183,0.501972520525126,0.706874808873015,0.503536048062901,HGF/MET,2
R-HSA-8943724,R-HSA-8943724,Regulation of PTEN gene transcription,3/379,58/8183,0.507589350987541,0.710748227843619,0.506295243972088,SCMH1/LAMTOR4/RRAGC,3
R-HSA-111447,R-HSA-111447,Activation of BAD and translocation to mitochondria ,1/379,15/8183,0.5093185037888,0.710748227843619,0.506295243972088,BAD,1
R-HSA-197264,R-HSA-197264,Nicotinamide salvaging,1/379,15/8183,0.5093185037888,0.710748227843619,0.506295243972088,NAXE,1
R-HSA-204174,R-HSA-204174,Regulation of pyruvate dehydrogenase (PDH) complex,1/379,15/8183,0.5093185037888,0.710748227843619,0.506295243972088,PDHB,1
R-HSA-392851,R-HSA-392851,Prostacyclin signalling through prostacyclin receptor,1/379,15/8183,0.5093185037888,0.710748227843619,0.506295243972088,GNG5,1
R-HSA-9614657,R-HSA-9614657,FOXO-mediated transcription of cell death genes,1/379,15/8183,0.5093185037888,0.710748227843619,0.506295243972088,DDIT3,1
R-HSA-72202,R-HSA-72202,Transport of Mature Transcript to Cytoplasm,4/379,80/8183,0.511121168618588,0.712192859576651,0.507324314671208,SEC13/MAGOH/SRSF11/SRSF7,4
R-HSA-2559583,R-HSA-2559583,Cellular Senescence,8/379,168/8183,0.519847964406603,0.723266733087448,0.51521269099242,RPS27A/H3F3A/UBA52/ANAPC11/TXN/SCMH1/UBB/HIST1H1C,8
R-HSA-8939211,R-HSA-8939211,ESR-mediated signaling,9/379,190/8183,0.521487632885171,0.724461861253651,0.516064030021884,H3F3A/TFF3/HSP90AB1/UHMK1/POLR2G/POLR2L/GNG5/CALM3/CALM2,9
R-HSA-196849,R-HSA-196849,Metabolism of water-soluble vitamins and cofactors,5/379,103/8183,0.522564221606776,0.724872343275168,0.516356433276776,CYB5A/CD320/NAXE/SHMT2/GSTO1,5
R-HSA-163125,R-HSA-163125,Post-translational modification: synthesis of GPI-anchored proteins,3/379,60/8183,0.530605262281475,0.732605625800725,0.521865169014128,NRN1/GPAA1/PIGP,3
R-HSA-390466,R-HSA-390466,Chaperonin-mediated protein folding,4/379,82/8183,0.530751507855121,0.732605625800725,0.521865169014128,GNG5/ACTB/PFDN5/TUBA1B,4
R-HSA-1660662,R-HSA-1660662,Glycosphingolipid metabolism,2/379,38/8183,0.531128204487574,0.732605625800725,0.521865169014128,HEXB/NEU1,2
R-HSA-4655427,R-HSA-4655427,SUMOylation of DNA methylation proteins,1/379,16/8183,0.532086413566475,0.732605625800725,0.521865169014128,SCMH1,1
R-HSA-8964616,R-HSA-8964616,G beta:gamma signalling through CDC42,1/379,16/8183,0.532086413566475,0.732605625800725,0.521865169014128,GNG5,1
R-HSA-68877,R-HSA-68877,Mitotic Prometaphase,9/379,193/8183,0.540680015430268,0.742668928752836,0.529033674293082,SEC13/DYNLL1/CETN2/DCTN2/RPS27/AKAP9/TUBB/TUBA1B/DYNC1H1,9
R-HSA-168928,R-HSA-168928,DDX58/IFIH1-mediated induction of interferon-alpha/beta,3/379,61/8183,0.541885751359638,0.742668928752836,0.529033674293082,RPS27A/UBA52/UBB,3
R-HSA-211945,R-HSA-211945,Phase I - Functionalization of compounds,3/379,61/8183,0.541885751359638,0.742668928752836,0.529033674293082,HSP90AB1/AIP/EPHX1,3
R-HSA-1489509,R-HSA-1489509,DAG and IP3 signaling,2/379,39/8183,0.545264366808546,0.742668928752836,0.529033674293082,CALM3/CALM2,2
R-HSA-73933,R-HSA-73933,Resolution of Abasic Sites (AP sites),2/379,39/8183,0.545264366808546,0.742668928752836,0.529033674293082,POLD2/PCNA,2
R-HSA-397014,R-HSA-397014,Muscle contraction,7/379,150/8183,0.547075124071966,0.742668928752836,0.529033674293082,MYL12B/MYL6/CALM3/NPPA/MYL12A/CALM2/AKAP9,7
R-HSA-212165,R-HSA-212165,Epigenetic regulation of gene expression,6/379,128/8183,0.547494179495218,0.742668928752836,0.529033674293082,H3F3A/POLR2L/ZNRD1/POLR1D/ACTB/SF3B1,6
R-HSA-70171,R-HSA-70171,Glycolysis,3/379,62/8183,0.553008708409472,0.742668928752836,0.529033674293082,GAPDH/TPI1/SEC13,3
R-HSA-1296041,R-HSA-1296041,Activation of G protein gated Potassium channels,1/379,17/8183,0.553800537388968,0.742668928752836,0.529033674293082,GNG5,1
R-HSA-1296059,R-HSA-1296059,G protein gated Potassium channels,1/379,17/8183,0.553800537388968,0.742668928752836,0.529033674293082,GNG5,1
R-HSA-162710,R-HSA-162710,Synthesis of glycosylphosphatidylinositol (GPI),1/379,17/8183,0.553800537388968,0.742668928752836,0.529033674293082,PIGP,1
R-HSA-193368,R-HSA-193368,Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol,1/379,17/8183,0.553800537388968,0.742668928752836,0.529033674293082,SCP2,1
R-HSA-196757,R-HSA-196757,Metabolism of folate and pterines,1/379,17/8183,0.553800537388968,0.742668928752836,0.529033674293082,SHMT2,1
R-HSA-3232118,R-HSA-3232118,SUMOylation of transcription factors,1/379,17/8183,0.553800537388968,0.742668928752836,0.529033674293082,SUMO2,1
R-HSA-392170,R-HSA-392170,ADP signalling through P2Y purinoceptor 12,1/379,17/8183,0.553800537388968,0.742668928752836,0.529033674293082,GNG5,1
R-HSA-418217,R-HSA-418217,G beta:gamma signalling through PLC beta,1/379,17/8183,0.553800537388968,0.742668928752836,0.529033674293082,GNG5,1
R-HSA-5576893,R-HSA-5576893,Phase 2 - plateau phase,1/379,17/8183,0.553800537388968,0.742668928752836,0.529033674293082,AKAP9,1
R-HSA-997272,R-HSA-997272,Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits,1/379,17/8183,0.553800537388968,0.742668928752836,0.529033674293082,GNG5,1
R-HSA-5578749,R-HSA-5578749,Transcriptional regulation by small RNAs,4/379,86/8183,0.5688055045219,0.759465583472233,0.540998623435302,H3F3A/POLR2G/POLR2L/SEC13,4
R-HSA-164938,R-HSA-164938,Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,1/379,18/8183,0.574509525428349,0.759465583472233,0.540998623435302,B2M,1
R-HSA-416700,R-HSA-416700,Other semaphorin interactions,1/379,18/8183,0.574509525428349,0.759465583472233,0.540998623435302,SEMA3E,1
R-HSA-418592,R-HSA-418592,ADP signalling through P2Y purinoceptor 1,1/379,18/8183,0.574509525428349,0.759465583472233,0.540998623435302,GNG5,1
R-HSA-428930,R-HSA-428930,Thromboxane signalling through TP receptor,1/379,18/8183,0.574509525428349,0.759465583472233,0.540998623435302,GNG5,1
R-HSA-500657,R-HSA-500657,Presynaptic function of Kainate receptors,1/379,18/8183,0.574509525428349,0.759465583472233,0.540998623435302,GNG5,1
R-HSA-5609975,R-HSA-5609975,Diseases associated with glycosylation precursor biosynthesis,1/379,18/8183,0.574509525428349,0.759465583472233,0.540998623435302,NEU1,1
R-HSA-5620916,R-HSA-5620916,VxPx cargo-targeting to cilium,1/379,18/8183,0.574509525428349,0.759465583472233,0.540998623435302,ARF4,1
R-HSA-6804114,R-HSA-6804114,TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest,1/379,18/8183,0.574509525428349,0.759465583472233,0.540998623435302,PCNA,1
R-HSA-8964038,R-HSA-8964038,LDL clearance,1/379,18/8183,0.574509525428349,0.759465583472233,0.540998623435302,NPC2,1
R-HSA-9006931,R-HSA-9006931,Signaling by Nuclear Receptors,10/379,221/8183,0.576816094249613,0.761430064670897,0.542398004325457,H3F3A/TFF3/HSP90AB1/UHMK1/POLR2G/POLR2L/GNG5/PDHB/CALM3/CALM2,10
R-HSA-427413,R-HSA-427413,NoRC negatively regulates rRNA expression,4/379,87/8183,0.578049211966642,0.761973961228756,0.542785444250974,H3F3A/POLR2L/ZNRD1/POLR1D,4
R-HSA-5693532,R-HSA-5693532,DNA Double-Strand Break Repair,7/379,155/8183,0.582266550032367,0.766444480042605,0.545969978977718,RPS27A/UBA52/UBE2N/POLD2/SUMO2/UBB/PCNA,7
R-HSA-204005,R-HSA-204005,COPII-mediated vesicle transport,3/379,65/8183,0.585395897941685,0.767914197155825,0.547016919026609,LMAN2/SEC13/FOLR1,3
R-HSA-2187338,R-HSA-2187338,Visual phototransduction,3/379,65/8183,0.585395897941685,0.767914197155825,0.547016919026609,RBP1/CALM3/CALM2,3
R-HSA-379724,R-HSA-379724,tRNA Aminoacylation,2/379,42/8183,0.585865572830091,0.767914197155825,0.547016919026609,AIMP1/PPA1,2
R-HSA-69618,R-HSA-69618,Mitotic Spindle Checkpoint,5/379,111/8183,0.589817454678507,0.769139585502667,0.547889813629396,ANAPC11/SEC13/DYNLL1/RPS27/DYNC1H1,5
R-HSA-1362277,R-HSA-1362277,Transcription of E2F targets under negative control by DREAM complex,1/379,19/8183,0.594259787505833,0.769139585502667,0.547889813629396,PCNA,1
R-HSA-1592389,R-HSA-1592389,Activation of Matrix Metalloproteinases,1/379,19/8183,0.594259787505833,0.769139585502667,0.547889813629396,TIMP1,1
R-HSA-176407,R-HSA-176407,Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase,1/379,19/8183,0.594259787505833,0.769139585502667,0.547889813629396,ANAPC11,1
R-HSA-176412,R-HSA-176412,Phosphorylation of the APC/C,1/379,19/8183,0.594259787505833,0.769139585502667,0.547889813629396,ANAPC11,1
R-HSA-190861,R-HSA-190861,Gap junction assembly,1/379,19/8183,0.594259787505833,0.769139585502667,0.547889813629396,TUBA1B,1
R-HSA-3296482,R-HSA-3296482,Defects in vitamin and cofactor metabolism,1/379,19/8183,0.594259787505833,0.769139585502667,0.547889813629396,CD320,1
R-HSA-389960,R-HSA-389960,Formation of tubulin folding intermediates by CCT/TriC,1/379,19/8183,0.594259787505833,0.769139585502667,0.547889813629396,TUBA1B,1
R-HSA-3928664,R-HSA-3928664,Ephrin signaling,1/379,19/8183,0.594259787505833,0.769139585502667,0.547889813629396,MYL12A,1
R-HSA-15869,R-HSA-15869,Metabolism of nucleotides,4/379,90/8183,0.605091327484478,0.778237831782566,0.554370869282499,GUK1/TXN/APRT/AK2,4
R-HSA-5250941,R-HSA-5250941,Negative epigenetic regulation of rRNA expression,4/379,90/8183,0.605091327484478,0.778237831782566,0.554370869282499,H3F3A/POLR2L/ZNRD1/POLR1D,4
R-HSA-418346,R-HSA-418346,Platelet homeostasis,3/379,67/8183,0.606139891608295,0.778237831782566,0.554370869282499,GNG5/CALM3/CALM2,3
R-HSA-4551638,R-HSA-4551638,SUMOylation of chromatin organization proteins,3/379,67/8183,0.606139891608295,0.778237831782566,0.554370869282499,SEC13/SCMH1/SUMO2,3
R-HSA-194315,R-HSA-194315,Signaling by Rho GTPases,18/379,405/8183,0.608127663301067,0.778237831782566,0.554370869282499,H3F3A/ACTG1/BRK1/RHOA/MYL12B/MYL6/SEC13/PFN1/CALM3/ARPC5/DYNLL1/MYL12A/ACTB/CFL1/RPS27/CALM2/TUBA1B/DYNC1H1,18
R-HSA-5578775,R-HSA-5578775,Ion homeostasis,2/379,44/8183,0.611411225102815,0.778237831782566,0.554370869282499,CALM3/CALM2,2
R-HSA-1296065,R-HSA-1296065,Inwardly rectifying K+ channels,1/379,20/8183,0.613095595998641,0.778237831782566,0.554370869282499,GNG5,1
R-HSA-141405,R-HSA-141405,Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components,1/379,20/8183,0.613095595998641,0.778237831782566,0.554370869282499,ANAPC11,1
R-HSA-141430,R-HSA-141430,Inactivation of APC/C via direct inhibition of the APC/C complex,1/379,20/8183,0.613095595998641,0.778237831782566,0.554370869282499,ANAPC11,1
R-HSA-156584,R-HSA-156584,Cytosolic sulfonation of small molecules,1/379,20/8183,0.613095595998641,0.778237831782566,0.554370869282499,SLC35B2,1
R-HSA-6804115,R-HSA-6804115,TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain,1/379,20/8183,0.613095595998641,0.778237831782566,0.554370869282499,NPM1,1
R-HSA-8862803,R-HSA-8862803,Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,1/379,20/8183,0.613095595998641,0.778237831782566,0.554370869282499,PRDX2,1
R-HSA-8863678,R-HSA-8863678,Neurodegenerative Diseases,1/379,20/8183,0.613095595998641,0.778237831782566,0.554370869282499,PRDX2,1
R-HSA-202733,R-HSA-202733,Cell surface interactions at the vascular wall,4/379,91/8183,0.613868634552627,0.778237831782566,0.554370869282499,MIF/PPIA/EPCAM/BSG,4
R-HSA-73854,R-HSA-73854,RNA Polymerase I Promoter Clearance,4/379,91/8183,0.613868634552627,0.778237831782566,0.554370869282499,H3F3A/POLR2L/ZNRD1/POLR1D,4
R-HSA-73894,R-HSA-73894,DNA Repair,14/379,318/8183,0.617810887972789,0.780078812083285,0.555682275395081,RPS27A/UBA52/POLR2G/POLR2L/INO80E/UBE2N/COPS5/COPS3/POLD2/SUMO2/ACTB/CETN2/UBB/PCNA,14
R-HSA-166016,R-HSA-166016,Toll Like Receptor 4 (TLR4) Cascade,5/379,115/8183,0.62143236621775,0.780078812083285,0.555682275395081,RPS27A/UBA52/UBE2N/UBB/SKP1,5
R-HSA-73864,R-HSA-73864,RNA Polymerase I Transcription,4/379,92/8183,0.622524542683956,0.780078812083285,0.555682275395081,H3F3A/POLR2L/ZNRD1/POLR1D,4
R-HSA-1483249,R-HSA-1483249,Inositol phosphate metabolism,2/379,45/8183,0.623726808799351,0.780078812083285,0.555682275395081,CALM3/CALM2,2
R-HSA-167161,R-HSA-167161,HIV Transcription Initiation,2/379,45/8183,0.623726808799351,0.780078812083285,0.555682275395081,POLR2G/POLR2L,2
R-HSA-167162,R-HSA-167162,RNA Polymerase II HIV Promoter Escape,2/379,45/8183,0.623726808799351,0.780078812083285,0.555682275395081,POLR2G/POLR2L,2
R-HSA-73776,R-HSA-73776,RNA Polymerase II Promoter Escape,2/379,45/8183,0.623726808799351,0.780078812083285,0.555682275395081,POLR2G/POLR2L,2
R-HSA-73779,R-HSA-73779,RNA Polymerase II Transcription Pre-Initiation And Promoter Opening,2/379,45/8183,0.623726808799351,0.780078812083285,0.555682275395081,POLR2G/POLR2L,2
R-HSA-75953,R-HSA-75953,RNA Polymerase II Transcription Initiation,2/379,45/8183,0.623726808799351,0.780078812083285,0.555682275395081,POLR2G/POLR2L,2
R-HSA-76042,R-HSA-76042,RNA Polymerase II Transcription Initiation And Promoter Clearance,2/379,45/8183,0.623726808799351,0.780078812083285,0.555682275395081,POLR2G/POLR2L,2
R-HSA-202040,R-HSA-202040,G-protein activation,1/379,21/8183,0.631059184032025,0.782918345964866,0.557704992361542,GNG5,1
R-HSA-5223345,R-HSA-5223345,Miscellaneous transport and binding events,1/379,21/8183,0.631059184032025,0.782918345964866,0.557704992361542,TUSC3,1
R-HSA-6783783,R-HSA-6783783,Interleukin-10 signaling,1/379,21/8183,0.631059184032025,0.782918345964866,0.557704992361542,TIMP1,1
R-HSA-70895,R-HSA-70895,Branched-chain amino acid catabolism,1/379,21/8183,0.631059184032025,0.782918345964866,0.557704992361542,HSD17B10,1
R-HSA-8956321,R-HSA-8956321,Nucleotide salvage,1/379,21/8183,0.631059184032025,0.782918345964866,0.557704992361542,APRT,1
R-HSA-9634638,R-HSA-9634638,Estrogen-dependent nuclear events downstream of ESR-membrane signaling,1/379,21/8183,0.631059184032025,0.782918345964866,0.557704992361542,UHMK1,1
R-HSA-6811442,R-HSA-6811442,Intra-Golgi and retrograde Golgi-to-ER traffic,8/379,187/8183,0.642301771030972,0.795802461304062,0.566882878515144,TMED3/ARF4/DYNLL1/KDELR2/DCTN2/ARF5/TUBA1B/DYNC1H1,8
R-HSA-936837,R-HSA-936837,Ion transport by P-type ATPases,2/379,47/8183,0.64744881317965,0.796716687088141,0.567534119205255,CALM3/CALM2,2
R-HSA-141424,R-HSA-141424,Amplification of signal from the kinetochores,4/379,95/8183,0.647749434847507,0.796716687088141,0.567534119205255,SEC13/DYNLL1/RPS27/DYNC1H1,4
R-HSA-141444,R-HSA-141444,Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal,4/379,95/8183,0.647749434847507,0.796716687088141,0.567534119205255,SEC13/DYNLL1/RPS27/DYNC1H1,4
R-HSA-1474228,R-HSA-1474228,Degradation of the extracellular matrix,4/379,95/8183,0.647749434847507,0.796716687088141,0.567534119205255,TIMP1/BSG/NCSTN/CTSL,4
R-HSA-196071,R-HSA-196071,Metabolism of steroid hormones,1/379,22/8183,0.648190839171925,0.796716687088141,0.567534119205255,TSPO,1
R-HSA-420092,R-HSA-420092,Glucagon-type ligand receptors,1/379,22/8183,0.648190839171925,0.796716687088141,0.567534119205255,GNG5,1
R-HSA-2500257,R-HSA-2500257,Resolution of Sister Chromatid Cohesion,5/379,119/8183,0.651559443060434,0.799797834867835,0.569728947705309,SEC13/DYNLL1/RPS27/TUBA1B/DYNC1H1,5
R-HSA-199992,R-HSA-199992,trans-Golgi Network Vesicle Budding,3/379,72/8183,0.654920416439144,0.801802304031036,0.571156813670021,FTH1/FTL/VAMP8,3
R-HSA-6785807,R-HSA-6785807,Interleukin-4 and Interleukin-13 signaling,3/379,72/8183,0.654920416439144,0.801802304031036,0.571156813670021,TIMP1/HGF/HSP90B1,3
R-HSA-112043,R-HSA-112043,PLC beta mediated events,2/379,48/8183,0.658858990578086,0.803444340678665,0.572326504022461,CALM3/CALM2,2
R-HSA-6791312,R-HSA-6791312,TP53 Regulates Transcription of Cell Cycle Genes,2/379,48/8183,0.658858990578086,0.803444340678665,0.572326504022461,NPM1/PCNA,2
R-HSA-75153,R-HSA-75153,Apoptotic execution phase,2/379,48/8183,0.658858990578086,0.803444340678665,0.572326504022461,HMGB2/HIST1H1C,2
R-HSA-446728,R-HSA-446728,Cell junction organization,3/379,73/8183,0.664140144879437,0.805069067024266,0.57348386353362,ACTG1/CDH18/ACTB,3
R-HSA-164952,R-HSA-164952,The role of Nef in HIV-1 replication and disease pathogenesis,1/379,23/8183,0.664528992823909,0.805069067024266,0.57348386353362,B2M,1
R-HSA-381753,R-HSA-381753,Olfactory Signaling Pathway,1/379,23/8183,0.664528992823909,0.805069067024266,0.57348386353362,REEP5,1
R-HSA-392518,R-HSA-392518,Signal amplification,1/379,23/8183,0.664528992823909,0.805069067024266,0.57348386353362,GNG5,1
R-HSA-5357769,R-HSA-5357769,Caspase activation via extrinsic apoptotic signalling pathway,1/379,23/8183,0.664528992823909,0.805069067024266,0.57348386353362,MAGED1,1
R-HSA-112040,R-HSA-112040,G-protein mediated events,2/379,49/8183,0.66997190561644,0.810604861032668,0.577427237668461,CALM3/CALM2,2
R-HSA-6807505,R-HSA-6807505,RNA polymerase II transcribes snRNA genes,3/379,74/8183,0.673180093338612,0.813425946117489,0.579436812796941,POLR2G/POLR2L/SUPT4H1,3
R-HSA-1266695,R-HSA-1266695,Interleukin-7 signaling,1/379,24/8183,0.680110305534661,0.815191769665629,0.580694681658365,HGF,1
R-HSA-191273,R-HSA-191273,Cholesterol biosynthesis,1/379,24/8183,0.680110305534661,0.815191769665629,0.580694681658365,FDFT1,1
R-HSA-2424491,R-HSA-2424491,DAP12 signaling,1/379,24/8183,0.680110305534661,0.815191769665629,0.580694681658365,B2M,1
R-HSA-399719,R-HSA-399719,Trafficking of AMPA receptors,1/379,24/8183,0.680110305534661,0.815191769665629,0.580694681658365,GRIA2,1
R-HSA-399721,R-HSA-399721,Glutamate binding, activation of AMPA receptors and synaptic plasticity,1/379,24/8183,0.680110305534661,0.815191769665629,0.580694681658365,GRIA2,1
R-HSA-4090294,R-HSA-4090294,SUMOylation of intracellular receptors,1/379,24/8183,0.680110305534661,0.815191769665629,0.580694681658365,SUMO2,1
R-HSA-2980766,R-HSA-2980766,Nuclear Envelope Breakdown,2/379,50/8183,0.680790540399636,0.815191769665629,0.580694681658365,BANF1/SEC13,2
R-HSA-373760,R-HSA-373760,L1CAM interactions,4/379,100/8183,0.687253942338688,0.821870693930802,0.585452354569583,ACTG1/CD24/ACTB/TUBA1B,4
R-HSA-196807,R-HSA-196807,Nicotinate metabolism,1/379,25/8183,0.694969748383339,0.826835803204793,0.588989206457135,NAXE,1
R-HSA-380994,R-HSA-380994,ATF4 activates genes in response to endoplasmic reticulum  stress,1/379,25/8183,0.694969748383339,0.826835803204793,0.588989206457135,DDIT3,1
R-HSA-400042,R-HSA-400042,Adrenaline,noradrenaline inhibits insulin secretion,1/379,25/8183,0.694969748383339,0.826835803204793,0.588989206457135,GNG5,1
R-HSA-5674400,R-HSA-5674400,Constitutive Signaling by AKT1 E17K in Cancer,1/379,25/8183,0.694969748383339,0.826835803204793,0.588989206457135,BAD,1
R-HSA-6805567,R-HSA-6805567,Keratinization,3/379,77/8183,0.699223168338894,0.830831114236227,0.591835231102939,KRT18/KRT19/KRT12,3
R-HSA-9018519,R-HSA-9018519,Estrogen-dependent gene expression,5/379,127/8183,0.707091480647107,0.838321721828516,0.597171099487645,H3F3A/TFF3/HSP90AB1/POLR2G/POLR2L,5
R-HSA-70326,R-HSA-70326,Glucose metabolism,3/379,78/8183,0.707546977701167,0.838321721828516,0.597171099487645,GAPDH/TPI1/SEC13,3
R-HSA-192105,R-HSA-192105,Synthesis of bile acids and bile salts,1/379,26/8183,0.709140680641578,0.838321721828516,0.597171099487645,SCP2,1
R-HSA-456926,R-HSA-456926,Thrombin signalling through proteinase activated receptors (PARs),1/379,26/8183,0.709140680641578,0.838321721828516,0.597171099487645,GNG5,1
R-HSA-193648,R-HSA-193648,NRAGE signals death through JNK,2/379,53/8183,0.711515767549699,0.840059328608296,0.598408868382498,BAD/MAGED1,2
R-HSA-1226099,R-HSA-1226099,Signaling by FGFR in disease,2/379,54/8183,0.721193748967773,0.849001358467087,0.60477864464307,POLR2G/POLR2L,2
R-HSA-1538133,R-HSA-1538133,G0 and Early G1,1/379,27/8183,0.722654923872772,0.849001358467087,0.60477864464307,PCNA,1
R-HSA-389661,R-HSA-389661,Glyoxylate metabolism and glycine degradation,1/379,27/8183,0.722654923872772,0.849001358467087,0.60477864464307,PDHB,1
R-HSA-5576891,R-HSA-5576891,Cardiac conduction,4/379,105/8183,0.72353535912125,0.849001358467087,0.60477864464307,CALM3/NPPA/CALM2/AKAP9,4
R-HSA-111885,R-HSA-111885,Opioid Signalling,3/379,80/8183,0.723663873434769,0.849001358467087,0.60477864464307,GNG5/CALM3/CALM2,3
R-HSA-112314,R-HSA-112314,Neurotransmitter receptors and postsynaptic signal transmission,6/379,155/8183,0.730324480813312,0.851101931027252,0.60627496901669,GNG5/GRIA2/CALM3/GRIK2/CALM2/TUBA1B,6
R-HSA-2219530,R-HSA-2219530,Constitutive Signaling by Aberrant PI3K in Cancer,2/379,55/8183,0.730597027807466,0.851101931027252,0.60627496901669,HGF/MET,2
R-HSA-2219528,R-HSA-2219528,PI3K/AKT Signaling in Cancer,3/379,81/8183,0.731459264885773,0.851101931027252,0.60627496901669,BAD/HGF/MET,3
R-HSA-416476,R-HSA-416476,G alpha (q) signalling events,5/379,131/8183,0.732432279823999,0.851101931027252,0.60627496901669,TAC3/GRP/GNG5/GHRL/GNRH2,5
R-HSA-114604,R-HSA-114604,GPVI-mediated activation cascade,1/379,28/8183,0.735542832633465,0.851101931027252,0.60627496901669,RHOA,1
R-HSA-163359,R-HSA-163359,Glucagon signaling in metabolic regulation,1/379,28/8183,0.735542832633465,0.851101931027252,0.60627496901669,GNG5,1
R-HSA-2172127,R-HSA-2172127,DAP12 interactions,1/379,28/8183,0.735542832633465,0.851101931027252,0.60627496901669,B2M,1
R-HSA-390918,R-HSA-390918,Peroxisomal lipid metabolism,1/379,28/8183,0.735542832633465,0.851101931027252,0.60627496901669,SCP2,1
R-HSA-4085001,R-HSA-4085001,Sialic acid metabolism,1/379,28/8183,0.735542832633465,0.851101931027252,0.60627496901669,NEU1,1
R-HSA-69205,R-HSA-69205,G1/S-Specific Transcription,1/379,28/8183,0.735542832633465,0.851101931027252,0.60627496901669,PCNA,1
R-HSA-75067,R-HSA-75067,Processing of Capped Intronless Pre-mRNA,1/379,28/8183,0.735542832633465,0.851101931027252,0.60627496901669,SNRPB,1
R-HSA-429914,R-HSA-429914,Deadenylation-dependent mRNA decay,2/379,56/8183,0.739730213470549,0.85275731441077,0.60745416679896,LSM6/LSM7,2
R-HSA-6784531,R-HSA-6784531,tRNA processing in the nucleus,2/379,56/8183,0.739730213470549,0.85275731441077,0.60745416679896,POP7/SEC13,2
R-HSA-9614085,R-HSA-9614085,FOXO-mediated transcription,2/379,56/8183,0.739730213470549,0.85275731441077,0.60745416679896,TXN/DDIT3,2
R-HSA-170822,R-HSA-170822,Regulation of Glucokinase by Glucokinase Regulatory Protein,1/379,29/8183,0.74783336193229,0.856776987497735,0.610317545540582,SEC13,1
R-HSA-5619107,R-HSA-5619107,Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),1/379,29/8183,0.74783336193229,0.856776987497735,0.610317545540582,SEC13,1
R-HSA-8964043,R-HSA-8964043,Plasma lipoprotein clearance,1/379,29/8183,0.74783336193229,0.856776987497735,0.610317545540582,NPC2,1
R-HSA-977444,R-HSA-977444,GABA B receptor activation,1/379,29/8183,0.74783336193229,0.856776987497735,0.610317545540582,GNG5,1
R-HSA-991365,R-HSA-991365,Activation of GABAB receptors,1/379,29/8183,0.74783336193229,0.856776987497735,0.610317545540582,GNG5,1
R-HSA-1638074,R-HSA-1638074,Keratan sulfate/keratin metabolism,1/379,30/8183,0.759554131594746,0.864866544932422,0.616080070573459,HEXB,1
R-HSA-168271,R-HSA-168271,Transport of Ribonucleoproteins into the Host Nucleus,1/379,30/8183,0.759554131594746,0.864866544932422,0.616080070573459,SEC13,1
R-HSA-168333,R-HSA-168333,NEP/NS2 Interacts with the Cellular Export Machinery,1/379,30/8183,0.759554131594746,0.864866544932422,0.616080070573459,SEC13,1
R-HSA-381042,R-HSA-381042,PERK regulates gene expression,1/379,30/8183,0.759554131594746,0.864866544932422,0.616080070573459,DDIT3,1
R-HSA-975634,R-HSA-975634,Retinoid metabolism and transport,1/379,30/8183,0.759554131594746,0.864866544932422,0.616080070573459,RBP1,1
R-HSA-5362517,R-HSA-5362517,Signaling by Retinoic Acid,1/379,31/8183,0.770731487675402,0.875445312806332,0.623615762752242,PDHB,1
R-HSA-9609736,R-HSA-9609736,Assembly and cell surface presentation of NMDA receptors,1/379,31/8183,0.770731487675402,0.875445312806332,0.623615762752242,TUBA1B,1
R-HSA-211000,R-HSA-211000,Gene Silencing by RNA,4/379,113/8183,0.774939875935584,0.879149394704428,0.626254332888363,H3F3A/POLR2G/POLR2L/SEC13,4
R-HSA-194068,R-HSA-194068,Bile acid and bile salt metabolism,1/379,32/8183,0.781390561052613,0.884305415435152,0.629927178871683,SCP2,1
R-HSA-8955332,R-HSA-8955332,Carboxyterminal post-translational modifications of tubulin,1/379,32/8183,0.781390561052613,0.884305415435152,0.629927178871683,TUBA1B,1
R-HSA-6804756,R-HSA-6804756,Regulation of TP53 Activity through Phosphorylation,3/379,89/8183,0.787716117996309,0.890378267357582,0.634253121484303,RPS27A/UBA52/UBB,3
R-HSA-3214841,R-HSA-3214841,PKMTs methylate histone lysines,2/379,62/8183,0.789133056144223,0.890894739783259,0.634621026070652,KMT2E/NSD3,2
R-HSA-159227,R-HSA-159227,Transport of the SLBP independent Mature mRNA,1/379,33/8183,0.791555323334671,0.891460364143902,0.63502394360523,SEC13,1
R-HSA-165054,R-HSA-165054,Rev-mediated nuclear export of HIV RNA,1/379,33/8183,0.791555323334671,0.891460364143902,0.63502394360523,SEC13,1
R-HSA-3108232,R-HSA-3108232,SUMO E3 ligases SUMOylate target proteins,6/379,167/8183,0.792576374164596,0.891528333605752,0.635072361053099,SEC13/SCMH1/NPM1/SUMO2/CETN2/PCNA,6
R-HSA-373080,R-HSA-373080,Class B/2 (Secretin family receptors),2/379,63/8183,0.796515442424108,0.894775858129994,0.637385706562654,GNG5/RAMP1,2
R-HSA-159230,R-HSA-159230,Transport of the SLBP Dependant Mature mRNA,1/379,34/8183,0.801248640200458,0.894775858129994,0.637385706562654,SEC13,1
R-HSA-3301854,R-HSA-3301854,Nuclear Pore Complex (NPC) Disassembly,1/379,34/8183,0.801248640200458,0.894775858129994,0.637385706562654,SEC13,1
R-HSA-381676,R-HSA-381676,Glucagon-like Peptide-1 (GLP1) regulates insulin secretion,1/379,34/8183,0.801248640200458,0.894775858129994,0.637385706562654,GNG5,1
R-HSA-6788656,R-HSA-6788656,Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism,1/379,34/8183,0.801248640200458,0.894775858129994,0.637385706562654,PCBD1,1
R-HSA-6806667,R-HSA-6806667,Metabolism of fat-soluble vitamins,1/379,34/8183,0.801248640200458,0.894775858129994,0.637385706562654,RBP1,1
R-HSA-2142753,R-HSA-2142753,Arachidonic acid metabolism,1/379,35/8183,0.810492322292006,0.901842775883671,0.642419763220219,GPX4,1
R-HSA-432040,R-HSA-432040,Vasopressin regulates renal water homeostasis via Aquaporins,1/379,35/8183,0.810492322292006,0.901842775883671,0.642419763220219,GNG5,1
R-HSA-432720,R-HSA-432720,Lysosome Vesicle Biogenesis,1/379,35/8183,0.810492322292006,0.901842775883671,0.642419763220219,VAMP8,1
R-HSA-375276,R-HSA-375276,Peptide ligand-binding receptors,3/379,93/8183,0.811978526915013,0.902414458655248,0.642826996410499,TAC3/GRP/GHRL,3
R-HSA-3214847,R-HSA-3214847,HATs acetylate histones,4/379,121/8183,0.818525211475025,0.905705351439722,0.645171234918495,KANSL1/VPS72/HIST3H2A/ACTB,4
R-HSA-2990846,R-HSA-2990846,SUMOylation,6/379,173/8183,0.81929407762578,0.905705351439722,0.645171234918495,SEC13/SCMH1/NPM1/SUMO2/CETN2/PCNA,6
R-HSA-383280,R-HSA-383280,Nuclear Receptor transcription pathway,1/379,36/8183,0.81930717377106,0.905705351439722,0.645171234918495,NR0B2,1
R-HSA-8957322,R-HSA-8957322,Metabolism of steroids,4/379,122/8183,0.823453716819167,0.905705351439722,0.645171234918495,SCP2/TSPO/SUMO2/FDFT1,4
R-HSA-1474290,R-HSA-1474290,Collagen formation,2/379,67/8183,0.823806148810492,0.905705351439722,0.645171234918495,PPIB/CTSL,2
R-HSA-416482,R-HSA-416482,G alpha (12/13) signalling events,2/379,67/8183,0.823806148810492,0.905705351439722,0.645171234918495,GNG5/RHOA,2
R-HSA-425407,R-HSA-425407,SLC-mediated transmembrane transport,6/379,175/8183,0.827573968840933,0.905705351439722,0.645171234918495,APOD/BSG/CALM3/LCN15/SLC35B2/CALM2,6
R-HSA-3232142,R-HSA-3232142,SUMOylation of ubiquitinylation proteins,1/379,37/8183,0.827713038646568,0.905705351439722,0.645171234918495,SEC13,1
R-HSA-5633008,R-HSA-5633008,TP53 Regulates Transcription of Cell Death Genes,1/379,37/8183,0.827713038646568,0.905705351439722,0.645171234918495,TMEM219,1
R-HSA-6814122,R-HSA-6814122,Cooperation of PDCL (PhLP1) and TRiC/CCT in G-protein beta folding,1/379,37/8183,0.827713038646568,0.905705351439722,0.645171234918495,GNG5,1
R-HSA-8939243,R-HSA-8939243,RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known,1/379,37/8183,0.827713038646568,0.905705351439722,0.645171234918495,SCMH1,1
R-HSA-5617472,R-HSA-5617472,Activation of anterior HOX genes in hindbrain development during early embryogenesis,3/379,96/8183,0.828603279496038,0.905705351439722,0.645171234918495,H3F3A/POLR2G/POLR2L,3
R-HSA-5619507,R-HSA-5619507,Activation of HOX genes during differentiation,3/379,96/8183,0.828603279496038,0.905705351439722,0.645171234918495,H3F3A/POLR2G/POLR2L,3
R-HSA-73886,R-HSA-73886,Chromosome Maintenance,3/379,96/8183,0.828603279496038,0.905705351439722,0.645171234918495,NPM1/POLD2/PCNA,3
R-HSA-157579,R-HSA-157579,Telomere Maintenance,2/379,68/8183,0.830095704661589,0.906269192854065,0.64557288238697,POLD2/PCNA,2
R-HSA-168276,R-HSA-168276,NS1 Mediated Effects on Host Pathways,1/379,38/8183,0.83572884497519,0.907083471505235,0.646152926616706,SEC13,1
R-HSA-3560782,R-HSA-3560782,Diseases associated with glycosaminoglycan metabolism,1/379,38/8183,0.83572884497519,0.907083471505235,0.646152926616706,HEXB,1
R-HSA-418597,R-HSA-418597,G alpha (z) signalling events,1/379,38/8183,0.83572884497519,0.907083471505235,0.646152926616706,GNG5,1
R-HSA-445717,R-HSA-445717,Aquaporin-mediated transport,1/379,38/8183,0.83572884497519,0.907083471505235,0.646152926616706,GNG5,1
R-HSA-977443,R-HSA-977443,GABA receptor activation,1/379,38/8183,0.83572884497519,0.907083471505235,0.646152926616706,GNG5,1
R-HSA-159231,R-HSA-159231,Transport of Mature mRNA Derived from an Intronless Transcript,1/379,40/8183,0.850661665545811,0.921136552656374,0.656163515277,SEC13,1
R-HSA-168253,R-HSA-168253,Host Interactions with Influenza Factors,1/379,40/8183,0.850661665545811,0.921136552656374,0.656163515277,SEC13,1
R-HSA-112315,R-HSA-112315,Transmission across Chemical Synapses,7/379,208/8183,0.854574557945694,0.924295092976228,0.658413473671814,GNG5/GRIA2/COMT/CALM3/GRIK2/CALM2/TUBA1B,7
R-HSA-1442490,R-HSA-1442490,Collagen degradation,1/379,41/8183,0.857612326083468,0.924347147238142,0.658450554067098,CTSL,1
R-HSA-159234,R-HSA-159234,Transport of Mature mRNAs Derived from Intronless Transcripts,1/379,41/8183,0.857612326083468,0.924347147238142,0.658450554067098,SEC13,1
R-HSA-1500931,R-HSA-1500931,Cell-Cell communication,3/379,102/8183,0.858103739178374,0.924347147238142,0.658450554067098,ACTG1/CDH18/ACTB,3
R-HSA-8936459,R-HSA-8936459,RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function,2/379,73/8183,0.858606940645775,0.924347147238142,0.658450554067098,H3F3A/KMT2E,2
R-HSA-2426168,R-HSA-2426168,Activation of gene expression by SREBF (SREBP),1/379,42/8183,0.864240295675014,0.927184964608569,0.660472048291948,FDFT1,1
R-HSA-3214842,R-HSA-3214842,HDMs demethylate histones,1/379,42/8183,0.864240295675014,0.927184964608569,0.660472048291948,KDM5B,1
R-HSA-8854214,R-HSA-8854214,TBC/RABGAPs,1/379,42/8183,0.864240295675014,0.927184964608569,0.660472048291948,RAB7A,1
R-HSA-425393,R-HSA-425393,Transport of inorganic cations/anions and amino acids/oligopeptides,2/379,75/8183,0.868736243798117,0.930932141160107,0.663141316525122,CALM3/CALM2,2
R-HSA-73728,R-HSA-73728,RNA Polymerase I Promoter Opening,1/379,44/8183,0.876587245489338,0.938261780639106,0.668362520691197,H3F3A,1
R-HSA-2022090,R-HSA-2022090,Assembly of collagen fibrils and other multimeric structures,1/379,45/8183,0.882334073595928,0.93937318890364,0.669154222585624,CTSL,1
R-HSA-5334118,R-HSA-5334118,DNA methylation,1/379,45/8183,0.882334073595928,0.93937318890364,0.669154222585624,H3F3A,1
R-HSA-428157,R-HSA-428157,Sphingolipid metabolism,2/379,78/8183,0.882686875780144,0.93937318890364,0.669154222585624,HEXB/NEU1,2
R-HSA-6811558,R-HSA-6811558,PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling,2/379,78/8183,0.882686875780144,0.93937318890364,0.669154222585624,HGF/MET,2
R-HSA-73884,R-HSA-73884,Base Excision Repair,2/379,78/8183,0.882686875780144,0.93937318890364,0.669154222585624,POLD2/PCNA,2
R-HSA-1793185,R-HSA-1793185,Chondroitin sulfate/dermatan sulfate metabolism,1/379,47/8183,0.893039298136472,0.947131964195024,0.674681117870321,HEXB,1
R-HSA-5620920,R-HSA-5620920,Cargo trafficking to the periciliary membrane,1/379,47/8183,0.893039298136472,0.947131964195024,0.674681117870321,ARF4,1
R-HSA-5625886,R-HSA-5625886,Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3,1/379,47/8183,0.893039298136472,0.947131964195024,0.674681117870321,H3F3A,1
R-HSA-418555,R-HSA-418555,G alpha (s) signalling events,3/379,112/8183,0.897467721354771,0.950244337633968,0.676898189693888,GNG5/REEP5/RAMP1,3
R-HSA-1650814,R-HSA-1650814,Collagen biosynthesis and modifying enzymes,1/379,48/8183,0.898021857871757,0.950244337633968,0.676898189693888,PPIB,1
R-HSA-174824,R-HSA-174824,Plasma lipoprotein assembly, remodeling, and clearance,1/379,49/8183,0.902772898543742,0.9530874901709,0.678923484377638,NPC2,1
R-HSA-427359,R-HSA-427359,SIRT1 negatively regulates rRNA expression,1/379,49/8183,0.902772898543742,0.9530874901709,0.678923484377638,H3F3A,1
R-HSA-8978868,R-HSA-8978868,Fatty acid metabolism,4/379,143/8183,0.903789861368957,0.9530874901709,0.678923484377638,DBI/SCP2/DECR1/GPX4,4
R-HSA-983189,R-HSA-983189,Kinesins,1/379,50/8183,0.907303150750765,0.955706383537696,0.680789030015509,TUBA1B,1
R-HSA-373076,R-HSA-373076,Class A/1 (Rhodopsin-like receptors),4/379,145/8183,0.909433459709849,0.956457145726947,0.68132382885268,TAC3/GRP/GHRL/GNRH2,4
R-HSA-199418,R-HSA-199418,Negative regulation of the PI3K/AKT network,2/379,85/8183,0.910077219479412,0.956457145726947,0.68132382885268,HGF/MET,2
R-HSA-68875,R-HSA-68875,Mitotic Prophase,3/379,120/8183,0.92157967758123,0.966097169163786,0.688190814694711,H3F3A/BANF1/SEC13,3
R-HSA-212300,R-HSA-212300,PRC2 methylates histones and DNA,1/379,54/8183,0.923413996819265,0.966097169163786,0.688190814694711,H3F3A,1
R-HSA-2299718,R-HSA-2299718,Condensation of Prophase Chromosomes,1/379,54/8183,0.923413996819265,0.966097169163786,0.688190814694711,H3F3A,1
R-HSA-425366,R-HSA-425366,Transport of bile salts and organic acids, metal ions and amine compounds,1/379,54/8183,0.923413996819265,0.966097169163786,0.688190814694711,BSG,1
R-HSA-1655829,R-HSA-1655829,Regulation of cholesterol biosynthesis by SREBP (SREBF),1/379,55/8183,0.926984681430595,0.968740748161703,0.690073944924625,FDFT1,1
R-HSA-163685,R-HSA-163685,Integration of energy metabolism,2/379,92/8183,0.931395371669544,0.971315939815402,0.691908360031843,GNG5/TKT,2
R-HSA-427389,R-HSA-427389,ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression,1/379,57/8183,0.933635580081184,0.971315939815402,0.691908360031843,H3F3A,1
R-HSA-446219,R-HSA-446219,Synthesis of substrates in N-glycan biosythesis,1/379,57/8183,0.933635580081184,0.971315939815402,0.691908360031843,NEU1,1
R-HSA-8873719,R-HSA-8873719,RAB geranylgeranylation,1/379,57/8183,0.933635580081184,0.971315939815402,0.691908360031843,RAB7A,1
R-HSA-983231,R-HSA-983231,Factors involved in megakaryocyte development and platelet production,3/379,126/8183,0.936138116991472,0.972828860658551,0.692986075877461,H3F3A/ACTB/TUBA1B,3
R-HSA-5693571,R-HSA-5693571,Nonhomologous End-Joining (NHEJ),1/379,59/8183,0.939682106848425,0.975419457668163,0.694831464854363,UBE2N,1
R-HSA-606279,R-HSA-606279,Deposition of new CENPA-containing nucleosomes at the centromere,1/379,61/8183,0.945179049390333,0.978309347537707,0.696890052465608,NPM1,1
R-HSA-774815,R-HSA-774815,Nucleosome assembly,1/379,61/8183,0.945179049390333,0.978309347537707,0.696890052465608,NPM1,1
R-HSA-3247509,R-HSA-3247509,Chromatin modifying enzymes,7/379,249/8183,0.94749071131835,0.978309347537707,0.696890052465608,KANSL1/VPS72/KMT2E/KDM5B/HIST3H2A/ACTB/NSD3,7
R-HSA-4839726,R-HSA-4839726,Chromatin organization,7/379,249/8183,0.94749071131835,0.978309347537707,0.696890052465608,KANSL1/VPS72/KMT2E/KDM5B/HIST3H2A/ACTB/NSD3,7
R-HSA-216083,R-HSA-216083,Integrin cell surface interactions,1/379,62/8183,0.947737180427154,0.978309347537707,0.696890052465608,BSG,1
R-HSA-2559586,R-HSA-2559586,DNA Damage/Telomere Stress Induced Senescence,1/379,63/8183,0.950176240717526,0.979737279317627,0.697907227100124,HIST1H1C,1
R-HSA-3214858,R-HSA-3214858,RMTs methylate histone arginines,1/379,65/8183,0.954719006176481,0.981150872349694,0.69891418765382,HIST3H2A,1
R-HSA-422356,R-HSA-422356,Regulation of insulin secretion,1/379,65/8183,0.954719006176481,0.981150872349694,0.69891418765382,GNG5,1
R-HSA-912446,R-HSA-912446,Meiotic recombination,1/379,65/8183,0.954719006176481,0.981150872349694,0.69891418765382,H3F3A,1
R-HSA-500792,R-HSA-500792,GPCR ligand binding,6/379,227/8183,0.955852713545574,0.981229334259173,0.698970079304402,TAC3/GRP/GNG5/GHRL/GNRH2/RAMP1,6
R-HSA-1474165,R-HSA-1474165,Reproduction,2/379,105/8183,0.958936615438748,0.983307380251004,0.700450357075352,H3F3A/CD9,2
R-HSA-201722,R-HSA-201722,Formation of the beta-catenin:TCF transactivating complex,1/379,69/8183,0.962602426478464,0.985976878335557,0.702351950538487,H3F3A,1
R-HSA-1630316,R-HSA-1630316,Glycosaminoglycan metabolism,2/379,109/8183,0.965021866330298,0.986741890054517,0.702896899902719,HEXB/SLC35B2,2
R-HSA-1296071,R-HSA-1296071,Potassium Channels,1/379,71/8183,0.966014674713504,0.986741890054517,0.702896899902719,GNG5,1
R-HSA-446193,R-HSA-446193,Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein,1/379,72/8183,0.967602499945701,0.986741890054517,0.702896899902719,NEU1,1
R-HSA-5619102,R-HSA-5619102,SLC transporter disorders,1/379,72/8183,0.967602499945701,0.986741890054517,0.702896899902719,SEC13,1
R-HSA-187037,R-HSA-187037,Signaling by NTRK1 (TRKA),1/379,73/8183,0.9691163271582,0.987200825030527,0.703223818193252,RHOA,1
R-HSA-1912408,R-HSA-1912408,Pre-NOTCH Transcription and Translation,1/379,74/8183,0.970559596209623,0.987586957546634,0.703498876292294,H3F3A,1
R-HSA-3214815,R-HSA-3214815,HDACs deacetylate histones,1/379,75/8183,0.971935587458428,0.987903861074941,0.703724619731242,HIST3H2A,1
R-HSA-1474244,R-HSA-1474244,Extracellular matrix organization,5/379,216/8183,0.974826616720891,0.989480191434592,0.704847504787799,TIMP1/PPIB/BSG/NCSTN/CTSL,5
R-HSA-5633007,R-HSA-5633007,Regulation of TP53 Activity,3/379,153/8183,0.975618938752857,0.989480191434592,0.704847504787799,RPS27A/UBA52/UBB,3
R-HSA-3781865,R-HSA-3781865,Diseases of glycosylation,2/379,124/8183,0.98100190047249,0.993320540559936,0.707583143683802,HEXB/NEU1,2
R-HSA-69473,R-HSA-69473,G2/M DNA damage checkpoint,1/379,85/8183,0.982616655424591,0.993320540559936,0.707583143683802,UBE2N,1
R-HSA-8876198,R-HSA-8876198,RAB GEFs exchange GTP for GDP on RABs,1/379,85/8183,0.982616655424591,0.993320540559936,0.707583143683802,RAB7A,1
R-HSA-166520,R-HSA-166520,Signaling by NTRKs,1/379,90/8183,0.986321976695497,0.994898689536327,0.708707324215986,RHOA,1
R-HSA-1912422,R-HSA-1912422,Pre-NOTCH Expression and Processing,1/379,90/8183,0.986321976695497,0.994898689536327,0.708707324215986,H3F3A,1
R-HSA-1500620,R-HSA-1500620,Meiosis,1/379,94/8183,0.98871015727437,0.99622478387689,0.709651955846968,H3F3A,1
R-HSA-112316,R-HSA-112316,Neuronal System,7/379,314/8183,0.991979081595138,0.997378103172551,0.71047351269551,GNG5/GRIA2/COMT/CALM3/GRIK2/CALM2/TUBA1B,7
R-HSA-1989781,R-HSA-1989781,PPARA activates gene expression,1/379,105/8183,0.993342708472015,0.997378103172551,0.71047351269551,FDFT1,1
R-HSA-400206,R-HSA-400206,Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha),1/379,107/8183,0.993952778587328,0.997378103172551,0.71047351269551,FDFT1,1
R-HSA-9007101,R-HSA-9007101,Rab regulation of trafficking,1/379,116/8183,0.99607728222996,0.997378103172551,0.71047351269551,RAB7A,1
R-HSA-388396,R-HSA-388396,GPCR downstream signalling,11/379,461/8183,0.996385797131294,0.997378103172551,0.71047351269551,TAC3/GRP/RBP1/GNG5/RHOA/REEP5/CALM3/GHRL/GNRH2/RAMP1/CALM2,11
R-HSA-194840,R-HSA-194840,Rho GTPase cycle,1/379,123/8183,0.997199468109228,0.997378103172551,0.71047351269551,RHOA,1
R-HSA-418594,R-HSA-418594,G alpha (i) signalling events,4/379,248/8183,0.997378103172551,0.997378103172551,0.71047351269551,RBP1/GNG5/CALM3/CALM2,4
